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This study is an examination of the purpose, development and
technique of the diagnosis of diabetes mellitus,
In recent years the definition of this disorder has relied heavily
on the results of diagnostic tests, especially the glucose tolerance
test (GTT) in one of its forms, the use of such a test individuals
may be graded into diabetics, non-diabetics and a substantial inter¬
mediate group often called diabetic "suspects". There is no obvious
dividing line between these three groups and any precise divisions
are therefore arbitrary.
It Is here shown that the "suspect" group is not an artefact
caused entirely by temporary physiological variables or by vagaries
in the tests themselves, but is rightly so named, many of its members
sooner or later developing clinical diabetes,
Evidence is presented from the literature to show that prompt
and adequate treatment of early diabetes - even sometimes when still
at the "suspect" stage - can prevent, delay or ameliorate many of
the histopathological accompaniments of the disease. In spite of
some contrary opinions on this matter it would seem, therefore, that
precise and early diagnosis is both desirable and important.
The development of the GTT is traced and variations in its
technique and interpretation are discussed. Of the different types
•fee intravenous GTT is subject to least physiological variability
and is capable of the most accurate interpretation. At the present
time it is thought that glucose disposal during an intravenous GTT
is best expressed by assuming a simple exponential relationship
between blood glucose and the time after glucose injection, at least
during part of the test. Shis relationship is represented by a
straight line fitted to blood glucose points plotted against time on
semilogarlthmlo graph paper. The slope of suoh a line is termed the
"k" value and represents the rate of fall of blood glucose if a simple
exponential relationship obtains. 3y a method of mathematical analysis
this assumption is shown to be roughly correct and adequate for
practical purposes but it is suggested that a more complex relationship
probably exists, even during that part of the test when cell metabolism
is tie chief factor in gluoose disposal. If this relationship could
be determined it might provide a more accurate guide to tie actual
efficiency of glucose metabolism.
Xt Is shown, on both theoretical and practical grounds, that
the use of "total" blood glucose (i.e. the observed level) is to be
preferred to "excess" blood gluoose (i.e. tie difference between the
observed and tie original fasting level) in the calculation of "k".
Suggestions are also made for the use of a simpler intravenous
GTT involving the oollection of blood samples only at the 20th, 40th
and 60th minutes after gluoose injection instead of tie more frequent
samples usually taken. Allowing for all the minor physiological and
technical variables to which the test is subject it is claimed that
the results of the simpler test are within acceptable confidence
limits*
Using the simpler test a number of known diabetics and non-
diabetics have been studied to show the ranges of "k" values for
each group* The diabetic and non-diabetic ranges overlap to some
extent and possible explanations for this overlap are discussed*
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Explanation of Terms* Blood sugar and Blood glucose
It is difficult to maintain both clarity and accuracy with these
terms when referring1 extensively to the work of other authors* Although
the key reducing substance contained in the blood of diabetic subjects
was recognised as glucose long ago (Chevreul 1815) glucose-specific
estimation techniques have only reoently been developed as routine
laboratory procedures, (Seller 1956),
Earlier non-specific methods for blood sugar estimation (still
widely used) measure, in addition to glucose, a number of other reducing
substanoes collectively termed "saeoharoids" by Benedict (1931), The
quantity of saocharoids estimated by these methods differs according to
the particular method used and varies from individual to Individual or
even in the same individual at different times. Moreover their blood
level is not in a constant ratio to that of glueose.
However, in spite of the inherent inaccuracies of such methods
it remains true that glucose forms the bulk of blood reducing
substanoes and that fluctuations in the level of blood reducing
substances mainly reflects fluctuations in the level of blood glucose.
Certainly massy earlier writers have used the term, "blood sugar", as
•> if it were equivalent to "blood glueose". In the majority of practical
situations the distinction is of little importance although in the
discussion of exact biochemical processes the terms used must likewise
be exact.
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With these considerations in mind, therefore, those terms are
used in this thesis as followst-
Blood gluoose - Glucose specifically
Blood sugar * Gluoose plus (varying amounts of) saccharoids.
When general statements are made combining the
views of two or more authors, one speaking of "blood
glucose" and another speaking of "blood sugar"
(as defined above) the term "blood sugar" is
used to cover both meanings*
Terms also usedt-
Hypo- or hyper-glycaemia - These refer to the level of blood sugar.
Glycosuria - Sugar in the urine
Gluoosuria - Gluoose in the urine
"Total" (see section on the Intravenous gluoose tolerance test)
- The observed level of blood sugar or blood
glucose
"Excess" (see IVGTT) - The difference between the observed level
of blood sugar or blood gluoose and the initial
fasting level (or some other level as explained
in detail in the text). This term is referred
to by some authors as the "increment".




Diabetes Mellitus is a disease which is ill understood but
frequently diagnosed. To the lay mind it still conjures up the image
of a serious and intractable illness. This attitude is, however,
changing with the advent of modern drug therapy and the increasing
appreciation that diabetic-like biochemical disturbances may be mild
or transient and in many cases - especially when the onset is in later
life - quite compatible with a normal life spaa.
So frequently do diabetic-like biochemical disturbances occur,
in fact, and in such a wide variety of clinical states that diabetes has
come to be regarded by many observers more as a symptom than a disease.
With this trend has been the inclination in some ciroles to regard the
diabetic tendency - particularly if revealed only by some specialized
diagnostic procedure - as of relatively small importance. As a
result older concepts of the disorder have come under scrutiny, the
object being not only to establish more precisely the fundamental
nature of the disease itself but also to discover the long term
aspects regarding prognosis and treatment.
The diagnosis of diabetes is closely connected with both these
matters. Developments in diagnostic techniques have paralleled
advances in knowledge of the underlying disorder and - more so
perhaps than with any other disease - form the basis for its
definition. Also the whole rationale of diagnosis - the purpose and
usefulness of it in the frequently diagnosed sub-clinical forms of
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diabetes at least - rests heavily on the outcome of long term studies
ourrently in progress. Can diagnosis at the stage before clinical
onset make any difference to the eventual outcome? Does early treat¬
ment help?
The purpose of the present study is to examine some of these
points. More especially, the mathematical and practical aspects of
the intravenous glucose tolerance test (iVGTT) aire discussed in
detail in order to determinei-
1. The correct form of exponential relationship between the
blood glucose and the time after glucose injection which most closely
represents the fall of blood glucose during an IVGTT;
2. The most appropriate section of the IVGTT blood glucose
curve to be used as an index of the efficiency of carbohydrate metabolism;
5. A simpler test of comparable accuracy to the usual IVGTT
procedure using only a few selected blood glucose readings and
4. The range of normality and abnormality for the IVGTT to be




Hp to fairly recent years the term "diabetes" stood for a speoifio
disease entity with definite signs and symptoms* As such it was known
to the ancient world, both in the East (Bose 1907) and the West.
Aretaeus the Cappadocian, in the early part of the second century A.D.,
describes it as "a melting down of the flesh and limbs into urine (with)
thirst unquenchable, disproportionate to the amount of urine, nausea
and restlessness and (the patient will) at no great time expire"*
(Adams 1856). The disorder was , however, ill understood and the same
writer observes that "if anyone is bitten by the dipsos (a type of
viper) the infection induced by the wound is (also) of this nature."
This symptomatic approach to diabetes was maintained until the present
century* Then, with increasing comprehension of the biochemical
disturbances involved, tine emphasis shifted away from the merely
clinical and a later definition speaks of diabetes as "a chronic
hereditary disease, characterised by an increase of glucose in the
blood, and the excretion of glucose in the urine." (joslin 1959a)*
While, however, this description is adequate for a florid
example of the disease it is unsatisfactory on at least three counts j-
(l) Such a definition excludes many individuals who, in spite
of raised blood glucose levels and markedly reduced glucose tolerance,
have no glycosuria, (it should be noted here that very small quantities -
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1-15 mg;. per 100 ml - of glucose ace almost invariably detectable in
the urine even in normal subjects (Bernard and Ginsberg 196p» Pine 1965)*
Throughout this study, therefore, unless contrary indication is given,
O ~t SM-^O-V
the term "glycosuria" refers to increased quantities of glucose/in the
urine, such as are capable of detection by simple routine side-room
methods, e.g. using Benedict's solution or "olinitest" tablets, that is,
a minimum of about 50 mg. per 100 ml.)
(2) It fails altogether to take account of the specific histological
changes which occur, it seems, sooner or later in all diabetics, some¬
times even at a stage when the biochemical disturbance is so slight
that it has to be sought for by special tests.
(5) It has been increasingly recognised that although in the
majority of diabetics no obvious primary cause exists, apparently
identical biochemical disturbances - and occasionally even histological
abnormalities (Lawrence 1948* Becker 1952) - may occur as temporary
phenomena in a great variety of aetiologically unrelated conditions,
all of which constitute some form of stress to the individual concerned.
Whether these states of temporary metabolic disturbance should be
called diabetes is debatable but many do, in fact, progress to florid
diabetes if allowed to persist unchecked.
In the light of these objections older views of a clear cut
disease entity have been replaced by the concept of a much more ill-
defined disorder, possibly representing the final common pathway of a
number of different pathological processes. In an attempt at
comprehensiveness Crombie (1964) refers to diabetes as a syndrome
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comprising a constellation of abnormalities, biochemical and histological,
of as yet unknown aetiology and arising in the course of a number of
different conditions.
However, some more detailed mention must be made of the particular
biochemical and histological changes to be expected, Lozner et al. (1941)
offered their definition of diabetes in two parts, (a) metabolically - a
state of subnormal maximum attainable carbohydrate metabolism and (b)
clinically - by the known signs and symptoms,
Lundbaek (1962) also gives a double definition* Diabetes mellitus -
a chronic disease with reduced glucose tolerance in patients not
suffering from disease of the pancreas or from acromegaly, Gushing's
disease or phaeochromocytoma. Diabetic aberration - any other condition
with transitory or permanent reduction of glucose tolerance.
Presenting features of diabetes
None of these definitions is entirely satisfactory. In practice
the two main aspects of the disease are (a) the biochemical disturbance,
manifested most strikingly and conveniently by a diminished metabolic
ability to handle carbohydrate and (b) various histo-pathological
abnormalities characterised particularly by a specific micro-angiopathy.
Certainly, definite symptoms and signs (the criteria for the majority
of specific diseases) are only found in the minority of diabetics
(Sharp et al. 1964).
Now although the typical biochemical disturbance of diabetes is
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often present in overt or latent form without any apparent specific
histological changes, the reverse is quite exceptional. Several
examples of "diabetic" lesions occurring in allegedly non-diabetic
individuals have been reported in the literature (Newburger and Peters,
1939» Siegal and Allen 1941, Horn and Smetana 1942, Laipply et al. 1944»
Sana and Zubroid 1954)• Examination of these papers shows, however,
that diabetes has usually been excluded chiefly or entirely on negative
grounds and often retrospectively at autopsy in subjects where diabetes
had not been suspected nor looked for oarefully during life. Bell (1950)
states that in his two examples diabetes was "definitely excluded" but
no clinical details are given to support this claim.
The best documented report is by Moore and Frew (1965) who published
their detailed histological findings in the amputated legs of 52
subjects suffering from extensive peripheral vascular disease. All
had normal OTT's, In three cases, however, there was typical "diabetic"
microangiopathy in the skin and subcutaneous tissues. Apart from these,
certain pre-diabetics - that is, persons in the months or years preceding
the development of impaired glucose tolerance - sometimes show diabetic¬
like changes in the capillaries of the ear lobe and renal glomeruli but
these are said to be somewhat different from true diabetic micro¬
angiopathy (Camerini-Davalos et al, 1965)#
If, therefore, we would seek a common denominator in all diabetics,
the almost invariable biochemical disturbance is clearly more
satisfactory than either histological changes or clinical symptoms.
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There are many altered biochemical processes in diabetes which are
currently under investigation and new diagnostic tests may well emerge
before long. For over a hundred years, however, diminished metabolic
ability to handle carbohydrate has been the most convenient test and is
still the technique usually employed.
Arbitrary standards
Descriptions of the salient features of diabetes may be found in
any standard textbook of medicine and are sufficient definition for the
clear out case. In those individuals, however, where the diagnosis is
less obvious, some form of gluoose tolerance test has come to be the
cardinal diagnostic tool and by implication the results of such a test
provide the most important definitive boundary mark between diabetes and
normality. On the basis of glucose tolerance tests many workers have
proposed standards to be used as criteria of normality or abnormality
(Exton and Rose 1934» Mosenthal and Barry 1950» Moyer and Womack 1950,
Fitzgerald and Keen 1964, WHO Expert Committee 1965» Sisk 1966).
However, as seen later,there is no self-evident dividing line between
these two groups and with any form of gluoose tolerance test so far
devised an unbroken range of results is possible in a given population
from the obviously normal to the definitely abnormal (Mitchell and
Strauss 1964* Sharp et al. 1964). Inevitably, therefore, any criteria
will be more or less arbitrary.
In this study it has been necessary to use the oral glucose
tolerance test (OGTT) to standardise the normal range for a series of
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intravenous glucose tolerance tests (IVGTT). There is little to choose
"between the various criteria suggested by different authors for a normal
OGTT and so the limits set out on p. 88 have been adopted. These are
manifestly arbitrary standards and it must not be assumed, therefore,
that figures only slightly in excess of those given necessarily imply
a diagnosis of diabetes. Furthermore, (whatever the actual blood glucose
or blood sugar levels decided upon), in view of the three quite distinct
criteria used, (that is, fasting, peak and two-hour blood glucose/blood
sugar levels), the interpretation of and definite diagnosis by an OGTT
will inevitably remain in doubt in a large number of oases, One
incidental purpose of the present study, therefore, is to show that the
IVGTT is more satisfactory both for diagnosis and for definition.
Grades of diabetes
There remains the question of classifying the severity of the
disease in diabetic subjects. Early investigators in this field
graded diabetics according to the maximum amount of carbohydrate
tolerated before glycosuria resulted. This was abandoned when it was
realised that results were materially influenced by the protein and fat
content of the diet. Subsequently diabetics were variously subdivided
into mild, moderate or severe according to their insulin requirements,
degree of glycosuria, maximum blood sugar or time taken by the blood
sugar to regain fasting levels following a standard glucose load,
(Wiahnofsky 1928, Joslin 1959b) or by assaying serum insulin levels,
(Bornstein and Lawrence 1951), All these methods also broke down
because of the influence of diet and other factors in treatment# In
fact, Joslin (1959b) has stated that " a diabetic may be mild, moderate
or severe, largely as the doctor with his diet, insulin and exercise,
makes hlra#" At the present time a common clinical differentiation is
as followsI-
(a) Mild diabetes • Adequate control (that is, blood sugar not
exceeding 200»220 mg per 100 ml at any time of the day) with diet
alone or diet and oral antidiabetic drugs#
(b) Moderately severe diabetes - Adequate control possible only
with the aid of insulin but not liable to ketosis#
(c) Severe diabetes - As for "b" but with a liability to ketoais.
In many ways these distinctions are no less arbitrary than the
definition of diabetes itself# They are, however, practicable and of
useful therapeutic application. As such, therefore, they are retained




Over the years changing estimates of the incidence of diabetes
reflect alterations in current views regarding its nature and definition,
They also closely parallel developments in the techniques of diagnosis.
In 1875 Bouchardat said that "among 20 men between the ages of 40 and
60 years belonging to legislative assemblies, in noted learned societies,
occupying high positions in commerce and finance and even in the army,
one is sure to find a glycosuria", (quoted by Joslin and Krall 1959)•
In spite of this prediction, since shown to be substantially correct
as far as Western Europe and North America is concerned, diabetes
itself was relatively infrequently recognised up to about 1900, Even
then diagnosis was usually only made when the disorder presented in
severe form. This period may be termed the clinical phase of diabetes
and at that time the gross incidence of the disease was put at about
O,!# (Sharp et al, 1964)•
The next fifty years was the "biochemical" phase when a variety
of different diagnostic techniques were introduced. Rather surprisingly
(for the investigators at that time) marked impairment of glucose
tolerance was found in many individuals without florid signs or symptoms
of diabetes. During this period diabetes was assessed on the basis of
mortality rates (De Porte 1929» Marks 1946,) or insurance statistics
(Barringer 1909)* and several studies were made in such groups as army
reoruits (B1otrier 1946), factory workers (Gates 1942), volunteers
in house to house diabetic "drives'* (Beardwood 1944» Sharkey et al.
1950) or consecutive hospital in-patients (Scott and Griffith 1957»
Cosnett 1959)# Each of these groups was, of course, specially selected
in some way and therefore gave a false impression of diabetic incidence.
However, on the basis of this work the frequency of diabetes was re¬
assessed variously at between 0,35$ (Marks 1946) and 1.85$ (Barringer 1909).
The first full scale whole population survey was in 1946 at Oxford,
Massachusetts (Vilkerson and Krall 1947)* 70.6$ of the total population
of 4983 were screened for glycosuria and raised 1-2 hour post prandial
blood sugar levels. In addition to 40 individuals already known to have
diabetes, 30 new diabetics were discovered — a total incidence of 1.4$.
This was the beginning of the "population survey" phase in diabetic
diagnosis. Many similar studies have since been undertaken - over a
hundred such in the U.S.A. and Canada alone (Krall 1959)* Table I
lists the principal details from ten of the better documented surveys
carried out in Britain and North America. It will be seen that with
this type of screening technique the frequency of diabetes seems fairly
uniform at about 1.2$ - 1.4$.
This estimate does not necessarily apply to other areas. Even by
the beginning of the present century great variation had been noted among
different religious classes in India (Charles 1907) and more recently
population surveys similar to those above have been carried out in a
number of different racial groups in other countries (Mills 1930,









No. f 'p I No. I p
Total
Wilkerson and Krall 1947 Oxford,
Massachusetts
4,983 70.6 183 5.21 78 1.56 40 0.80 30 0.60 1.40
Kenny et al. 1951 Ontario 3,5021 81 92 2.62 63 1.80 28 0.75 16 0.50 1.25
Kenny and Chute 1953 Ontario 10,1861 54 96 1.44 95 1.40 52 0.75 35 0.50 1.27




OCM 105 5.27 62 3.11 9 0.45 19 0.95 1.40
College of &.P.*s
Working Party
1962 Birmingham 19,412 95.5 612 3.30 416 2.25 119 O.64 127 0.69 1.33
Harkness 1962 Halstead,
Essex
6,132 95.3 186 3.03 • 38 0.62 35 0.57 1.14
Stewart and Robertson 1963 Forfar, Angus 10,758 85.4 302 3.60 161 1.75 54 0.59 34 0.37 0.96
Mitchell and Strauss 1964 Arbroath,
Angus
17,0001 66.7 436 3.85 218 1.94 1355 OCM. - - 1.20
Sharp et al. 1964 Bedford 65,000^ 66 1046 4.10 2615 1.02 - «■» 2615 1.02 _6
Walker and Brown 1964 Ibstock, 5,4061 81 200 4.84 99 2.40 33 0.80 25 0.60 1.40
Table I. Details of ten diabetic detection surreys. Notes } * Figures are tor % of those tested,
1 Persons over 5 years of age,
2 Constructed random sample,
3 Total known and new diabetics,
4 Persons over 21 years of age,
5 Abnormal test = 2 hour blood sugar (after
50 grams of glucose) >120 mg/100 ml,
6 Known diabetics excluded, therefore total not given.
Cohen 1954* Cosnett 1959* Krall 1959* Rudwiok and Anderson 1962,
Campbell 1963* Davidson 1963, (Jelfland and Forbes 1963* Sloan 1963,
Poon-King et al. 1963)* From these surveys the incidence of diabetes
has been shown to vary widely from as little as 0.03$ in Eskimos
(Soott and Griffith 1957) up to 4*9$ in pure Hawaian stock (Sloan 1963)
and efforts have been made to relate the different incidence to such
things as climate (Hills 1930) or dietary habits (Bimaworth 1955b).
Asymptomatic diabetes
The above figures include not only those individuals with obvious
symptoms and signs of diabetes, (not all of whom, however, will have
reported them), but many others with none. As the diagnosis in the
latter group usually rests entirely on the results of a glucose tolerance
test (GTT) such persons are often referred to as "GTT diabetics". They
form a substantial proportion of the total number.
The harder that diabetes is looked for the more commonly it will
be found - ohiefly by increasing the proportion of GTT diabetios. Thus
it has been shown that a glucose oxidase urine testing strip ("clinistix")
for detecting glycosuria will reveal twice as many positive reactors
as would be found by "olinitest" tablets (Redhead i960, The College of
General Practitioners* Working Party 1963)* It is also clear that fifty
grams of glucose by mouth is a severer test of the efficiency of carbo¬
hydrate metabolism than an ordinary large meal (Kenny and Chute 1953*
The College of General Practitioners* Working Party 1962, Keen 1962,
Mitchell and Strauss 1964* Sharp et al, I964) and will reveal a
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correspondingly greater number of GTT diabetics.
The College of General Practitioners* Working Party (1962)
performed standard fifty gram OGTT*s on a random sample of a large
population who had not shown glycosuria following the largest meal of
the day. They found that as many as 15$ now had glycosuria and many
also had abnormal OGTT*s. Combining these results with those obtained
by -toe initial screening these workers arrived at an estimate of 6.2$
for the total incidenoe of diabetio abnormality in the general population*
Using rather less strict criteria, Mitchell and Strauss (1964) found
diabetic abnormalities of the glucose tolerance test in as many as
12$ of the general population and Sharp et al. (1964) also gave an
estimate of 12 - 14$ on the basis of a similar survey.
Even -this has not contented some workers who feel like Best
(1934) that standard OGTT*s put too little strain on carbohydrate
metabolism. Techniques such as the one-hour, two-dose test (Exton
and BOse 1934) and the corticotrophin or cortisone GTT (Berger 1952,
Pajana and Conn 1954)# have therefore been designed to increase the
strain and discover still more diabetics. These procedures will be
discussed in a later section.
Diabetic suspects
Any screening test will, of course, reveal not only those
individuals with clear cut diabetes but many others with lesser
abnormalities of carbohydrate metabolism such as "lag storage" (high
peak blood sugar in an OGTT with normal fasting and two hour values),
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normal fasting and one hour but slightly higher than normal two hour
blood sugar levels and a number of other minor variants, "Renal
glycosuria" (glycosuria occuring even at normal blood sugar levels
and after an ovemi^it fast) is also sometimes included in this category#
Members of this intermediate or indeterminate group are often referred
to as diabetic "suspects"# They are of great interest and aire the
subject of several long term follow up surveys (Marble et al, 1939»
Wilkerson et al# 1959t Sharp et al# 1964# Walker and Brown 1964)*
Even among those individuals olassed as normal, however, refined
diagnostic procedures indicate that there are grades of normality#
Thus, gluoose tolerance is significantly worse in persons with a family
history of diabetes, but no evidence of diabetes themselves, than in
those with no such family history and is worse in close relatives
(e.g. identical twins) of diabetics than in those more distantly
related (e.g. uncles or aunts), (Taton et al# 1964)*
Or again, glucose tolerance may be appreciably poorer (though
Still within acceptably normal limits) in obese persons than in thin
persons (Vajda et al. 1964) and, depending not so much on the degree
as on the duration of the obesity, gluoose tolerance may show a
gradual diminution from normal through the suspect range to frank
abnormality (Allison 1927, Ogilvie 1935).
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Diabetogenic factors
Obesity is, of course, oy no means the only condition associated
with an increased incidence of diabetic aberrations, that is, diabetic¬
like abnormalities of glucose tolerance. Table II lists some of the
other conditions associated with reduced glucose tolerance,
©lis catalogue oertainly does not exhaust the possibilities.
Indeed, old age itself is frequently assooiated with reduotion in
glucose tolerance, as noted originally by Spence (1921) and since
confirmed by many other workers (Hale-White and Payne 1926, Allibone
and Tunbridge 1939, Joslin 1940, Hoffstetter et al, 1945# Horvath
et al. 1947# Wilkerson and Krall 1947# Bedhead i960, The College of
General Practitioners* Working Party 1963)# The incidence of reduced
glucose tolerance appears to increase steadily with increasing age
(Keen 1962, The College of General Practitioners* Working Party 1963)#
and is not merely a result of inactivity, decreased carbohydrate intake
or poor intestinal absorption (Smith and Shock 1949# Schneeberg and
Pinestone 1952), The College of General Practitioners* Working Party
(1965) found the incidence of florid or GTT diabetes was 14.5$ la
those over 50 years of age and Sharp et al, (1964) found that glucose
tolerance was at least slightly abnormal in nearly 50$ of persons over
the age of 70 years - though even on direct questioning only about 3$
in fact admitted to any symptoms referable to their deranged carbo¬
hydrate metabolism.
If, therefore, diabetic abnormalities occur so frequently and in
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Condition Reference
Thyroid overactivity Hamman and Hirschman 1917, John 1932, Althausen 1940, Crawford 1940, Root and Bradley 1959.
Thyroid underactivity Crawford 1940, Scow and Cornfield 1954*
Pituitary overactivity Ilamman and Kirschman 1917, Houssay 1937, Root and Bradley 1959, Young 1961, Luft 1965.
Adrenal overactivity Hamraan and Hirschman 1917, Houssay 1937, Sprague et al. 1943, Simpson 1953, Root and Bradley 1959,
Fhaeochromocytoma Freedman et al. 1958, Root and Bradley 1959.
Gout Weiss et al. 1957*
Alcoholism Bowman et al. 1939.
Uraemia Perkoff et al. 1958.
Metabolic acidosis Mackler et al. 1952, Amatuzio et al. 1953.
Poor nutritional states Hofmeister 1889, Goldblatt 1925, Blotner 1934, Conn 1940.
Poor antecedent diet (especially if low Bernard 1877, Southwood 1923, Sweeney 1927, Tolstoi 1929, Dann and Chambers 1930, Himsworth
in carbohydrate) 1934a and b, 1935a and b, Chambers 1938, MeCullagh and Johnston 1938, Allibone and
Tunbridge 1939, Conn 1940, Wayburn and Grey 1942, Silverstone et al. 1957.
Fever or Infection Hamman and Hirschman 1917, Sweeney and Lackey 1928, Ross and Tonks 1938, Tunbridge and
Allibone 1940, Freeman et al, 1944, Paul and Presley 1958.
Liver disease Himsworth 1933, Ross and Tonks 1938, Soskin 1944, Amatuzio et al, 1953, Megyesi et al. 1967.
Inactivity or Bed rest Loeb and Stadler 1914, Blotner 1945,
Table II. Conditions associated with reduced glucose tolerance.
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Condition Reference
Disseminated sclerosis Henneman et al. 1954b.
Psychosis Lawrence and Buckley 1927* Henneman et al. 1954a.
Fear or Excitement Charles 1907, Folin et al. 1914, Hale-White and Payne 1926, Ross and Tonks 1958,
Hinkle et al. 1950.
Drugs - Corticosteroids Sprague et al. 1943* Ingle 1950, Fajans and Conn 1954 and 1961, Volk et al. 1955,
Conn 1958, Dunlop et al. 1959a.
- Sedatives or Hypnotics Macleod and Pierce 1915, Ross and Tonks 1938, Hunter and Greenberg 1954, Merrivale
and Hunter 1954*
- Benzothiadiazine diuretics Lancet 1965, Breckenridge et al. 1967*
myocardial infarction Vallance-Owen and Ashton 1963.
Poor blood supply to large muscle masses Cajori et al. 1925, Loughlin et al. 1943*
Trauma Howard 1955, Ross et al. 1966.
Paget's disease Moehlig and Abbott 1947*
Neoplasia Rohdenberg et al. 1919, Lozner et al. 1941, Marks and Bishop 1957«
Pregnancy Lund and Weese 1953, Jackson 1955 and 1959, Hagen 1961, O'Sullivan 1961.
Especially with :
(a) increasing parity Lund and Weese 1953, Wilkerson et al. 1959, Fitzgerald et al, 1961.
(b) big babies or foetal abnormalities Wilkerson et al. 1959, Fitzgerald et al, 1961.
Table II (continued). Conditions associated with reduced glucose tolerance.
so many conditions we are in some difficulty regarding our definition
and there is considerable justification for Keen*s (1962) remark that*
"We are all diabetics, some of us more than others#® Does a definition
which includes so many individuals within its scope mean anything?
Should all those so included be treated alike as suffering from a serious
or potentially serious disease? Is any useful purpose achieved by
making the diagnosis at all in the majority of oases? Perhaps we should
abandon the term "diabetes" altogether now and refer simply to benign
and malignant hyperglycaemia (Butterfield 1962)?
The main purpose of a definition is to provide an adequate basis
for diagnosis and therapy# While, therefore, in the case of diabetes
it must clearly be recognised that all definitions at the present
time are arbitrary and provisional, the criteria suggested in the first
(PP ~r,8 i ?■ 88)
section/have at least the merit of convenient diagnostic applicability#
Dy itself, of course, this is not enough and it remains to be seen
whether they also form a satisfactory guide to therapy, For this reason,
therefore, before passing to the description and discussion of the main




I. How suspicious should one be of the so-called
diabetic "suspects"? What proportion of them do,
in fact. develop clinical diabetes?
Definitions
The term "diabetic suspect" is used to describe at least three
different groups of individuals. A World Health Organisation Expert
Committee (1965) has proposed names and definitions for two of these
groups as follows f—
Potential diabetics 1. The identical twin of a diabetic;
2. A person with both parents diabetic;
5. A person with one diabetic parent whose
other non-diabetic parent has or had a diabetic parent, sibling
or offspring or a sibling with a diabetic child;
4. A woman who has given birth to a live
or stillborn child weighing 4.5 kg or moire at birth or to a
stillborn child showing hyperplasia of the pancreatic islets
not due to rhesus incompatibility.
Latent diabetics 1. A person in whom the GTT has produced
a normal result but who is known to have been diabetic according
to the GTT at some time during pregnancy, during infection, when
under some other stress or when obese.
2, A person who has abnormal blood-glucose
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responses (similar to those found in diabetes mellitus) to
provocative tests, such as the cortisone-augmented Off.
The third group of suspects may be said to manifest "spontaneous"
diabetic aberrations, fhat is, they are found on testing to have
unexplained glycosuria or other minor abnormalities of glucose
tolerance not marked enough to bring them within the arbitrary
definition of diabetes proper. They are otherwise in good health
and do not belong to either of the first two groups.
POTENTIAL DIABETICS
With the recognition of diabetes as at least partly genetically
determined (Pincus and White 1955» Ponteva 1959* Blotner 1946,
Steinberg 1959» White 1959&# Nilsson 1962, Taton et al. 1964# The College
of General Practitioners' Working Party 1965)# interest has centred
increasingly on those persons with a strong family history of the
disease in whom, evidently, there is a greatly increased risk of
diabetes. Thus, Joslin et al, (1957) found that out of 15 pairs of
identical twins, one each of whom had diabetes, the second twin also
had diabetes in nine oases, compared with only two such examples in
the non-identical twins of 16 other diabetics.
Berg (1959) traced the identical twins of 46 established diabetics
and found that 50 of them also had diabetes, compared with 18 diabetic
non-identical twins of 80 further diabetics.
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White (1959a) also reports comparable figures of 16 diabetic
"pairs" cut of 33 sets of identical twins, one each of whom had
diabetes, as against two diabetic "pairs" in 63 sets of non-identical
twins.
As the relationship to a diabetic becomes more distant the
chance of developing diabetes becomes less, although still higher
than a comparable group of normal controls (Joslin et al# 1937* White
1959a, Wilkerson et al. 1959, Pfeiffer and Ziegler 1965, Cooke et al.
1966, Hunter and McKay 1967) end this close correlation between nearness
of relationship to a diabetic and reduction in glucose tolerance may
be seen even among those individuals within the range of normal
(assessed by a standard GTT), (Taton et al. 1964, Ityke and Taylor 1967,
Taylor et al, 1967)#
In women of child bearing age there is an inoreased tendency to
foetal abnormality, perinatal mortality or other obstetric accidents
in individuals who subsequently develop diabetes or who are at the
time of pregnancy diabetic suspects for any reason (Miller et al. 1944,
Miller 1946, Barns and Morgans 1946, Paton 194Q, Patterson and Burnstein
1949, Moss and Mulholland 1951, Cosnett 1959, White 1959c, Jackson i960)
although some have denied this (Dolger and Herzstein 1944)*
LATENT DIABETICS
1. Stress situations
Many of the stresses referred to in this group are relatively
short lived - for example, subarachnoid haemorrage, myocardial infarction,
burns or acute infections - and diabetic aberrations are similarly
transient although occasionally a permanent diabetic state may first
become apparent at such a time (Hinkle et al. 1950, Roe 1965, Peters
and Hales 1965)# No long term studies in these individuals appear to
have been undertaken and there is therefore no evidence as yet that
these patients are more likely to develop clinical diabetes than the
general population. Where, however, the stimulus for the diabetic
aberration is such that it can act for prolonged periods or repeatedly
there is good evidence that diabetes can and often does result. Such
a sequence is seen in acromegaly (Hamman and Hirsohman 1917, Houssay
1957* Root and Bradley 1959, Young 1961, Luft 1965), pregnancy (Joslin
et al, 1956, Lund and Weese 1955, Pyke 1956, Cosnett 1959, Wilkerson
et al, 1959, 0*Sullivan 1961, Wildberger and Ricketts 1965)* hyper-
adrenocorticism (Hamman and Hirsohman 1917, Sprague et al. 1945*
Simpson 1955# Root and Bradley 1959) and obesity (joslin et al, 1955#
Ogilvie 1955, Cosnett 1959# Wilkerson et al, 1959). Hirasvorth (1955b)
Vallance-Owen and Lilley (1961) and 0,Sullivan and Mahan (1965) have,
however, suggested that obesity is a result rather than a cause of
diabetes. Likewise, Jackson and Woolf (1957) and Jackson (1959# I960)
while agreeing that glucose tolerance is reduced during at least the
first trimester of pregnancy deny that permanent diabetes is
produced as a result. Hyperthyroidism is also said to precipitate the
onset of diabetes (Shpiner 1950, John 1952, Dunlop et al, 1959<*»
Root and Bradley 1959) Lut others (Althausen 1940, Simpson 1956) doubt
if a true diabetic state exists more commonly in thyrotoxic than in
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euthyroid subjects,
Undoubtedly, some of this group of suspects will develop florid
diabetes. In practice, however, such patients present comparatively
little problem, in that there is usually an obvious cause for their
biochemical disturbance. If this cause is recognised and corrected
early enough the onset of clinical diabetes may be considerably delayed
or even prevented altogether.
2. "Provocative1* glucose tolerance tests
Studies have been made in diabetic suspects by means of "provoc¬
ative" GTT's such as the ACTS or cortisone GTT (Berger 1952, Fajans
and Conn 1954, Duncan 1956b). These studies have usually been in
women suspect on account of pregnancy glycosuria, a history of
obstetric accidents or large babies (Jackson and Woolf 1957) or
individuals with a strong family history of diabetes (Fajans and
Conn 1954» Duncan 1956b, Wilason 1962, Medley 1965). Although some
workers have not found these tests satisfactory (Jackson I960, West
I960, Nilsson 1962), others report a much higher incidence of abnormal
results in diabetic suspects than in matched controls (Berger 1952,
Duncan 1956b, Pajans and Conn 1959» Goto et al, I960). These findings
were interpreted as showing that frank diabetes is "nearer the surface"
in such individuals and more likely to manifest itself spontaneously
t
or following some naturally occu^lng stress than in normal people.
Follow up studies, however, have not so far been long enough to prove
this point.
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SPONTANEOUSLY OCCURRING DIABETIC ABERRATIONS
With regard to the prognosis in the third group of suspects opinion
is even more divided, Lawrence (1928) stated that renal glycosuria
is "entirely different from true diabetes it is not progressive
and requires no treatment," and this is echoed by Marble (1959b),
Smelo*s (1956) view is that there is no evidence that minor abnormal¬
ities in the glucose tolerance curve ever deteriorate to become
frankly diabetic and similar doubts have been expressed by others (The
College of General Practitioners* Working Party 1962),
Survey follow up
Nevertheless while diabetes may develop only rarely in true
renal glycosuria there is a mounting body of evidence that such a
progression does, in fact, take place fairly frequently in other
forms of non-diabetic glycosuria. On general grounds it would seem
likely that reduced glucose tolerance occurring spontaneously is more
suspicious than that which follows some obvious precipitating event.
Marble et al, (1939) followed (for up to 35 years) 1946 patients
presenting with glycosuria in whom diabetes had originally been
excluded. They found that 193 (9*9f°) subsequently developed the
disease and all except one of these (a case of pregnancy glycosuria)
had had minor abnormalities of the GTT in addition to glycosuria when
first seen. They found that the higher the blood sugar levels were
initially the greater was the risk of subsequent diabetes.
Wilkerson and Krall (1947) in their large scale survey followed
the progress of three broad groups classified respectively as normal,
suspect and diabetic on the basis of standard OGTT*s. After 16 years
they found that of 84 original suspects still living in the area, 24
had become florid diabetics compared with 171 originally normal persons,
of whom only 5 had become diabetic. These authors also found that
the higher the blood sugar in the original OGTT the more likely the
suspect was to develop diabetes. No mention is made by these authors
of any suspects who reverted to normal during the same time. Out of
17 "unclassified" glycosurics (that is, those with glycosuria but
without an abnormal OGTT), 4 developed diabetes after 4 years
(Wilkerson et al. 1962).
McCullagh et al, (1954) made a retrospective study of 200 out-*
patients who had not been diagnosed as diabetic at the time of their
initial visit but who had had elevated blood sugar levels without
glyoosuria. They estimated that these patients were twice as likely to
develop diabetes as individuals with normal initial blood sugar levels.
Ackerman et al. (1958) also examined 31 individuals three months to
twenty-two years after an initial diagnosis of non-diabetic glycosuria.
They found 4 with florid diabetes and 17 others with GTT diabetes*
Walker and Brown (1964) in a five-year follow up of their
population survey found that of 32 suspects still available, 7 (22$)
had become frankly diabetic, 10 remained suspect, 8 had persistent
glycosuria but now had a normal result to an OGTT and ^ were quite
normal. This oompared with 21 individuals (0.7$) out of the original
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control group of 2957 who also developed diabetes daring the same
interval# Of 61 persons who showed glycosuria but had a normal OGTT
originally, one developed diabetes and 10 more were now graded suspects#
OTHER BIOCHEMICAL ABERRATIONS
Finally, an important recent advance in the investigation of this
problem is the discovery of the occurrence of certain phenomena
associated with the diabetic state in many diabetic suspects from any
of the above three groups# These phenomena are manifold and include the
following i-
Baised fasting levels of non-esterified fatty acids (Hales et al# 1965,
Pfeiffer and Ziegler 1965)#
Increased insulin-like activity (Jackson and Keller 1962, Csmerini-
Davalos et al, 1963, Pfeiffer and Ziegler 1965).
Increased immunologically measurable insulin (Hales et al# 1965,
Pfeiffer and Ziegler 1965)#
A sluggish rise of insulin-like activity in the serum following a
glucose load (Srodsky et al# 1965, Pfeiffer and Ziegler 1965).
An increased fraction of not fully active bound insulin, both before
and after glucose, with a normal rise in the free insulin fraction
(Camerini-Davalos et al# 1963, Pfeiffer and Ziegler 1965)#
A lower than normal fall in blood sugar following intravenous
tolbutamide (Jackson and Keller 1962)#
Raised serum levels of human growth hormone, with resistance to toe
diabetogenic effects of exogenous human growth hormone (Pfeiffer and
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Ziegler 1965).
Increased insulin antagonism by certain serum albumen fractions or
other serum factors (Vallance-Owen and Lilley 1961, Stimmler and
Elliott 1964).
Increased urinary albumen excretion (Keen and Chlouverakis 1964)*
Early microangiopathy in the capillaries of the ear lobe and renal
glomeruli (Csmerini-Davalos et al, 1963# Pfeiffer and Ziegler 1965).
Studies in juvenile pre-diabetics during the years just before
the onset of the disease (that is, when they were 3till diabetic
suspects, usually for genetic reasons) have shown that they have an
increased adolescent growth spurt, bone development and sexual maturity,
raised levels of serum follicle-stimulating hormone and urinary 17-
ketosteroids, not infrequent hypoglycaemia and a diabetic vascular
pattern in the bulbar conjunctivae (White 1959b)#
None of the phenomena referred to are absolutely specific for
diabetes - indeed, if they were the individuals displaying them would
no longer be merely "suspect**, they would be diabetic# The micro¬
angiopathy seen in these oases is said to be still within the range of
physiologioal variation (Camerini-Davalos et al. 1963) and has been
described in normal controls (Moore and Frew 1963)# Similar alterations
in non-esterified fatty acid levels to those mentioned above may also
be seen in thyrotoxic patients (Hales and Hyams 1964) or even normal
subjects (Hales et al, 1965)# Nevertheless, the evidence provided by
these observations strongly supports the belief that diabetic suspects -
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of whatever group - have a m^uxlU likelihood of developing
florid diabetes than do a comparable group of normal subjects,
II* What is the purpose of early and accurate diagnosis
in subjects with a diabetic tendency? la any real
benefit conferred by the discovery and treatment of
the large number of mild and GOT diabetics or diabetic
suspects now known to exist?
This question may be approached from three aspects.
SYMPTOMS
Bapid correction of the biochemical disturbance in a severe
diabetic brings about such obvious improvement that supporting refer¬
ences are unnecessary, Much less widely appreciatedt however, is the
fact that many individuals found during routine investigation to have
diabetes - often only in mild form - have symptoms, sometimes of long
standing and hitherto unrecognised both by themselves and their medical
attendants (Andrews 1957t Ellenberg 1958, The College of General
Practitioners* Working Party 1962, Mitchell and Strauss 1964)• Kenny
et al, (1951) reported that as many as 17 of the 21 diabetics discovered
in their survey had at least one symptom of diabetes and Reid (i960)
states that 48$ of the newly discovered diabetics in his series had
had symptoms for more than four months and 20$ for more than a year.
Mild though these symptoms often are, they are alleviated by appropriate
treatment and patients feel better for it. In addition, of course,
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control can now be adequately supervised, minor ailments such as obesity,
pruritus or paraesthesia may be attended to, the risks of dangerous
ketosis or (in women of childbearing age) obstetric accidents are
substantially reduced and, probably, the expectation of life is increased.
BIOCHEMISTRY
1. Diet
The effect of diet on glucose tolerance has been known since at
least the time of Claude Bernard (1877) who noted that after a severe
reduction in the proportion of dietary carbohydrate glycosuria might
occur following a glucose load. This observation has been amply
verified by other workers (Southwood 1925, Sweeney 1927$ Tolstoi 1929$
Darn and Chambers 1930$ Himsworth 1955a, Conn 1940).
Hamman and Hirschman (1919) observed the complementary effect,
that is, that glucose loads repeated at short intervals gave
progressively less hyperglycaemia. Himsworth (1933$ 1934a and b, 1955 a)
oonfirmed these findings, not only in respect of repeated doses of
glucose but with regard to the carbohydrate content of the diet as a
whole. Ellis (1934) applied these observations clinically and reported
dramatio improvement in eight severe diabetics (judged by insulin
requirements, blood sugar levels and ketosis) with repeated large doses
of glucose and insulin. Himsworth (1935b) extended his earlier
assertion by suggesting that the development of diabetes itself depended
largely on the nature of the antecedent diet. He maintained that,
provided the total calorie intake was not too large, persons eating
proportionally more carbohydrate were less lively to develop diabetes
than those taking diets relatively rich in fat. Figures for the dietary-
habits and mortality rates from diabetes among various racial groups
were published to support this .'argument. Although not abandoning this
idea himself, (Himsworth 1949)# it does not seem to have been followed
up by others. Some, indeed, have categorically denied that the
proportion of dietary carbohydrate and fat has any bearing at all on -fee
development of diabetes (joslin et al, 1934# Poulsen 1941)« trend
has rather been in the opposite direction and correction of obesity#
especially by reduction in the carbohydrate component of the diet,
has been shown to be followed by improved glucose tolerance and reduced
glycosuria, blood sugar levels, insulin requirements and diabetic mortality
(Allen 1914* Newburgh and Conn 1939# Himsworth 1949# Fraser 1965)* Karaa
et al, (1965) and Rudnick and Taylor (1965) also showed an improvement
in the serum insulin response to glucose loads after reduction to normal
weights of diabetic and non-diabetic individuals.
Similar benefits have been shown to result from strict dieting
even without weight loss, Watson (1942) gave 45 subjects with minimal
to severe reduction of glucose tolerance a low calorie, fat restricted
diet. After up to nine years on this regime and in many cases without




Haist et al. (1940) showed (in cats) that injected insulin
protected the pancreatic islet cells from exhaustion and ultimate
degeneration produced by excess pituitary growth hormone. These
findings were confirmed by Lukens and Dohan (1940) who concluded that
insulin may prevent, restore or hinder the development of islet cell
degeneration and functional (that is, overt) diabetes. Fhjans and Conn
(i960) and Fhear (1962) showed that in younger patients with mild or
asymptomatic diabetes, glucose tolerance is improved by administration
of sulphonylurea drugs and Grodsky et al. (1963) reported that in non-
diabetic overweight subjects insulin secretion in response to glucose
was restored to normal by diguanide compounds.
Baker et al. (1955) found that while the cijfi lipoprotein ratio
was higher than normal in diabetics generally it was more so in
diabetics with evidence of atheroma than in those without. Poor
diabetic control in younger patients and the presence of obesity in
older patients appeared to be the chief factors associated with this
altered ratio.
Sehrade et al, (1963) also reported that in young, well
controlled diabetics serum non-esterified fatty acids and triglyceride
levels were raised but cholesterol and phospholipids were normal. In
older arteriosclerotic or young, poorly controlled diabetics all four
fractions were increased. This compared with arteriosclerotic non-
diabetics, in whom similar changes were found, except for normal or
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depressed levels of non-esterified fatty acids.
One possible interpretation of these findings is that good
control in the younger diabetic may prevent or delay the rise of
cholesterol and phospholipid serum fractions which appear to be related
to arteriosclerotic vascular lesions.
HISTOPaTHOLOGY
On the subjects of the preceding two sections there is a general
measure of agreement among workers in this field and controversy centres
chiefly around this third element of the diabetic state. The overall
increase in the death rate and decrease in the expectation of life for
diabetics of all ages compared with the general population has been
amply documented (Beardwood 1944, Joslin 1959c, Wilkerson et al. 1962) ,
Whereas ketosis was by far the greatest single factor responsible for
this in the pre-insulin era (Warren and Le Compte 1959), mortality
and morbidity now occur chiefly as a result of lesions of the cardio¬
vascular system, especially in relation to the coronary, renal,retinal or
peripheral limb vessels and hypertension (Clawson and Bell 1949# Hardin
et al, 1956# Bryfogle and Bradley 1957# Cosnett 1959# Warren and Le
Compte 1959, Wilkerson et al. 1959)# although Panthania and Sachar
(1961) reported no increase in mortality from cardiovascular disease
in their series of Indian diabetics. The other major complications are
various forms of peripheral neuropathy (Collens et al, 1952, Keen 1959#
Root 1959# Lawrence and Locke 1961, Skillman et al, 1961) and an
increased incidence of obstetric accidents and perinatal deaths in
diabetic pregnancy (Miller et al* 1344» Vilkeraon and Hemein 1357#
Farquhar 1959)*
At least one of these features is seen in nearly all diabetics at
some stage of their illness and there is increasing evidence that they
are not so much "complications" as originally thought but intrinsic
parts of the disease process* She discovery of identical vascular
(Camerini-Davalos et al* 1965# Keen et al. 1965# Pfeiffer and Ziegler
1965) and neurological (Ellenberg 1958# Skillman et al* 196I)
abnormalities in diabetics before or very soon after their biochemical
disturbance is first apparent has strengthened this view* As a result
several workers have reasoned that because these changes are apparently
not the result of long standing bioohemioal upset, biochemical control
does not and cannot play any part in their prevention.
Ems, diabetic control (assessed usually by blood sugar levels,
glycosuria and strictness of adherence to a diet) and/or severity of
diabetes (assessed by insulin requirements and the presence or absence
of ketosis) is said to bear no relation to the incidence of cardio¬
vascular disease generally (Mirsky 1945, Dolger 1947# Downie and Martin
1959# Markman et al* 1959# Schlesinger et al* I960, Panthania and Sachar
1961)# retinopathy (Dolger 1947# Downie and Martin 1959# Schlesinger
et al* I960, Knowles et al, 1965)# renal lesions (Goodof 1945, Downie
and Martin 1959) or neuropathy (Collens et al* 1952)* In the light of
these reports doubts have been cast on the wisdom or necessity for
55
large scale diabetic detection surveys. For example, Ashton (1965) has
stated that the only treatable lethal complication of diabetes is ketosis
and it is unnecessary to mount a detection drive to discover this.
Also, in view of the greatly increased incidence of reduced glucose
tolerance in the elderly, Sharp et al, (1964) hint that perhaps diabetes
is just one more manifestation of the normal ageing process and wonder
if the young diabetic is merely "one older than his years with respect
to his blood sugar." Even the College of General Practitioners1
Working Party (1962) seems to look upon early diagnosis in the course
of a survey as mainly of research interest, fraught with grave risk
to the psyche of the newly discovered "suspect".
Against this nihilistlo attitude may be set the views of Joslin
and his co-workers at the Joslin clinic (Wilkerson and Krall 1947*
Joslin 1959o) es well as others from the British Isles (Lawrence 1951*
Scott 1951# Bunlop et al. 1959b). In 1944 Beardwood noted that the
overall mortality rate was lower in diabetics who were well controlled
than in those with poor control. More detailed studies have since been
made with respect to cardiovascular disease generally (Jackson et al.
1950, Keiding et al, 1952, Dunlop 1954)# retinopathy (Jackson et al.
1950, Spoont et al, 1951, Keiding et al, 1952, Hardin et al. 1956, Paul
and Presley 1958* Markman et al. 1959) hypertension (Jackson et al, 1950*
Dunlop 1954, Paul and Presley 1958), nephropathy (Jackson et al. 1950*
Wilson et al. 1951a, Keiding et al. 1952, Diuilop 1954* Lambie and
McFarlaae 1955, Paul and Presley 1958* Johnsson i960) and neuropathy
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(Dunlop 1954# Ellenburg 1958* Markman et al. 1959) to show that there
Is a significant reduction of these features in well controlled diabetics*
Other workers have shown that even though the incidence of these
"complications'* is more closely related to the duration of the diabetes,
yet their severity is greatly influenced by the strictness of control
(Wilson et al. 1951b* Johnsson i960, Collyer and Hazlitt 1961),
These conflicting views are difficult to reconcile. There is
increasing evidence that diabetic "complications" and clinical control
are not directly related but are both caused by common antecedent
metabolic disturbances, probably genetioally determined. Thus, both
Keen et al. (1965) and Pirart (1965) found a close correlation between
blood sugar levels and the incidence of diabetic "complications" in
the groups studied. Bloom (1967), on the other hand, found in his
series no relation between the average blood sugar in a particular
individual and the strictness of his adherence to a treatment regimen.
Combining these observations, therefore, it would seem that even the
strictest treatment cannot materially influence the development of
"complications". It is possible that this view may one day be
established as correct but in view of the evidence cited above it
must at present still be regarded as unproven. Its co/rollary • that
it is futile to diagnose and treat the asymptomatic diabetic - must
also at present be rejected.
As regards the problem of the pregnant diabetic, however, there
seems to be no dissent from the general opinion that good control
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reduces the incidence of obstetric accidents (mainly toxaemia of
pregnancy and hydramnios) and the perinatal death rate (Pederson
1954* Wilkerson and Hemein 1957* Carrington and Shuman 1958# Farquhar
1959# White 1959o# Dolger et al. 1962, Jackson et al. 1962)* Further¬
more this is not only true for established diabetics* Similar beneficial
results have followed active treatment even of those women with
suspected prediabetes (because of their family or previous obstetric
history) or who showed minimal abnormalities of glucose tolerance
during early pregnancy (Wilkerson and Remain 1957» Carrington and
Shuman 1958# Jackson 1959# Wilkerson 1959)*
To summarise* therefore#-
1* The diagnosis of diabetes is important not only for those
with florid symptoms and signs but also in the case of diabetic
"suspects", many of whom do, in fact, develop frank diabetes later*
2* There is evidence that appropriate treatment does prevent,
delay or ameliorate all the major manifestations of the disease and
therefore the earlier the diagnosis is made the more likely treatment
is to be beneficial*
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DIAGNOSTIC TESTS
The Oral glucose Tolerance Test
Some early approaches to the diagnosis of diabetes have already
been mentioned# At first the disease was chiefly recognised on clinical
grounds alone (Adams 1856). Hindu writings dating from about the 6th
century A.D. tell of the presence of an unnatural sweetness in the urine
of diabetics (Bose 1907* Barach 1949) and. possibly this fact was known
even earlier to Chinese and Japanese physicians (Barach 1949)* It was
rediscovered in the Western world by Thomas Willis who also noted the
sweetness of diabetic urine and claimed that diabetes was a disease
primarily producing increased amounts of sugar in the blood which
subsequently overflowed into the urine (Willis 1689)* Dobson (1776)
verified that the blood in diabetes is sweet and demonstrated ferment¬
able sugar in the urine, finally Chevreul (1815) identified the sugar
as grape sugar or glucose,
For some time after Chevreul*s discovery diagnosis still
depended largely on clinical features but glycosuria was increasingly
used as an additional criterion* "Alimentary glycosuria" was the name
applied to the glycosuria whioh followed the oral administration of
glpcose or other carbohydrate foods and the investigations into this
phenomenon provided the forerunners to present day OGTT's. The
earliest published account of such experiments appears to be that of
Worm Muller (1884) who found little or no glucose in the urine of two
59
normal men following the ingestion of 50 grams of glucose or 100 grams
of lactose* The following year he reported considerable glucosuria
after similar carbohydrate loads in three mild diabetics (Worm
Mailer 1885).
As a result of experimental work with dogs Hoftoeister (1889)
proposed the term "tolerance" to represent the largest dose of sugar
which could be ingested without producing glycosuria. He expressed his
results in grams of sugar per kilogram body weight*
Measurement of glycosuria continues to be used to assess the
degree of diabetic control but it was soon realised that it was too
imprecise by itself to give much information regarding glucose tolerance*
There was poor correlation between blood glucose levels and urine
glucose concentration (Hopkins 1915* Williams and Humphreys 1919)
because of wide variations of renal threshold even in normal subjects
(Allen and Vishart 1920, Campbell et al. 1952* Butterfield et al, 196?).
Furthermore when glycosuria followed a carbohydrate load its appearance
was often delayed until after the time of peak blood sugar levels and
disappeared only when the blood sugar had fallen considerably (Hammaa
and Hirschxaan 1917* Robinson et al. 1955).
The Introduction of Bang*s new micromethod for blood glucose
determination (Bang 1911* Hopkins 1915) allowed more precise
observations to be made on alterations in blood glucose levels
following a gluoose load and the first reported glucose tolerance test
of the type used today was by Jacobsen (1915). He measured the rise
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and fall of blood glucose in "normal" subjects (althou^i judging from
his case reports several of his patients were far from normal) follow¬
ing the ingestion of various types of food. Numerous other papers
quickly followed reporting "toe blood sugar curve in a variety of
diseases. Prominent among these was that by Hamman and Hirschman
(1917) who gave fasting subjects 100 grams of glucose in 300 ml of
water flavoured with lemon. Samples for blood sugar estimation were
taken fasting and at J, 1, 1$ and 2 hours after the glucose and urine
was collected as far as possible simultaneously with the blood.
Blood sugar curves obtained by this technique in normal subjects
showed a smooth, moderately rapid rise of blood sugar for the first
tj> to 1 hour, from fasting levels of below 120 mg per 100 ml to peak
figures of less than 180 mg per 100 ml, followed by an equally smooth
fall to fasting levels or just below in 1-3? to 2 hours. In the diabetic,
on the other hand, not only were the fasting and peak levels usually
raised above normal but the time taken to reach the peak and return to
the fasting value was prolonged, sometimes considerably,
PHYSIOLOGICAL VARIABLES
There were many factors, however, other than diabetes itself
which were capable of producing abnormal gluoose tolerance curves and
it soon became apparent that repeated tolerance tests often gave
inconsistent results. These anomalies might be the result of
concomitant disease (see p, 17 and 18) or might even, apparently,
occur spontaneously (Gray 1923, Lennox and Bellinger 1927# Soisalo 1929#
41
Glassberg 1930, Mayers and McKean 1935* Freeman et al. 1942, Horvath
et al. 1947. Uhger 1957).
Gastrointestinal tract absorption. One obvious variable was the
rate of glucose absorption from the gastrointestinal tract. Many-
early workers appear to have assumed not only that glucose absorption
was constant for different individuals but also that it proceeded at
a uniform rate regardless of the concentration or the total quantity
administered (Janney and Isaacson 1918). Cori (1925) gave his subjects
glucose in concentrations varying from 25$ to 80$ and appeared to
confirm this view by finding that there was a linear relationship
between the amount of glucose absorbed and the time after ingestion.
Even when as much as 70$ of the original quantity of glucose had been
absorbed the absorption rate, he claimed, was unaltered* Varren et al,
(1940) also described experiments to show that variations in the
concentration of glucose made little difference to the rate of
absorption because the rapid dilution of solutions in the stomach soon
eliminated initial concentration differences.
Gastric emptying However, by simultaneously measuring gastric
emptying^ intestinal transit and absorption of test substances, other
workers have shown that glucose absorption is influenced by the
concentration of glucose and also that Increasing the concentration of
glucose has a marked effect on the rate of absorption, chiefly by
delaying gastric emptying (Maokay and Bergman 1955* Qttigley and Phelps
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1934» Fenton 1945* Reynell and Spray 1956b)#
Fenton (1945) demonstrated that there was little or no glucose
absorption from the stomach but his experiments were criticised as
being grossly unphysiological by Reynell and Spray (1956a) who showed
that glucose absorption did take place in the stomach although the
absorptive capacity was soon saturated. These findings were confirmed
by Warren et al, (1940) who demonstrated, however, that absorption
from the upper small intestine was better# If, however, high
concentrations of glucose inhibited gastric emptying, the intestinal
load of glucose would not increase proportionally# Therefore the
intestinal absorption rate would increase less in proportion to a
larger load, although absorption would go on for longer#
The effect of disordered gastric emptying on the glucose
tolerance test may also be seen after stomach operations such as partial
gastrectomy or gastro-enterostoray where emptying is very rapid (McKean
et al# 1935* Myers and McKean 1935* Evenson 1942, Gilbert and Dunlop
1947, Zollinger and Hoerr 1947)• In these circumstances blood sugar
curves characteristically rise very rapidly to a peak figure often
exceeding 200 mg per 100 ml even in non-diabetics and fall again
equally rapidly, sometimes to severe bypoglyeaemic levels# On the
other hand, if the subject is nauseated (perhaps from the strong
glucose solution) or excited, gastric emptying may be delayed and the
slow absorption will produce flat blood sugar curves (Hale-White and
Payne 1926)# Bisell (1957) also found that the supine position during
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the test or insufflation of intragastric CO^ or Og increased glucose
tolerance (that is, produced flatter blood sugar curves), presumably
also by delaying gastric emptying. Paradoxically, in pyloric stenosis,
where gastric emptying is also slow, prolonged hyperglycaemia in non-
diabetics has been observed (Meyers and McKean 1955)#
Intestinal mucosa. More important even than variations in gastric
emptying time in determining the rate of absorption is the state of
the intestinal muoosa. Diminished absorption and flat blood sugar
curves in steatorrhoea were first demonstrated by Thaysen and Norgaard
(1929)« These workers also performed IVGTT's in their patients and
found diabetic-like curves, but because of the normal rise in the
respiratory quotient during these tests, concluded that the fault
lay with the endocrine glands conoerned with glucose metabolism rather
than with intestinal absorption itself. Other workers, however, have
shown that absorption is affected in conditions causing steatorrhoea
(pairley 1936, Groen 1938* Ross and Tonka 1938, Lozner et al. 1941#
Prazer et al, 1952, Taylor and Wightman 1952), although the efficiency
of absorption is not closely correlated with the clinical state
(Taylor and Wightman 1952). Poor glucose absorption may lead to
systemic carbohydrate deprivation and diabetic-like blood sugar curves
during an IVGTT, Moreover, if the two opposite processes - poor
absorption leading to flat GTT curves and carbohydrate deprivation
leading to diabetic curves - are nicely adjusted in a particular
individual, OGTT's may even give an entirely normal curve (Ross and
Tonka 1958).
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Ir s tsatorrhoea associated vith the cceliac syndrome definite
histological changes are present in the small intestinal mucosa, but
other unrelated disorders may also produce functional mucosal disturbance
and absorptive defects* Groen (1958) found reduced absorption in such
differing conditions as pernicious anaemia, pellagra, ulcerative colitis
and tuberculous enteritis and A1thansen (1940) reported diabetic or "lag-
storage" blood sugar curves in thyrotoxicosis and flat curves in
myxoedema. These were shown to be partly because of disordered gastric
and intestinal motility and partly as a result of functional alterations
in the intestinal mucosa.
VARIATIONS OF TECHNIQUE
Even if there was agreement on the physiological principles
involved, there are numerous differences of opinion regarding the
technique, method of calculation and interpretation of these tests.
Diet. The importanoe of an adequate carbohydrate intake for a few
days at least before a GTT has already been pointed out (p.17). It is
not entirely clear, however, what constitutes an "adequate" diet. Conn
(1940) proposed an intake of at le&3t 500 grams of carbohydrate for
five days before a test and this practice is still frequently adopted
(Nnger 1957). Other workers, on the other hand, have shown that a diet
containing as little as 150 grams (Marble 1959a, Wilkerson et al. i960),
125 grams (Mosenthal and Barry 1950), or even 100 grams (Irving and
Wang 1954) of carbohydrate is adequate preparation. Indeed,
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Dann and Chambers (1930) report that even after three weeks fast,
diabetic-like blood sugar curves in normal subjects could be corrected
completely by four further days on a diet containing as little as 50
grams of glucose daily.
As to the remainder of the diet, Jacobsen and Edwards (1920)
showed that the proportion of protein and fat made little difference
to gluoose tolerance, but Du Vigneaud and Karr (1925) and Srinivasen
(1957) reported that a good protein intake before a test improved
glucose tolerance, while a high proportion of fat decreased it.
Activity. Comesatti (1907)» In experimental animals and Devlin (1965),
in humans, have both shown improved gluoose tolerance after a period
of training. Prolonged inactivity is associated with reduced tolerance
(Loeb and Stadler 1914» Blotner 1945)* During a GTT it is customary to
keep the subject at rest.
Pre-teat fast. It is usual to perform a GTT after an overnight fast
but four hours (Hale-White and Payne 1926) or five hours (McLean and
De Wesselow 1921) are probably sufficient in most oases. Penton
(1945) reported delay in gastric emptying and distortion of the blood
sugar curve if the pre-test fast was prolonged beyond 48 hours,
Dos® of test substance, Myers and McLean (1955) described satisfactory
GTT results following a variety of carbohydrate foods, including potatoes,
oatmeal and bread, but the usual test substance is dextrose. In the
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United States this is commonly given in a dose of 100 grams (Hopkins
1915, Vilkerson and Krall 1947, Marble 1959a), while in the British
Isles the dose is more often 50 grams (Hale-White and Payne 1926,
Walker 1953, The College of General Practitioners* Working Party
1962, Sharp et al. 19&4), Hagedorn (1921) and Hale-White and Payne
(1926) claimed that the peak rise observed in a GTT varied directly
with the dose of glucose and some workers therefore adjust the dose
according to the subject*3 weight (Janney and Isaacson 1918), Others
have shown that there is no need for this unless, perhaps, the subject
is grossly over or underweight. Increasing doses of glucose evidently
have very little effect on the peak height of GTT curves, although
they may delay the return to fasting levels (McLean and De Wesselow 1921,
Gray 1925, Howe and Rogers 1927)•
Blood sugar estimation. Results obtained in apparently comparable
groups of subjects may vary considerably according to whether the
blood is venous or capillary and whether "blood sugar" (i.e, glucose +
saocharoids - see p, xiv) or "blood glucose" alone is measured,
Mosenthal and Barry (1946) found that differences of up to 70 mg.
per 100 ml might exist between "blood sugar" (as defined above) and true
glucose. During the preliminary stages of the present study both
methods were used and similar differences were also observed.
Moreover, such differences were not a constant proportion of the




Until fairly recently no settled standards of normality existed
either for the type of subject studied (see some of the "normal"
subjects reported by Jacobsen (1913)) or for blood sugar levels
(Gray 1925) and this fact contributed largely to the anomalous, even
bizarre conclusions among earlier workers. Of the three salient
features of an OGTT curve, viz, fasting blood sugar, peak level and
time taken to return to normal fasting levels, the fasting blood
sugar has been shown to be quite unreliable as an indication of
mild diabetes, although it will commonly be raised in a severe case
(Prethem 1965, Mitchell and Strauss 1964* see also the appendix to the
present study). As to the remaining two features argument still
exists but the time taken to return to the fasting level is normally
considered more important (Wishnofsky 1928, Moyer and Womack 1950,
Marble 1959a)• Standards of normality for blood sugar at various
points of the GTT have been agreed upon and have been referred to
elsewhere (p»7)« (Sae dUo p. 88)
©lis information has been turned to good account by several
workers who have tried to simplify the testing of glucose tolerance by
estimations of the blood sugar at a single point after a glucose load
instead of the usual repeated measurements. Random blood sugar
readings were, and still are, used extensively but because they depend
on the interval since the last meal they may be misleading, Pedersen
and Nissen (1959) suggested averaging several blood sugar readings
over three of four days to eliminate the errors inherent in single
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random estimations but this seems even more inconvenient than a
standard QGTT.
Ralli and Shannon (1931) found good correlation between the
clinical severity of diabetes and the 4-hour blood sugar reading
during a 5-hour OGTT. Moyer and Woraaok (1950) compared 2 - 2& hour
post prandial blood sugars with the results of standard OGTT'a, 1-hour
2-dose tests (Exton and Hose 1934) and rVGTT#s done in the same
subjects and found that if a 2-hour post prandial blood sugar of
134 rag per 100 ml was regarded as the upper limit of normal, the
single blood sugar reading was effective in detecting the majority of
diabetics. Wilkerson and Krall (1947) in their diabetic survey
measured the blood sugar 1 - 1^ hours post prandial taking the upper
limit of normal as 190 mg per 100 ml (in capillary blood). A single
blood sugar reading (in this case, two hours after a main meal) was
also used by Stewart and Robertson (1963)♦ They took the upper limit
of normal as 1J0 mg per 100 ml (in venous blood). Mitchell and Strauss
(1964) did not agree with this plan, estimating that about 30/° of
diabetics would be missed if post prandial blood sugar and glycosuria
were the only screening procedures used. They recommended a blood
glucose reading exactly 2 hours after 50 grams of glucose by mouth as
being a more sure method, the upper limit of normal being taken as
115 rag per 100 ml (in venous blood). This procedure was adopted by
Sharp et al. (1964) in their very large diabetic detection drive.
Unfortunately notwithstanding all attempts at standardization,
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inconsistent results for successive 0^77*8 in the same individual
continue to be reported (Freeman et al. 1942, Horvath et al. 1947*
linger 1957) and constitute a real drawback to the use of the OGTT
as an accurate diagnostic technique*
The One-flour Two-Pose Test
Hamman and Hirschman (1919) showed that the effect of repeated
doses of sugar on the blood sugar in normal subjects was different
from that found in diabetics. This observation was applied by Exton
and Hose (1954) who proposed a new technique as an alternative to the
standard OGTT. In this, subjects were prepared in the same way as
before and given 50 grams of glucose by mouth, followed by a further
50 grams half an hour later* Blood sugar was estimated fasting and
at | and 1 hour* Urine samples were taken at the same intervals.
The rise of blood sugar during the first half hour was, of course,
the same as for a standard OGTT and was judged by the same criteria.
Exton and Eose*s full criteria of normality were as followsi»
1. Fasting blood sugar within normal limits (that is, less than
120 mg per 100* ml).
2, A ir hour rise less than 75 ®g per 100 ml.
5. A 1 hour figure of no more than 5 rag per 100 ml in excess of
the is- hour figure.
In their original series of diabetics all had a rise of the
1 hour blood sugar of more than 10 mg per 100 ml over the % hour level.
Results falling "between these two limits were classified as "suspect".
This test was claimed by its originators to have several
advantages over the standard OGTT, There were no discrepancies from
the results of OGTT*s in obvious cases and there was better differen¬
tiation in those with equivocal OGTT results. As it took less time
than a standard OGTT it was better for the patient, saving him time,
anxiety or boredom. No very concentrated glucose solutions (such as
those required by the loading dose of 100 grams of glucose commonly
given) were required. Finally it appeared that the necessity for
special preparatory dieting was largely eliminated.
These authors were supported in their conclusions by Kelly et al.
(1935)» Gould et al, (1937)* Matthews et al, (1939)* Way-burn and Gray
(1942) and Goldberg and Luft (1948), Gould et al, (1937) proposed
modifications of the criteria. They defined a diabetic result as one
showing at least two of the followingt-
1, Fasting blood sugar more than 120 mg per 100 ml,
2, A £ hour blood sugar more than 50 rag per 100 ml over the fasting
level,
3, A 1 hour blood sugar more than 30 mg per 100 al over the
£ hour level,
Matthews et al* (1939) further suggested that the single 1 hour blood
sugar reading was as good a criterion alone as the usual three readings*
In their series all subjects with a blood sugar at this point of less
than 158 mg per 100 ml were normal. All others were classed as
"presumptive" diabetios.
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©lis test, however, has not met with general approval* Sweeney
et al. (1957) found that the antecedent diet had at least as much
effect on the 1-hour 2-dose test as a standard OGTT, Leonards and
Free (1945) also largely discredited the test by finding that between
38 and 62 grams of glucose were still in the stomach at the end of one
hour and that there was no correlation between the amount of gastric
glucose at a given moment and the blood sugar, ©lis would imply that
the second dose of 50 grams of glucose had little or no influence on
the shape of the curve. Indeed, Warren et al, (1940) had previously
shown that the average maximum rate of glucose absorption from the
stomach and duodenum combined was in the region of 43 grams per hour,
Reports of comparative series have confirmed that the 1-hour 2-dose
test is less satisfactory than common alternative tests (Gould 1957*
Langner and Dewees 1942, Moyer and Womack 1950) and it is now seldom
used.
Cortisone Oral Glucose Tolerance Test
The 1-hour 2-dose OGTT of Exton and Rose (1954) was an attempt
to place a greater strain upon carbohydrate metabolism than is usually
done with a standard OGTT, The tendency of adrenocortical over¬
activity or therapeutic adrenocortical hormones to produce decreased
glucose tolerance or even frank diabetes has been known for some time
(Hamman and Hirschman 1917» Housssy 1957» Sprague et al, 1945» Dunlop
et al, 1959a) and Berger (1952) first conceived the idea of producing
temporary reduction in tolerance by means of an injection of 100 ag ACTH
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one hour "before a standard OGTT. In this way he hoped to produce a
critical 3train and discover those individuals with diminished reserve
functional capacity of the pancreatic islet beta cells* In other words,
to discover those whose metabolic efficiency with respect to carbohydrates
was reduced but appeared normal when faced only with the usual GGTT
glucose load# As predicted, he found a definite rise in the general
level of the GTT blood sugar curve in some non-diabetic siblings of known
diabetics.
In 1954 Fajans and Conn reported similar results in a comparable
group by means of oral cortisone instead of ACTH. The same authors have
since used the test extensively to study many individuals whom they
regard as potential diabetics, usually on genetic grounds.
Goto et al, (196Q), comparing the cortisone OGTT with a standard
OGTT, calculated indices of difference by taking the sum of -fee differences
in observed blood sugar levels for both tests at the fasting, 1,
and 2 hour points. They found the average "index" for non-diabetic
healthy volunteers was 15 compared with 189 in diabetics and 110 in those
with a strong family history of diabetes.
Jackson (i960) and West (i960) criticised the test because, they
claimed, a number of individuals who were almost certainly pre-diabetics
on genetic or obstetric grounds and even some mild diabetics gave a
normal response to the test, that is, showed no significant rise of
the blood sugar curve following cortisone.
However, Fajans and Conn (1961) continued to report good results.
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They found that of 57 individuals who seven years earlier had shown a
positive reaction to the test, 15 (26*) were now diabetic and 5 more
($fc) had probable diabetes. This compared with 71 subjects who had
had a negative test originally of whom only 2 (2.8*) had developed
diabetes. This test would appear to have real value in studying the
suspected pre-diabetic, A. few more years* experience may show more
conclusively how reliable it is in predicting the onset of clinical
diabetes,
Prolonged Fast
Prolonged carbohydrate deprivation will cause reduced tolerance
to sudden glucose loads in both diabetic and non-diabetic subjects
(see p»17), Southwood (1963) has suggested that a pre-GTT carbo¬
hydrate deprivation of 24 to 36 hours instead of the usual 12 hours
may be sufficient to impose a critical strain on an individual's
carbohydrate metabolism and produce diabetic abnormalities of the
blood glucose curve in a similar way to those produced by the cortisone
OGTT, This procedure has the merit of simplicity but it is in¬
convenient for the subject being tested, Southwood himself only
reports one case and no further accounts appear to have been published.
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The Intravenous Glucose Tolerance Test
HISTORY
At a very early stage in the development of GTT's investigators
explored the possibility of eliminating the errors due to inconsistent
gastrointestinal traot absorption by injecting glucose directly into
the blood stream# The earliest recorded experiment using this technique
(in rabbits) appears to be that of von Becker (1854* quoted by Ross and
Tonks 1958) and in fact antedates Worm Muller,s first OGTT by 50 years,
Blumenthal (1905) was one of the first to point out that glucose
tolerance should be related not merely to the maximum "assimilable?
quantity of glucose in a given subject but also to a time factor, He
expressed tolerance as the maximum amount of glucose capable of being
dealt with in unit time. In rabbits, for example, 0,85 grams of glucose
per kilogram body weight per hour was the average maximum which could be
given without producing glycosuria but the same quantity could often be
given repeatedly at short intervals also without glycosuria,
Woodyatt et al, (1915) - la rabbits, dogs and man - and Allen and
Wishart (1920) » in dogs «* repeated these experiments and found that
glucose tolerance was closely similar in these three species, -
approximately 0,8 - 0,9 grams per kilogram body weight per hour.
All these workers used glycosuria as the criterion of tolerance,
Thannhauser and Pfizer (1915) were the first to use the IVGTT clinically
in human subjects. They gave an infusion of up to 500 ml of 7$ glucose
over a period of 15 minutes and followed the resultant blood sugar changes.
Allen and Wishart (1920) and Thelheiraer et al, (1926) also
employed muoh the same technique, the former, however, using inter¬
mittent injections of glucose rather than a continuous infusion. Both
sets of authors reported a moderate rise of blood sugar at the start
of the infusion followed by a fall about one hour later. This fall
often continued to below the starting level even before the infusion
had been stopped,
Jorgenaen and Plum (1925) introduced the IVGTT as we know it
today. Their method was to inject 20 grams of glucose in 50 ml of
water over a period of 5 minutes. Blood sugar was estimated fasting,
at the end of the injection, every 2-5 minutes for 15 minutes and every
5-10 minutes for up to 2-5 hours. Blood sugar curves obtained in this
way in non-diabetic subjects rose rapidly to a peak within 1-2 minutes
of the end of the injection (Tunbridge and Allibone 1940* Greville
1945) end fell again to the fasting level or Just below over the next
45-^0 minutes. In diabetics the peak and the return to normal were
delayed but there did not seem to be a elose correlation between the
peak figures and fasting levels (Jorgensen and Plum 1925),
Although the IVGTT did not win immediate favour it gradually
became established and is now increasingly used. It has also remained
muoh the same as regards the actual test procedure. As with the 0GTT,
however, there has been considerable argument on matters of detail,
especially with respeot to the Interpretation of results.
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VARIABLES
Apart from the important factor of gastrointestinal absorption,
the same physiological variables exist for "toe IVGTT as for the OGTT
(see p,40).
Similarly, doubt has existed as to the optimum dose and strength
of glucose and the rate of infusion# Tunbridge and Allibone (1940)
reviewed the literature up to that time and quoted great variation
in these details* Different workers have given from J,5 to 100 grams
of glucose in strengths of from 7$ to 54$ over intervals of from 20
seoonds to 30 minutes#
The usual method of administration is by rapid injection of
concentrated glucose but slow infusion of weak solutions have
occasionally been suggested as being more physiological (Thelheimer
et al, 1926, Jokipi and Turpeinen 1934* HIad et al* 1956)#
Just as in the OGTT, many users of the IVGTT vary the dose of
glucose in direct proportion to the weight of the individual concerned
(McKean et al# 1935» Crawford 1938, Hamilton and Stein 1942)# On the
other hand, Nilsson (1962) suggests that instead of increasing the
glucose load for overweight subjects it should actually be proportion-
ally decreased* In these individuals the volume of extracellular fluid -
the volume into which injected glucose rapidly diffuses to become
available for metabolism and disposal - is relatively small (Posberg-
Petersen 1957)* However, Tunbridge and Allibone (1940) and Lozner et
al. (1941) found no features in IVGTT results in different individuals
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which could be attributed to differences in their weight and in common
with Jorgensen and Plum (192J), Boss and Tonks (1938), Araatuzio et al,
(1953)» Duncan (1956a) and Lundbaek (1962) recommended a constant dose
of glucose in all subjects tested. This is usually 25 grams in a
strength of 50$.
IHTEaPHETATION
Criteria for the interpretation of IVGTT results have been
subject to much discussion, Jorgensen and Plum (1923) plotted the
blood sugar levels obtained in their tests on linear graph paper and
expressed their results as the area below the curve plus the time
taken for the blood sugar to regain the fasting level.
Other criteria used since that time have been*-
(a) Area below the curve alone (Ross and Tonks 1938),
(b) Time taken for the blood sugar to return to the fasting level
(Crawford 1940, Tunbridge and Allibone 1940),
(c) Hood sugar at a certain predetermined time after injection
(McKean et al. 1935, Lozner et al. 1941),
(d) Height of peak blood sugar level and time of peak after
glucose injection (McKean et al, 1935)*
However, several workers have found great variation in peak
blood sugar levels in the same individuals with successive IVGTT's
when other parts of the curves have not varied and there is no
apparent correlation between this feature and the dose of administered
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glucose, the fasting blood sugar or the time taken to return to
normal (Jorgensen and Plum 1923» MoXean et al. 1935* Crawford 1938*
Turibridge and Allibone 1940)• Consequently any criterion based on the
peak blood sugar figure (all except "b" and ncw above) are fallacious.
Factors in glucose assimilation.
Unfortunately - and this drawback applies equally, of course, to
the OGTT - nobody knows precisely what is being measured in a GTT or
what exactly is involved in glucose disposal. Clearly several factors
play a part. If one plots the blood sugar curve for a normal IVGTT
on linear graph paper the curve is seen to drop very steeply at first
then gradually becomes less steep until it finally approximates to the
original fasting level or drops slightly below. The first rapid fall
is partly at least accounted for by rapid dispersal and equilibration
of the injected glucose throughout the body's extracellular fluid. A
certain proportion may be a result of urinary loss but in a non-
diabetic subject this is usually small - between 0 and 2.8 grams
following a 23 gram glucose load (Pijoan and Gibson 1938, Tunbridge
and Allibone 1940). Then probably follows true cell metabolism
of the glucose producing a rather slower fall. Finally, homeostatic
mechanisms, especially hepatic glycogenolysis - temporarily inhibited
by the sudden rise of blood glucose (Soskin et al. 1938* Searle and
Chaikoff 1952) - retard the fall progressively until a fairly steady
level is reached and maintained.
Mechanisms concerned with the third phase, especially normal liver
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function (Soakin et al. 1954. Lang et al. 1954)» undoubtedly play a
significant part in the final shape of a blood sugar curve but in
the diagnosis of diabetes it is the seoond phase - true metabolism -
with which we are chiefly concerned. Unfortunately the three phases
referred to are not mutually exclusive although one or other may be
predominant at a given moment, and precise sections of the blood
sugar curve cannot be assigned to each one. Assessment of glucose
disposal is therefore a crude estimation at best. In faot, gross
abnormalities of two opposite metabolic processes may on occasion
produce normal or near normal glucose tolerance curves, as was shown
by Houssay and Biasotti (1951) with hypophysectomised-pancreatectomised
dogs.
Exponential relationship.
In 1950 Pishberg demonstrated that the logarithm of the
concentration of certain non-fermentable reducing substances was
proportional to the time after their injection into the blood stream.
Hamilton and Stein (1942) applied these findings to their study of
glucose disposal. They found that although the disappearance of blood
sugar in an XVGTT was presumably caused by multiple factors they ell
seemed to work together (at least between about the 20th and 60th
minute after injection of gluoose) to produce, in effect, a mono-
molecular reaction. In other words the amount of sugar disappearing
from the blood during that period was constantly the same percentage
of the total quantity present* To put it another way, the rate of
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fall of blood sugar at any moment was proportional to the blood sugar
at that moment, or ff" = which on integration gives, log S « kt + C
(where S » blood sugar at any time, t, k and C are constants).
In the present context (for use in actual graphs) this general
formula was rewritten as, log S ® SQ - kt,
(where SQ » the intercept on the blood sugar scale of the slope
extrapolated back to t = 0,
k m a constant representing the slope),
A simple exponential relationship oould therefore be demonstrated
between observed blood sugar values and time - that is, a straight
line resulted if the blood sugar curve was plotted on semilogarithmio
graph paper.
Hamilton and Stein (1942) suggested that calculation of "k"
would provide a suitable expression of glucose assimilability for a
given individual. This "glucose assimilation coefficient" (to use a
phrase introduced later by Conard et al, 1955), may be defined as the
blood glucose decrease per unit of blood glucose per unit of time. It
may be multiplied by a hundred and expressed as a percentage. In
practical terms it represents the rate of fall of blood glucose. The
larger the value for k, therefore, the faster the fall and the more
efficient the body in disposing of glucose. Thus, normal subjects
would be expected to have high k values and diabetics low values,
Greville (1943) using all the blood sugar values in an IVGTT
between 5 and 90 minutes, claimed that the graph of log blood sugar
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against time did not produoe a straight line. Instead he related time
to the blood sugar value above a theoretical equilibrium level, S oa .
S eo was calculated as followsi- The curve of blood sugar
against time was plotted on linear graph paper (Fig. Ia), The slope
of this curve ( * ^ ) was then measured for various values of t (time)
and a second graph drawn of - ^ against blood sugar values Fig lb).
—?> I iihC
Figure la,, Figure lb.
Figure la.
Figure lb.
Graph of blood sugar vs. time.
Graph of blood sugar vs. - •
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The straight line graph of Pig lb is seen to pass not through
zero as might be expected if the fall of blood sugar depended on the
total quantity of blood sugar present, but through a certain positive
value of S* This represents Soo * It may be defined as the blood
sugar level to which the falling curve of blood sugar against time
(on linear graph paper) appears to approach asymptotically. It was
not the initial fasting blood sugar level (usually lying well below
it) and was not reproducible in repeated tests; neither was it the
physiological equilibrium level, as the blood sugar tended to rise
again after passing through this minimum point* Greville himself
seems to have regarded it as being of mathematical but not physio¬
logical importance. If, then, the fall of blood sugar was proportional
to the quantity of blood sugar in excess of S , the simple
exponential relationship described by Hamilton and Stein (1942)
had to be amended to give t-
log <S - S*, ) - log (So - S « ) - kt .
Amatuzio et al, (1955) using Greville,s formula assumed -that
for practical purposes S was equal to the fasting blood sugar and
related time to the blood sugar value in excess of the starting or
fasting level. These authors used the whole curve from 4 to 72 minutes
after the injection of glucose unless the blood sugar fell to within
30 mg per 100 ml of the fasting level.
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Continuous infusion,
Jokipl and Turpeinen (1954) returned to the earlier technique of
oontinuoue Intravenous infusion of glucose, claiming that this provided
a more physiological test. They administered 135 to 630 mg glucose over
a period of one hour and found that towards the end of this period, in
spite of continued glucose infusion, blood sugar levels reached a
plateau or even fell somewhat. In other words, at that stage glucose
administered equalled gluoose eliminated.
Graph of excess blood sugar and time for a
continuous slow infusion (after Jokipi and Turpeinen, 1954)*
Prom results obtained in this way these authors derived a
formula similar to the foregoing but including a factor, v,
representing the volume of gluoose distribution. Mow the rate of
change of gluoose oonoentration is -the rate of infusion ( f> ) divided
by the volume of distribution (v), or ^ » £ . Therefore if
glucose is simultaneously disappearing from the blood by a first
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order or monomolecular reaction (that is, at a rate depending on the
amount present) the net increase of blood glucose is expressed by
•j-SL m £* » ks. If the concentration of glucose in excess of the
fasting blood glucose is 0 at t « 0, this givesI
/° t. -kt \
s - ^ (1 - e ) .
HIad et al. (1936) also used a continuous infusion and compared
it with the single injection technique# Both were equally satisfactory.
They, like Jokipi and Turpeinen (1934), used the blood sugar excess
value and incorporated the factor "v** into their formulae. They showed
that v could be calculated by making use of a theoretical value, ,
eq
(blood sugar at t » °° ). Thus for a continuous infusion,
S — S «• (S - S ) e~kt and v - ®1S1
eq V o eq>
where, - Bate of glucose infusion,
«■ concentration of gluoose infusion,
» fasting blood sugar.
Or for a single injection, S - S m (S^ * S ) e6^ O 6(J
In the case of a single injection would correspond roughly to the
eq
S»o of Greville (1943), In the case of a continuous infusion
would represent the equilibrium level, when glucose infused equalled
glucose eliminated. Therefore on semilogarithmic paper straight line
graphs would be produced in the case of a continuous infusion by
plotting Seq -S against t and for a single injection by plotting
S - S against t.
eq
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In a later publication HIad and Elrick (1959) claimed that the
above formulae which express exponential relationships did not depend
merely on empirical observations (at best only approximations) but
were accurate mathematical derivations from the actual blood sugar
and time relationships reported by other investigators. This avoided
a circular argument. These authors agreed with Greville (1943) that in
normal subjects S was always below S-. In diabetics, however, S was
©(J X
usually above S^«
A further refinement was introduced by Marks and Bishop (1957)
who calculated not only values for k (as defined earlier) but also what
they termed the "mean net rate of glucose disappearance". This was
defined as the number of milligrams of glucose disappearing per unit
volume of blood per unit time and was given byt- k x Sav# (where Sav *
average total blood sugar concentration during the test). S&y was
calculated by the formulas-
s - s.O - •"**>
av
tk
or (using excess blood sugar values over the fasting level)s-
S .... - S„ » <So "* Sf ^ (1 * ® )
av
tk
These authors reported reduced values for both "k" and "mean net
disappearance of glucose" in a variety of malignant disorders. In
view, however, of the close correlation between these two factors no
additional information would seem to be gained by calculating anything
other than "k" alone.
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Macho and Lickc (1957) calculated glucose clearance by the formula
*
V sf
where I « total glucose injected minus total glucose lost in the urine
during the 60 minutes following injection#
As already stated above, however, urinary loss of glucose is so small
during a normal IVGTT that this formula seems an unnecessary complication#
"Half" time.
Finally Lundbaek (1962) revived the simplified formula for k
using the "half" time. This is the terra given to the time taken for
the blood sugar to halve itself during the course of an IVGTT. It had
already been used by Amatuzio et al, (1955) and Jokipi and Turpeinen
(1954) among others.
If we take the simple exponential equation,
-kt
S m SQe ,
then let be the blood sugar at time
and let Sg at tg be ^ or fl
Let T «■ the interval between and Sg, that is, the half time#
Then, substituting, we derive t- m g g-kT
T 1
1 -kT
or i » e
or log ^1 - log « -kT
or k - l0ge2 - 0.695 (approx.)
T T
This method has the merit of simplicity. A straight line is usually
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drawn by eye through a series of points plotted on semilogarithmio
paper and the mathematics is reduced to a minimum. Inevitably, however,
accuracy is sacrificed and this is a disadvantage if the IVGTT is to be
used definitively in diabetes as well as diagnostically.
Triple foleraace Seat
In some ways comparable to the one-hour two-dose test of Exton
and Hose (1954) was the suggestion of Soskin (1944) of a triple IVGTT.
In this test three doses of 25 grams glucose were given intravenously
at two hour intervals* In normal subjects the three successive two
hour blood sugar levels were progressively lower but in patients with
defects of carbohydrate metabolism (Soskin illustrates his report with
the result of such a test on a hypopituitary subject) the two hour
blood sugars become progressively higher*
Fifiure I#* Graph of blood sugar and time for the triple
tolerance test (after Soskin, 1944)*
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This test, however, is lengthy, tedious and seems to offer
no advantages of accuracy over the normal IVGTT.
Cortisone IVGIT
In view of the apparent success of the cortisone OGTT it is
rather surprising to find so little mention of a cortisone IVGTT in
idie literature, Duncan (1956b) reported its satisfactory use in -toe
prediction of two prediabetics by a lowering of the k values after
cortisone but Holten et al, (1957) and Nilsson (1962) found no
difference between the results in normal subjects and diabetio
suspects, Bastenie et al, (1954) actually recorded an improvement
in k values in their subjects after six weeks treatment with oortisone
in a total dose of 10 grams. This test certainly merits more detailed
study than it has received so far.
Comparison of QGTT with IVGTT
Both these procedures are equally liable to be affected by all
the physiological variables previously mentioned with the exception
of those relating to gastrointestinal absorption. This, however, is
a very important exception. Glucose administration can be timed
precisely in the IVGTT with no additional risks apart from the very
rare occurrence of chemical phlebitis. Furthermore, the subject is
saved what is often a rather nauseating draught of concentrated
glucose and, if anything, the IVGTT takes less time than the OGTT.
Hot only is the IVGTT preferable on practical grounds but it
has certain advantages in respect of its interpretation. The chief
of these is the ability to express an individual*s status regarding his
carbohydrate metabolism in one figure - the k value. This contrasts
with the doubt that sometimes arises with an OGTT blood sugar curve
where three factors - fasting blood sugar, peak rise and time to return
to the fasting level - have to be considered. In all published
reports of OGTT series a proportion of individuals so tested are
found to have only one of these three factors in the abnormal range
or who are slightly abnormal without being definitely diabetic. There
is, of course, no clear dividing line between normality and abnormality
and with any diagnostic test a proportion of those tested will fall
into the "doubtful" range. It seems likely, however, that a test
with only one criterion will result in fewer doubtful results -than one
with three criteria. Thus, provided the ranges for normality and
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abnormality have been determined, the IYGTT may be used not only for
diagnosis but also for definition - all k values above a certain
figure being normal and those below it being abnormal.
Lundbaek (1962) has further recommended that the k value be
used to evaluate the degree of diabetic!ty for a given individual.
The results of the present study do not, however, suggest that this
is a valid procedure. Many subjects in this series who were clinically
very mild diabetics had k values less than others with clinically
more severe diabetes (judged by insulin requirements, stability and
liability to ketosis). Furthermore, the number of possible variables
is so great that G7T,s (of any type) may produce different results
at different times regardless of the "diabetioity* of the patient.
However, while the k value is of only limited use in determining an
individual•s diabeticity in any absolute sense, it nay nevertheless
be used thus in a relative sense for research or other purposes. For
example, the effects of various treatments on the k value may be studied
under controlled conditions.
Dupre (1964) and Elrick et al, (1964) showed that the rate of
disposal of intravenous glucose is increased after prior administration
of oral glucose, Balsano et al. (19&4) find Molntyre et al, (1964)
suggested that this might be due to a huraoral substance released from
the jejunal wall during glucose absorption, facilitating the release
of insulin from the pancreatic islet cells.
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One possible hormone responsible for such an effect is secretin,
shown by Boyns et al. (1967) and Persson et al. (1967) to have a
marked insulinotropic action. This, however, is only so if exogenous
secretin is given, the (more physiological) stimulation of endogenous
secretin by duodenal infusions of citric acid producing no significant
alteration in plasma insulin levels (Boyns et al, 1966, Mahler and
Weisberg 1968). Another contender for the role of insulinotropic
hormone is pancreatic glucagon (Samols et al, 1966, Ryan et al, 1967,
Turner et al, 1967).
Whatever hormone is finally credited with this action, however,
the fact remains that orally administered glucose produces a hitter
plasma insulin response than that produced by intravenous gluoose.
This in turn leads to a more rapid fall of blood gluoose levels and
therefore to greater "tolerance" during an OGTT. The same tendency
would presumably result in lower k values (representing poorer toler¬
ance) in a given IVGTT than would be otherwise expected from an OGTT
in the same subject. Thus a number of borderline or suspect diabetics
(on an OGTT) might be brought more clearly into the diabetic range on
an IVGTT, This advantage, if it can be called such, is seen in the
results of the present series of tests and may be of some value in the
study of this intermediate group.
In this connection, however, it is of interest to note that
Moyer and Womack (1950) found that although the IVGTT was very
specific it was too insensitive - that is, a normal result was
produced In two diabetics diagnosed by an GGTT. It all depends,
perhaps, upon what one calls "normal".
As with any new diagnostic test there is the danger of a
circular argument* The new test (or the interpretation of it) seems
to divide neatly between diabetics and non-diabetics* But the
criteria for this classification are older tests and one could argue
that the old tests are therefore as good as the new. In these
circumstances theoretical considerations must be applied, at least
partly, in the evaluation of any new teat designed to improve the
aocuracy (though not necessarily those designed to improve the
practicability) of an older test (West and "Wood 1959) •
theoretical basis for the IfGTT has been described in the preceding
pages and is seen to offer a much more accurate measure of
carbohydrate metabolism than the OGTT. From the practical point
of view also, the results of many comparative series confirm the
superiority of the IVGTT and its use is strongly recommended in
preference to the OGTT (jorgensen 1926, Lennox 1927, McKean et al.
1935. Baird and Duncan 1959. Lund'baek 1962).
Other Diagnostic Tests
Although the GTT in some form has for many years held pride of
place in toe diagnosis of diabetes a great many other procedures have
been used with varying degrees of success from time to time.
Respiratory quotient
Babinowitoh (1925) measured toe respiratory quotient in
subjects following the intravenous injection of dextrose. He found
that it rose less, or even fell slightly, in diabetica as compared
with non-diabetics, Thayson (1929), however, using toe same method,
found toe same rise of respiratory quotient after dextrose injections
in normal subjects and in those with steatorrhoea - a group whose
glucose toleranoe is usually reduced (Fairley 1936, Ross and Tonka
1938, Frazer et al. 1952).
This technique has theoretical possibilities. It is probable,
however, that any procedure depending on toe measurement of respired
gases would be subject to at least as many variables as a GTT and
hence be very inaccurate. It is no longer used as a diagnostic test.
Serum phosphorus
Wertoeim et al. (1954) found that toe serum phosphorus fell
less in diabetics than in normal subjects during the course of an
IVGTT. Kritzer et al, (1956) who confirmed these findings noted also
that as phosphorus is utilized in toe peripheral rather than toe
hepatic metabolise: of glucose, measurement of its response to injected
glucose might distinguish a true diabetic from those individuals with
liver disorders and failure of glycogen metabolism. However, the same
authors found a great overlap in the results obtained from diabetics
and normal subjects and their observations are therefore more useful
statistically than diagnostically.
Plasma insulin
Since that time, however, much work has been carried out on
aspects of glucose metabolism other than the fluctuations of actual
blood glucose itself. Particularly is this so in respect of plasma
insulin. Valiance-Owen et al. (1955) studied plasma insulin levels
in obese non-insuiin-dependent diabetics and found a higher than
normal fasting level but a smaller than normal rise following glucose.
This pattern has been confirmed by Berson and Yalow (1961), Phear
(1962), Hales and Handle (196?) and Hales et al. (1965). Similar
responses to glucose loads axe seen also after myocardial infarction
(Nikkila et al. 1965), in obese non—diabetics (Fhear 1962) and in
likely pre-di&betics (Steinke et al. 1965# Pfeiffer and Zeigler 1965).
In some katotic insulin-dependent diabetics detectable insulin
activity may be very low or absent (Vallance-Owen et al, 1955»
Taylor l$6j). It may be that a clearer assessment of the diabetic
and suspected pre-diabetic is now possible by studying the plasma
insulin response as well as the blood sugar levels during a GTT
(Samols and Marks 1965# Lister 1966, Johansen and Lundbaek 1967)*
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Similar information may also "be obtainable from urinary insulin measure¬
ments (McArthur and Stimraler 1966, Lieberman 1968),
Non-ebterlfled fatty acids
Hales and Handle (1963) observed that fasting levels of non-
esterified fatty acids, as well as serum insulin, were frequently raised
in mild diabetics. Unfortunately further work, while confirming this,
showed that there was too wide a scatter of values between normal and
diabetic subjects for this finding to have real diagnostic importance
in any particular individual (Hales et al. 1965).
Skin surface glucose
Miller and Ridolfo (i960) suggested that measurement of the
skin surface glucose lay means of a glucose oxidase test paper held
between the fingers might be a satisfactory and simple screening
procedure. West et al. (1963)1 however, found it entirely without
value in differentiating diabetics from normal individuals.
Tolbutamide tolerance test
In 1956 Mirsky et al, published a report of the effect of oral
tolbutamide on the blood sugar in normal and diabetic subjects. They
found that although many diabetics had as great (or occasionally greater)
hypoglycaemic responses the mean levels were different for the two
groups and in diabetics the fall tended to be slower. These
observations led to the development of the tolbutamide tolerance test
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introduced "by linger and Madison (1957)• These authors injected tol¬
butamide intravenously and found in normal subjects a sharp fall of
blood sugar to a nadir at between 20 and 40 minutes after the injection
and a subsequent slower rise to a level usually about 79$ of the starting
figure by 60 minutes. In diabetics, although the same level was often
reached by the end of one hour, there was usually no intervening nadir,
the blood sugar falling gradually throughout the test period.
The same technique was also used by others who found it
satisfactory, both for the diagnosis of diabetes (Kaplan 1961) and
the prediction of pre-diabetes (Dolger et al. 1962) although it was
less suitable in the case of children (DiGeorge and Chianovitch 1963).
Boshell et al. (1963) also used it but preferred to give the tolbutamide
by mouth, claiming that this method reduced the risk of hypoglycaemie
symptoms which occasionally complicated the intravenous test.
Kaplan (1961), however, noted that the tolbutamide tolerance test
was often normal when the OGTT and I7GTT were abnormal and especially
was this so if the subject being tested was obese. This last
observation is perhaps not surprising in view of the fact that
individuals with early diabetes, pre-diabetes or even obese non-
diabetics frequently have raised serum insulin levels (Phear 1962,
Steinke et al. 1963, Hales et al. 1965)# Although the increased
plasma insulin is usually in an inactive form (Camerini-Davalos et al.
1965, Steinke et al. 1963) it may evidently on occasion be active,
even to the extent of producing spontaneous hypoglyoaeaia (McClellan
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and Wardlaw 1932, Gkillearn and J^raeareoa 1935» Seltser et al» 1956).
Such insulin activity could lead to normal or near normal blood sugar
curves in the tolbutamide tolerance test and false negative results
in the very group (mild diabetics and pre-diabatics) where early
diagnosis might be so important, Shis weakness has been demonstrated
by Conn and Pajans (l96l) and Drury unci Timoney (1963) who
confirmed the inferiority of the tolbutamide tolerance test to the
cortisone DOT? in the diagnosis of early diabetes.
Prednisone induced glycosuria
Joplin et al. (1561) returned to the measurement of glycosuria
for diagnosis in their prednisone glycosuria test. In this test
20 mg of prednisone is given at 12 noon, 4,00 p.m. and 3.00 p.m. and
the subject is then fasted until 6.00 a.m. the next morning. Prom
10.00 p.m. to 6.00 a.m. all urine is collected and blood is taken
for blood sugar estimation at 12 midnight and 1,00 a.m. Joplin et al,
(1961) found that normal subjects lost less than. 60 mg of gluoose per
hour in their urine during the test period, while all the mild
diabetics in their series and 25 out of 47 suspected pre-diabetics
passed more than this quantity. Figures for the night blood sugars
werej— Normal subjects, 90 - 155 P®r 100 ml (mean, 111);
Suspect pre-diabetics, 115 - 166 mg per 100 ml (mean, 141).
This Is a simple procedure and useful for screening diabetic
suspects especially, for example, during pregnancy when the subjects
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under investigation are in hospital (Davey et al, 1961), Difficulties
nay be encountered, however, (especially in this particular group)
with cases of lowered renal glucose threshold and the test does not
seen to have the same degree of specificity that can be claimed for
the cortisone GTT•
Experimental work
There remain a number of other procedures suggested during
the course of experimental work in this subject. These have as yet
not reached the point of becoming actual diagnostic tests and only
brief mention need be made.
They include the pyruvate tolerance test (Moorhouse 1964),
observations on the effect of glucagon (Batterfield et al, i960) and
metyrapone (Mlrouze et al, 1962) on normal and diabetic subjects, the
prediction of hereditary diabetes in hamsters by a rise in the level
of serum - 2 globulin fractions (Green et al, 1963) and studies in
urinary albumen (Keen and Chlouverakis 1964) or steroid (Charro-
Salgado et al, 1963) excretion patterns.
It is possible that from this and other work currently in
progress a more satisfactory diagnostic teat than the GTT will sooner
or later emerge* For the present, however, one or other form of GTT




(E.B. Although the following arguments are strictly concerned
with blood glucose as such, earlier workers her© quoted
have, in fact, in most cases based their views on
observations of the blood "sugar". In spite of apparent
inconsistencies in the line of argument, therefore, these
two terms are used here in exactly the same wsy as in
other sections of the thesis).
It will be apparent from the preceding section that there
exist at least three schools of thought regarding the best way of
considering blood sugar levels during an I7GTT. All agree that an
exponential relationship appears to exist (at least approximately and
for some part of the test) between the blood sugar and the time after
glucose injection. Some workers, however, have considered that the
rate of fall of blood sugar is proportional to the "total" sugar
(that is, the actual blood sugar level measured at a given moment) and
have therefore used these figures for the calculation of k (ikkos and
Luft 1957* West and Wood 1959* Lundbaek 1962)# This value may be
called "k (total)".
Others have preferred to use "excess" sugar (that is, either the
difference between the observed blood sugar (s) and the fasting level
(sp (Amatuzio et al, 196J, Duncan 1956a) or tide difference between
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the observed blood, sugar and some other level (s«a ox S ) lying
rather below the fasting blood sugar (Greville 1943» HIad et al, 1956) ),
arguing, instead, that the rate of blood sugar fall is proportional
to these values. In both oases the term Mk (excess)" is substituted.
These three views may be represented by three formulae, all of
which have already been introduced earlier,
viz. log S ■ log SQ - kt .. ,, .. M 1*
log (S - Sf) - log (S0 - Sf) - kt 2.
log (S - Sco) . log (Sc - S<*> ) - kt .. .. 3.
It is readily seen that equations H2" and "5" differ from wl",
only by constant terms, respectively and S *> , which are subtracted
in each case from the observed blood sugar figure, S.
It is difficult to compare these three forms of the simple
exponential equation directly as each depends on different theoretical
hypotheses and there is no constant proportional relationship between
them, What is certain, however, is that the inclusion of a constant
term into the equation in this way does not result merely in a shift
of the blood sugar graph bodily up or down but affects the shape and
slope of the line also.
In Figure IV a straight, line A-A has been drawn across semi-
logarithmic graph paper to represent an imaginary IVGTT blood sugar
slope and points have been marked along it to represent blood sugar
levels at definite time intervals. Best fitting straight lines
Tlsae (minutes)
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B-B, B'-B*, and Bw-B* have been drawn through points at the same time
intervals but respectively 100, 200 and 300 rag per 100 ml in excess
of comparable points along A-A. Likewise, best fitting straight lines
C-C, C'-C* and Cn-C" have been drawn through points respectively
100, 200 and 500 mg per 100 ml below comparable points on A-A,
The Standard Error (SE) of these points from the best- fitting straight
lines has been calculated and shown in each case. It will be seen that
within the range of variation illustrated the greater the displacement
of a line from A-A in either direction, the greater the slope alters
and the larger the SE becomes.
The implication of this would seem to be that whereas a slope
representing an exponential relationship between two functions may be
moved up or down by adding or subtracting constant terms, there is only
one position (within the rang® illustrated, at least,) where the points
fall actually in a straight line; in all other positions the points
will be scattered to a greater or lesser degree from straight lines
fitted to them. In an actual IVGTT, of course, it is unlikely - for a
variety of technical and physiological reasons - that a perfect straight
line would ever be obtained and because of the calibration of semi-
logarithmic paper any scatter of points about a best-fitting straight
line is less obvious (visually) the higher up the scale it lies, Never¬
theless, the exact degree of scatter about any line can be determined
by calculation of the SE of the observed points from that line.
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fs • s ^
('She SB is given by the formula*- SE » * 1
n - 2
where S - represents the difference between the observed blood
sugar level at a given moment and the calculated, blood sugar level
lying on the beat-fitting line at the same time,
n • the number of blood sugar readings,)
Thus the SE of a series of points from any line may be taken
as an index of the goodness of fit of that line,
A series of graphs may therefore be drawn for any set of blood sugar
readings obtained during an IVGTT using all the various forms of the
exponential equation ("1% "2", or "3" above). As explained, a
perfect straight line is unlikely to result from any actual IYGTT but
one of the three equations will be found which provides a better straight
line fit than the others. This would be the graph with the smallest SE,
In the present context, supporters of the view that "total" blood
sugar should be used for calculation of k claim that equation "1" would
produce the best straight line available (illustrated in Figure IF by
line A-A), If this is so it follows that deduction of (or of
some other value for S «» ) from the observed figures would move the whole
slope downwards toward C-C, C'-C' or C"-C" with consequent increase of
SE, On the other hand, those who claim that equations "2" or "3"
produce the best straight lines would argue that use of "total" blood
sugar results in lines tending towards B-B, B'-B1 or B"-B", again with
increasing SB,
If S« in equation "3" is equal to zero then equation "3"
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becomes equation **1", Similarly, if S«, * S„ then equation "3W
becomes equation "2". Thus by allotting various arbitrary values to
Sos in a given TVOTT that value may be found which produces the graph
with minimum SE»
If minimum SE is obtained when Soo m 0 it follows that "total'*
blood sugar values should be used for calculation of k. If, on the
other hand, a better fit xs producod wn.sn S oo ^ 3^ (or some other
value lying between 0 and S^.), then "excess" blood sugar values are to
be preferred.
One further possibility i3 that minimum SE may be obtained when
S oo is negative# This would mean the addition of a constant figure
to all observed blood sugar readings rather than the subtraction proposed
by users of "excess" blood sugar values. This point is discussed on
pages 162 and 170 ff.
In any event, calculation of SE for best-fitting straight lines
drawn through series of points derived from a given ITOTT by substituting
different values of S 00 will determine that value of which gives
the best fit. Thus, preference for equation "2" or "3", that is,
for "total" or "excess" blood sugar (or, in the present study, blood
glucose) may be established.
It may be argued, however, that only the central part of the blood
sugar slope (that is, that part relating to true metabolism of glucose)
should be used for calculation of k. In the present study this
practice has been adopted so far as the later stages of the test are
concerned and blood glucose values less than 25 mg per 100 ml in excess
of the fasting level have been ignored. It is probable that this
degree of limitation is unnecessary as in many cases good fitting
straight lines can be drawn to include blood glucose points right
down to the original fasting level. Hevertheless seme arbitrary limit
must be fixed and this, while possibly excluding some points that
could be included, is at least fairly certain to exclude any points
that should not be included. All points 25 mg per 100 ml or more
in excess of S^, are referred to below as "valid" points.
Consideration of the earlier part of the slope is a little
more difficult. If the fall of blood glucose is steeper in the
first few minutes than during the later parts of the test, k values
based on all blood glucose readings will tend to be higher than if
only the central points are used. If, however, a true exponential
relationship between blood glucose and time exists for the central
part of the test, then during that time the graph will be a straight
line. If there is a straight line seotion in an IVGTT graph it may
therefore be found as follows! k could first be calculated for the
slope of the best-fitting straight line through all the blood glucose
readings available (that is, every 5 minutes, starting 5 minutes after
gluoose injection). It could then be recalculated using all except
the first (5 minute) reading; then again, omitting the first two
points, and so on until a stage is reached when omission of further
points produces no further change in k. At this stage, presumably,
a straight line slope is present. In praotioe, again, there will
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always be a certain scatter of points and omission of any one is
liable to alter the value of k for the best-fitting straight line
through the remainder. However, in spite of some continuing
variability of k, it may be possible to decide approximately at what
stage a reasonably steady value has been reached.
These two aspects of the IVGTT form the main part of -toe
present study. Two further subsidiary objects have also been mentioned
already on p.2, namely (a) to establish, if possible, a simpler test
of oomparable accuracy using fewer readings and (b) to determine
(using the simpler test) the ranges of normality and abnormality




For the main study twenty four subjects were selected (oases
1 - 24* see below). There were twelve diabetics and twelve non-
diabetics. Of these, three were healthy volunteers; the rest were
all in-patients at the Adelaide Hospital, Dublin. Hone was suffering
from any endocrine disorder apart from diabetes and the majority were
ambulant.
The average age of the group as a whole was 56.9 years (range
22 - 77)I that for the diabetics, 63*5 years (range 51 - 77) and
for the non-diabetics, 50.0 years (range 22 - 77)* The possible
hearing on the results of the unmatched age structure for the two
groups is discussed on page 168. There were 17 males and 7 females.
Preparation
The question of an adequate pre-test carbohydrate intake has
been discussed in the previous section (p. 44), In the light of this
evidence it was felt unnecessary to insist on the very high (500 grams
or more) oarbohydrate diets recommended by some workers (Conn 1940,
Unger 1957)* whioh would be excessive for many bed patients. In the
present series, therefore, all subjects were already taking a full
diet containing at least 175 grams of carbohydrate per day and this
was not ohanged. Several days were allowed to elapse after any
surgical procedure or acute illness and any anti-diabetic treatment
was stopped at least 36 hours (or, in the case of those patients
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receiving chlorpropamide, at least 48 hours) before a GTT. Even
48 hours may not be long enough to eliminate all significant effects
of chlorpropamide in those patients receiving that drug, but a longer
interval without treatment was not thought to be clinically justifiable.
The names of patients receiving chlorpropamide are therefore marked
with an asterisk in all relevant tables and their results discussed
with this in mind. In the case of those patients newly discovered to
have diabetes, GTT*s were performed before starting any antidiabetic
treatment. There was no patient in this series currently receiving
protamine zinc insulin.
All subjects apart from established diabetics had a standard 50
gram OGTT performed during the few days just before or after the
IVGTT. This test was done after an overnight fast of approximately
12 hours, Venous blood and urine samples were collected fasting and
at 1 and 2 hours after 50 grams of glucose in 180 ml of water by
mouth. Blood sugar was estimated by the method of Folin and Wu
(Harrison 195®) and glycosuria by "olinitest" tablets.
With this method the limits of normality were taken as followsi-
(a) Easting blood sugar less than 120 mg per 100 ml,
(b) Peak blood sugar not exceeding 180 mg per 100 ml*
(e) Return to less than 125 ®g per 100 ml by 2 hours.
An individual whose test figures lay below all three criteria was
considered non-diabetic} if any two were exceeded he was regarded
as diabetic. Diabetics were further subdivided into two grade®
(see p.9)i viz. mild (7 patients) or moderate (5 patients).
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Brief details of each patient are included in Table VII and this
information is expanded in the Appendix.
It is necessary to explain that although the present study may
incidentally illustrate some of the previously described advantages
of the IVGTT over the OGTT, it cannot be used to prove this point
because "blood sugar" was estimated in venous blood by the method of
Polin and Wu for the OGTT but as true glucose in capillary blood for
the IVGTT. This apparent absurdity was dictated by the fact that
whereas IVGTT's were performed by the writer personally. OGTT*s were
nearly all done as routine investigations by the methods currently
used in the hospital. As the object of this study was not the direct
comparison of these two tests, repeated OGTT*s using true glucose
methods were not considered justifiable and routine OGTT*s were used
merely as a convenient means of grading the subjects.
Intravenous glucose tolerance test.
After an overnight fast capillary blood was obtained by finger-
priok for blood glucose estimation. 50 ml of dextrose solution,
to which had been added about 1.000 units of heparin to prevent
thrombophlebitis, was then injected slowly and evenly into an ante-
cubital vein over a period of 4 minutes timed with a stop watch.
Further blood samples were obtained at 5 minute intervals for
50 minutes, with a final sample at 60 minutes, timed from the mid
point of the glucose injection# In one or two instances blood
samples were not taken exaotly at these intervals. In such cases
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the actual times were noted and the final calculations adjusted
accordingly* Urine was not collected. Because of possible dis¬
tortion of the curve by homeostatic mechanisms blood glucose readings
within 25 tag per 100 ml of the fasting level were ignored in the
calculation*
Beagents.
Reagents were obtained from a special kit (reference TC-M-1
article No, 15982, Messrs* Boehringer and Co*, Mannheim) for the
estimation of true glucose as follows
1* Buffer/enayme powder containing 0.12 M phosphate buffer (Sodium
ortho-phosphate dihydrogen, s^po4, and sodium ortho-phosphate mono-
hydrogen, at pH?), 6 sag peroxidase and 67*5 mg of glucose
oxidase were completely dissolved in 150 ml of distilled water.
2* Chromogen (15*2 mg o-dianisidine hydrochloride) was dissolved in
2*0 ml of distilled water,
5* "Glucose reagent" was obtained by mixing one volume of chromogen
with 100 volumes of buffer/enzyme solution freshly before each test*
4* Gluoose "standard" solution containing 91 /■€> glucose per ml**
Blood glucose estimation
0*1 ml of each blood sample obtained was mixed in separate tubes
with 1 ml of 0*55 M perchloric aold to precipitate the proteins* After
oentrifuging,0*2 ml of the supernatant from each tube was pipetted
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into further tubes * 5 ®1 of "glucose reagent" was added and thoroughly-
mixed. 0.2 ml of glucose "standard" solution and 0.2 ml of distilled
water (as control) were added respectively to two further tubes
containing 5 ml "glucose reagent" and the whole set allowed to stand
for exactly 55 minutes* At the end of this time colour changes (optical
density) were read on an EEL colorimeter* using a 624 green filter*
comparing the test solutions with the known glucose "standard".
Blood glucose was calculated by the formular-
Colorimeter reading of test solution x 100 (in mg/100 ml.)
Colorimeter reading of glucose "standard"
Reliability criteria
Accuracy The series of tubes for each test also included one
tube containing a solution of known glucose content ("Lab-trol" or
"Patho-trol"l Dade controls* Armour Pharmaceutical Co* Ltd*) This
was treated in exactly the same way as all the other tubes* Using
the above method for glucose estimation figures obtained for the
glucose concentration of these control solutions differed from the
actual concentration by an average of 2.65$ " SD 2.4.
2. Precision On several occasions blood gluoose estimations were
carried out in duplicate or triplicate on the same series of tubes
in a given IVGTT* Results for such double or triple estimations
varied from each other by an average of 0.55$ ~ SD 1.1.
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3» Specifldfcy. The method described is specific for d - glucose
with the exception that elevated, blood levels of glutathione or
vitamin C nay cause falsely low readings. The manufacturers of the
special kit used claim an average error margin of less than ~ 556,
4* Sensitivity. This is limited by the accuracy with which one can
read an EEL colorimeter. Inevitably it is less in the upper part of
the scale. With very high blood glucose levels, however, blood samples
were diluted so as to give colorimeter readings near the middle of the
scale* In this way the smallest change in readings which could be
accurately appreciated represented about 3 glucose per 100 ml.
Procedure
Exponential relationship
Blood glucose (in mg per ml) was plotted against time (in
minutes) on semilogarithmic graph paper and best-fitting straight
lines, using all valid points, were calculated by the method of least
squares, viz. l(log S) » nSQ + k i(t)
£(iog s.t) - S0£(t) + k£(t2)
(where S ■ blood gluoose at time, t,
SQ m theoretical blood glucose at t m 0, found by
extrapolation,
n » total number of blood glucose readings,
k » a constant, representing the slope)*
In this way, k was found for each individual*
Exponential relationships axe customarily expressed as functions
of "e" by use of Naperian logarithms. Calculations in the present study
have all been done by logarithms to base 10 and the final results
multiplied by a factor of 2,505 to comply with this praotioe. All
values for k and SE throughout (including all relevant Tables) have
been further multiplied by 100 for convenience.
Graphs obtained in the way desoribed represent title special case
of the equation, log (S - S <*> ) * log(S^ - S ^ ) - kt when S <*> • 0.o
In other words, they are based on the assumption that the rate of fall
of blood glucose in an IVGTT is proportional to the total amount of
glucose present.
In view of the inevitable slight scatter of points about these
straight lines, the SE was also calculated in each case.
For each subject the values for k and SE were also calculated
for further best-fitting lines obtained by means of a series of
arbitrary values for S » ranging from 10 to 100 by increments of 10
and also the special case where S ao «• S^.
In addition to the foregoing 24 subjects the mean blood glucose
values at stated time intervals were also determined for the 12 diabetics
as a group and the 12 non-diabetics as a group. These two sets of mean
blood glucose values are referred to below as "cases" (Nos. 25 and 26
respectively for diabetios and non-diabetics - see Appendix* pp. 244 and
245 for details), k and SE were calculated for these two ''oases'* in
the same way as that described for cases 1 - 24*
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For comparison, mean blood sugar values at stated time intervals
were also calculated from figures published in four other reports,
namely Greville (1943) Amatuzio et al, (1953)» Duncan (1956a) and
Xkkos and Luft (1957)t Sets of mean values thus obtained are likewise
referred to below as "cases" (see Appendix pp. 246 - 252 for details).
These reports refer to the following groups of patientsj-
Number of subjects Type of subject Case No,
Greville (1943) 6 Non-diabetics 27
Amatuzio et al, (1953) 26 Diabetics 28
70 Non-diabetics 29
Duncan (1956a) 15 Diabetics 30
20 Non-diabetics 51
Xkkos and Luft (1957) 47 Diabetics 32
16 Non-diabetics 53
These reports all refer to blood "sugar" rather than blood glucose
and therefore should not, strictly speaking, be compared with cases
1 • 24 or cases 25 and 26. However, they are the only other detailed
I7BTT figures available for comparison, so far as the present writer
has been able to discover, and they have therefore been included.
Accordingly, the same calculations for the determination of k and
SE have been made with cases 27 * 33 us described above for cases 1 • 26.
The results obtained for cases - 35, here and in subsequent sections,
are, however, commented upon separately in the text.
Results from the calculations referred to above - for all cases -
are shown in Table IV.
In view of theoretical objections to the use of blood sugar or
blood glucose points prior to the 20th minute after glucose injection
the whole calculation was repeated in each case (including Nos. 25 - 33)
using only those points from 20 minutes onwards. Results are shown in
Table V.
Section of slope to be used
Having obtained the values of k for the best-fitting straight
lines when S <*> «• 0, using all valid points in each ease, k was
recalculated (again taking S » 0) omitting the first blood glucose
reading. This process was repeated, this time omitting the first two
readings, then again, omitting the first three readings and so on
several times until only the last four or five points were used. In
each case and for each section of the IVGTT blood glucose slope
used the SE from best-fitting straight lines was also calculated*
Results are shown in Table VI,
Exactly the same procedure was used for eases 25 and 2(S and
for cases 27 - 35* all these results being included in Table VI.
Simple test
As described above k values were obtained from best-fitting
straight lines based on all valid points, omitting those points prior
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to the 20th minute after glucose injection. These were compared with
k values obtained from best-fitting straight lines based on the 20,
40 and 60 minute points only. In six oases the blood glucose had
fallen to within 25 mg per 100 ml of the original fasting level by the
60th minute. In these cases, therefore, k was calculated from the 20
and 40 minute points only. (As there were only two points, the SB was,
of course, zero).
Values for k were calculated both for "total" and "excess"
(over S^) blood glucose. In each case and for both k (total) and
k (excess) the differences between k values using all except the first
three valid points (k) and values obtained by using only the 20, 40
and 60 minute points (k*) were expressed as a percentage change from
the mean of the two values
viz. Difference between k and k* x 2 x 100
k + k«
Only cases 1-24 have been treated in this way. Results are
shown in Table VH,
Range of k values
Using the simple test as described a further 100 subjects
(cases 34 - 133) were studied, comprising 50 diabetics and 50 non-
diabetics, Pour subjects were healthy volunteers, The rest were in
or out patients at the Adelaide Hospital, Dublin, There were 61 men
and 39 women* The classification into diabetics and non-diabetics,
preparation, IVGTT technique and calculation of individual k values
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were exactly the same as described for the longer test except that
blood glucose was estimated only at the 20th, 40th and 60th minute after
glucose injection# In a few tests blood samples were not taken precisely
at these times. In such cases the actual times of collection were
noted and the calculation of k adjusted accordingly.
The diabetic group was further subdivided according to severity,
via# mild (55 patients), moderate (9 patients) and severe (6 patients)#
The number of subjects, by age, for each subgroup is shown in Table III#
A large number of all cases studied were under investigation or
treatment for varying degrees of peripheral vascular disease but
many other disorders were also represented# As before, no patient had
any endocrine disorder other than diabetes and the majority were
ambulant# Subjects were graded according to body build, either obese,
average or thin.
Brief details of all patients are given in Tables VIII and IX
and this information is expanded in the Appendix# The range of k
values obtained in this series is shown in Figures XXXVIII and XXXIX,
Calculations were cheeked by I.B.M# computer, I ^
yuse3>. o^ous IbXo , *0-0,000 doJO^vfc* ( <-JVK*.
p«\^>ar wlr duwvdL
p CO<}T*-vu^«_<L OftAJsIr .
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10-19 20-29 30-59 40-49 50-59 60-69 70-79 80-89 Total Mean
age
Hon*
diabetica 2 8 5 8 10 11 5 1 50 49.0
Mild
diabetics - • 1 3 6 14 7 4 35 64.2
Moderate
diabetics m m <«S 1 2 2 4 9 64.5
Severe
diabetics m i 1 «■» m 1 3 6 57.5
All
diabetics m l 2 4 8 17 14 4 50 63.4
Total 2 9 7 12 18 28 19 5 100 56*2
gable III. Age distribution (in years) for subjects
undergoing the simple IVGTT.
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RESULTS
"Total" or "Excess" blood glucose
Table TV records the variation in SE from best-fitting straight
lines through series of points obtained in each case by allotting a
number of different arbitrary values to in the formula,
log (S - S « ) - log (SQ - S co ) - kt.
For this purpose all valid blood glucose readings have been
included in the calculation. The actual fasting blood glucose level
has been included in brackets beside the individual values for SE in
the column headed "S <*> m s^".
It will be seen that in most eases an increase in the value of
S oo is accompanied by a progressive increase in SE, In these eases,
therefore, it would appear that the closest approximation to a straight
line occurs when "total" blood glucose is used, that is, when S oo ® 0,
In two cases, however, (Nos. 19 and 24) this progressive rise is
not seen. In these cases the SE first rises then falls to a minimum
and finally rises sharply again as Sw increases. The implication
here, therefore, is that the "ideal" value for S (that is the value
which gives the closest approximation to a straight line) lies above
0 and that the use of "excess" blood glucose is to be preferred. Of
these two cases No, 19 shows that the SE when S oo «■ is greater
than when S <*> = 0, while in No, 24 the SE when S «*> = S^. is less




Sec = 0 Sec =+10 S oo =+20 Soo =+30 S 00 =+40 So« =+50 S«p=+60 Soo =+70 Spo=+80 S as =+90 Sq»=+100 Sao= S|, (sf)
1 4.39 4.52 4.67 4.83 4.99 5.17 5.36 5.56 5.78 6.01 6.25 6.86 (122)
2 2.26 2.54 2.42 2.51 2.60 2.71 2.81 2.93 3.06 3.23 3.48 3.48 (100)
3 1.10 1.13 1.17 1.21 1.25 1.31 1.39 1.49 1.64 1.86 2.17 2.17 (100)
4 3.07 3.13 3.20 3.27 3.34 3.42 3.50 3.58 3.67 3.76 3.85 12.10 (263)
5 2.52 2.62 2.74 2.86 3.00 3.15 3.31 3.49 3.69 3.91 4.16 10.59 (200)
6 3.33 3.42 3.50 3.60 3.69 3.80 3.92 4.05 4.21 4.40 4.67 4.50 (94)
7 1.92 1.98 2.03 2.09 2.16 2.22 2.30 2.38 2.47 2.58 2.70 2.79 (106)
8 4.58 4.70 4.83 4.97 5.12 5.27 5.43 5.60 5.77 5.96 6.16 6.57 (119)
9 1.70 1.80 1.91 2.02 2.16 2.32 2.49 2.70 2.94 3.23 3.57 3.15 (88)
10 4.43 4.53 4.64 4.75 4.87 5.00 5.12 5.26 5.40 5.54 5.69 6.82 (171)
11 1.19 1.23 1.27 1.31 1.36 1.41 1.46 1.52 1.59 1.65 1.73 6.17 (260)
12 1.66 1.70 1.74 1.79 1.83 1.88 1.93 1.98 2.03 2,09 2.14 2.32 (192)
13 6.15 6.41 6.71 7.07 7.52 8,11 8.93 10.13 12.03 15.29 19.38 14.59 (88)
14 1.79 1.94 2.13 2.35 2.64 3.01 3.50 4.19 5.19 6.75 9.41 7.58 (94)
15 3.84 3.93 4.02 4.12 4.22 4.32 4.43 4.55 4.67 4.80 4.93 5.00 (105)
16 2.89 3.15 3.46 3.84 4.32 4.93 5.72 6.79 8.29 10.50 14.09 9.28 (85)
17 3.66 3.81 3.98 4.17 4.37 4.59 4.84 5.23 5.45 5.84 6.33 5.48 (82)




S oo= 0 So. =+10 So. =+20 S*. =+30 s=+40 S„=+50 Sea =+60 Sea =+70 Sc. =+80 So. =+90 S.O=+100 SoO = S rt
f (sf)
18 1.69 1.88 2.11 2.41 2.78 3.27 3.93 4.83 6.13 8.09 11.33 6.29 (81)
19 4.30 4.34 4.35 4.35 4.32 4.26 4.17 4.09 4,15 4.74 6.74 4.50 (88)
20 6.55 7.01 7.56 8.22 9.03 10.04 11.35 13.10 15.57 19.32 25.69 17.23 (85)
21 5.38 5.61 5.86 6.16 6.52 6.99 7.67 8.72 10.58 14.27 23.02 11.94 (85)
22 2.11 2.15 2.19 2.23 2.27 2.31 2.35 2.40 2*44 2.49 2.55 2.64 (113)
23 2.75 2.85 2.97 3.09 3.22 3.37 3.53 3.72 3.95 4.23 4.63 3.53 (60)
24 6.31 6.43 6.54 6.61 6.64 6.58 6.39 6.01 5.39 4.96 8.47 5.73 (75)
25 1.49 1.51 1.54 1.56 1.58 1.60 1.62 1.63 1.64 1.65 1.65 1.62 (156)
26 1.53 1.53 1.55 1.60 1.70 1.90 2.25 2.84 3.78 5.27 7.71 9.04 (104)
27 3.36 3.34 3.30 3.24 3.17 3.10 3.14 3.49 4.60 7.17 12.76 5.55 (89)
28 1.97 2.02 2.06 2.10 2.14 2.18 2.20 2.22 2.23 2.23 2.23 2.29 (115)
29 3.70 3.72 3.72 3.69 3.61 3.47 3.22 2.82 2.29 1.93 3.41 2.19 (94)
30 2.78 2.84 2.89 2.95 3.00 3.06 3.11 3.16 3.21 3.26 3.30 3.19 (169)
31 5.35 5.41 5*44 5.44 5.38 5.25 5.00 4.56 3.86 2.92 3.19 2.67 (96)
32 1.03 1.05 1.08 1.11 1.14 1.17 1.20 1.24 1.28 1.32 1.36 2.05 (212)
33 1.30 1.21 1.10 1.00 0.99 1.25 2.00 3.42 6.03 11.39 27.06 4.04 (72)
Table IV (continued)* Variation of SB for different values of S«® , using all valid points. (Cases 18 - 33)
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Cases 27 - 33 give more equivocal results, Nos. 27#29» 31
and 33 all fail to show the progressive rise of SE with increasing
values for S « • Values for SE in cases 29 and 31 behave as described
above for cases 19 and 24* Values for SE in oases 27 and 33 show no
initial rise, the SE first falling to a minimum and then rising again.
As above, the implication here is that for all these cases the "ideal"
value for S <*> lies above 0 and that the use of "excess" sugar is to
be preferred# Cases 29 and 51 show the SE when S «> =* Sf to be less
than when 8 00 «• 0 but only in case 51 is SE minimal when S «*> « 8^,.
In the other three oases minimum SE is obtained at a value for S <*>
less than S^«
Table V shows, as above, the variation of SE from best-fitting
straight lines through series of points obtained in each case by
allocating the same arbitrary values to S* as described for Table IV#
This time, however, blood glucose readings prior to the 20th minute
after glucose injection have been omitted from the calculations. In
this way any distortion of the blood gLueose slope which might have
been produced by the relatively rapid blood glucose fall in the early
minutes of the IVGTT has largely been eliminated# It will be seen
that the SE of points from best-fitting straight lines is less in
nearly all cases and for nearly all values of S #0 than corresponding
figures in Table IV. This confirms the view that in general the
middle section of an IVGTT blood glucose slope is more nearly a




Sao = 0 S« =+10 S~=+20 Soo =+30 S eo =+40 Soo =+50 Soo =+60 Soo =+70 Soo =+80 S 00 =+90 ^ S 00 =+100 S 00 = sf (Sf)
1 2.84 2.95 3.06 3*19 3.32 3.47 3.63 3.81 4.00 4.22 4.45 5.08 (122)
2 1.44 1.52 1.61 1.71 1.83 1.97 2.15 2.36 2.63 3.,00 3.52 3.52 (100)
3 1.03 1.07 1.11 1.15 1.21 1.26 1.33 1.41 1.51 1.64 CMco•<r- 1.82 (100)
4 0.31 0.33 0.35 0.37 0.40 0.43 0.46 0.50 0.54 0.59 0.64 10.59 (263)
5 1.78 1.85 1.94 2.02 2.12 2.23 2.29 2.47 2.62 2.78 2.96 8.05 (200)
6 2.12 2.24 2.39 2.55 2.74 2.96 3.22 3.53 3.91 4.37 4.96 4.59 (94)
7 1.23 1.29 1.36 1.44 1.53 1.63 1.74 1.88 2.04 2.23 2.46 2.62 (106)
8 1.01 1.06 1.11 1.17 1.24 1.32 1.41 1.51 1.64 1.78 1.96 2.42 (119)
9 1.58 1.66 1.75 1.86 1.98 2.11 *.27 2.44 2.65 2.89 3.18 2.83 (88)
10 2.33 2.40 2.47 2.54 2.62 2.71 2.79 2.89 2.99 3.09 3.21 4.25 (171)
11 1.23 1.26 1.30 1.35 1.39 1.44 1.49 1.54 1.60 1.66 1.73 5.42 (260)
12 1.14 1.18 1.21 1.25 1.29 1.33 1.38 1.43 1.48 1.53 1.59 2.16 (192)
13 4.05 4.45 4.94 5.54 6.29 7.26 8,54 10.30 12.87 16.95 24.34 16.10 (88)
14 1.51 1.58 1.65 1.72 1.80 1.88 1.98 2,11 2.31 2.73 3.82 3.02 (94)
15 3.38 3.49 3.60 3.71 3.84 3.97 4.12 4.28 4.45 4.63 4.84 4.95 (105)
16 2.52 2.69 2.88 3.11 3.40 3.76 4.23 4.89 5.83 7.33 10.00 6.49 (85)
17 3.80 4.00 4.22 4.46 4.74 5.05 5.40 5.81 6.28 6.83 7.48 6.38 (82)




Sea - 0 w 1 it+ o S -=+20 So. =+30 s *0 =+40 s - =+50 S 00 =+ 60 S 00 s+70 S « =+80 Soo =+90 S eO =+1 00 S 00 = Sj, (Sf)
18 1.41 1.49 1.58 1.70 1.86 2.08 2.39 2.87 3.64 4.94 7.34 3.74 (81)
19 1.41 1.49 1.58 1.70 1.86 2.08 2.39 2.87 3.64 4.94 7.34 4.54 (88)
20 7.44 8.00 8.65 9.U2 10.35 11.50 12.95 14.85 17.47 21.37 27.93 19.20 (85)
21 3.88 4.21 4.60 5.08 5.67 6.44 7.46 8.91 11.11 14.88 22.86 12.57 (85)
22 1.81 1.87 1.92 1.98 2.04 2.10 2.17 2.24 2.31 2.39 2.47 2.58 (113)
23 2.00 2.12 2.25 2.39 2,56 2.76 2.99 3.27 3.61 4.04 4.60 2.99 (60)
24 2.38 2.52 2.67 2.83 3.03 3.25 3.53 3.90 4.48 5.73 9.66 4.15 (75)
25 0.53 0.55 0.56 0.57 0.58 0.60 0.61 0.63 0.65 0.68 0.71 1.34 (156)
26 1.04 1.19 1.36 1.58 1.86 2.21 2.69 3.33 4.24 5.61 7.79 8.99 (104)
27 0.83 1,01 1.13 1.29 1.49 1.79 2.21 2.87 3.93 5.85 9.89 5.77 (89)
28 0.53 0.54 0.56 0.61 0.67 0.75 O.84 0.96 1.13 1.32 1.60 2.25 (115)
29 1.03 0.76 0.75 0.73 0.69 0.61 0.49 0.34 0.43 1.15 2.76 1.65 (94)
30 1.39 1.48 1.52 1.58 1.63 1.69 1.75 1.81 1.89 1.96 2.05 2.92 (169)
31 1.52 1.06 1.04 1.01 0.94 0.84 0.67 O.48 O.63 1.57 3.68 2.57 (96)
32 0.32 0.36 0.37 0.38 0.39 0.40 0.42 0.43 0.45 0.47 0.48 0.89 (212)
33 0,70 0.73 0.78 0.90 1.11 1.49 2.16 3.52 5.52 10.30 25.68 3.66 (72)
Table V (continued)* Variation of SE for different values of S«o, omitting the first three valid points* (Cases 18 - 33)
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It will also be seen that in all cases minimum SE is obtained
when S« = 0 and that an increase in the value of S «. results in a
progressive rise of SE. This confirms that the use of "total" blood
gluooae is preferable to that of "excess*1 blood gluoose in the
calculation of k in an IYGTT.
Results for oases 27 - 33 in general support this conclusion.
Nob, 29 and 51 show a fall followed by a rise of SE for increasing
values of S <*> but in both oases minimum SE is obtained when S °o
is substantially less than S^.
Section of Slope to be used
Table 71 shows the effect produced on the k values in each
case by omission of the earlier* points of the IVGTT blood glucose/
time graph. For this purpose S <*> is taken as zero. The first and
second column of this table record respectively the case number and the
maximum number (referred to as "X") of valid blood glucose points for
each test. The remaining columns show the values of k calculated from
best-fitting straight lines obtained first by using all valid points
(points "1-X"), then by using all points except the first ("2-X"),
then all except the first two ("3-X") and so on until only the last
four or five points are used. For each combination of points in each
case the SE of the observed points from best-fitting straight lines
has also been calculated and is shown in brackets below the various
k values.
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Case Valid k and SS (in brackets) for points
No. points
(X)















































































































































































































































Table VI. Variation of k and 3E for different sections of the blood glucose /
blood sugar vs. time graphs. (S«,= 0) Cases 1 - 17.
o
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Case Valid k and SB (in brackets) for points ■# mam*
Wo. points
(X)















































































































































































































Table VI (continued). Variation of k and SB for different sections of the
blood glucose / blood sugar vs, time graphs. (S«o = 0)
Cases 18 - 33*
io8
It will be seen that in the majority of oases values for k
decrease if the first point is omitted. Value3 usually fall by
rather less if the second point is also omitted and omission of further
points results either in a progressive fall in k value (for example,
Bos, 1+ 12 and 1?) or a fall followed by a rise (for example, Nos. 2,
7 and 26), In four cases (Nos. 5» 9» 11 and 16) there is a steady rise.
fhere is no essential difference between the results obtained
here for eases 1-26 and those obtained for cases 27 - 33*
It is commonly assumed that a good straight line or exponential
relationship between blood glucose (or blood sugar) and time is not
established until at least 20 minutes after glucose injection. Using
the present technique, the 20 minute blood glucose/blood sugar reading
is the fourth point on the graph (or the third point for Cases 27-53*)
and the supposed true exponential section of the slope would be
represented in Table VI, therefore, by k values in column "4-X"
(or W5-X" for Cases 27-55).
It has already been explained that because of the scatter of
points in an actual IVGTT omission of any point will almost certainly
affect the k value calculated from the remainder. This variation of
k makes it impossible to be categorical as to the limits of the true
exponential section of the blood glucose/blood sugar slope. In
such circumstances it might be thought that calculation of the SE
for each section of the slope would provide a further clue - the
smaller the SE of a series of points from a best-fitting straight line
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the closer those points approximate to the line, Unfortunately this is
of little help, The SE from best-fitting straight lines of points
lying in a curve will vary according to the arc of curve considered,
the SE being smaller the smaller the arc, irrespective of the number
of points involved. Similar considerations will also apply to a
scattered series of points such as an actual IVGTT graph. It is no
surprise, therefore, to find that in the range considered here no less
than 17 cases out of 33 have a minimum SE when a short section only
(that is, the last four or five points) of the slope is taken. This
may indicate that no true straight line section exists in an IVGTT
blood glucose/blood sugar slope, although on the other hand it may
merely reflect the soatter of points* Inspection of Table VI and
Figures V to XXXVII indicates, however, that in most cases deviation
from best-fitting straight lines is small, While no particular
section of the curve is always clearly superior to other sections,
that part from the "twenty minute" point onwards usually represents
the slope fairly well. In Figures V to XXXVII best-fitting lines
calculated from this section of each curve have been drawn.
In these Figures individual IVGTT*s are shown, blood glucose
- or, for Cases 27 - 55# blood sugar - (in mg per ml) being plotted
against time after glucose injection (in minutes) on semilogarithmic
graph paper, On eaeh Figure two series of points have been plotted
to represent "total" blood glucose (S <« » 0) and "excess" blood
glucose (S«o » S^) and blood glucose values less than 25 mg per
110
100 ml in excess of have been omitted* For each series of points
best-fitting straight lines (based on points "#-X" for Oases 1-26
and on points "3~X" for Gases 27 - 35)* calculated mathematically,
have been annotated with their respective values of k and the S3
from the points they represent#
Once again there is no essential difference between the graphs
of individual IVGTT,s in cases 1-24 and either the mean values &r
the diabetics and non-diabetics in this series (cases 23 and 26) or
other series (oases 27 - 55)*
It is interesting to note that although in most oases the first
two or three points deviate significantly from a straight line fitted
to the remainder, they approximate fairly closely to it in several
tests (if "total" blood glucose is used) - for example, Nos. 3, $,
11, 14 and 18* This indicates that on oocasion, at least, a good
straight line or simple exponential relationship appears to exist
between blood glucose and time almost from the very start of an IVGTT.
As seen already from Table V these graphs show that in almost
every case use of "total" blood glucose/blood sugar in the calculation















































Table VII shows the difference between k values calculated from
all valid points excluding the first three and those calculated fro®
the 20, 40 and 60 minute points only (referred to as k»). In each
case both "total" and "excess" (S n « S^.) blood glucose values have
been used. It will be seen that when "total" blood glucose is
considered the percentage difference between k and k* is small in
most cases, the mean difference being 5*7$ (Standard Deviation - 4*3)*
If "excess" blood glucose is used the mean percentage difference
between k and k* is somewhat greater (6,6$) and the variation in the



















Sex Build Complaint Ambulant(A)
or bed(B)
patient
Grade k(T) k' (T) Difference k(E) k»(E) Difference
m
M.W.* 67 M Obese
E.McD.* 67 F Obese
A.D.* 58 F Obese
H.H. 58 F Obese
M.B. 66 F Obese
G.McR. 61 M Obese
W.I.* 77 M Average
C.F. 59 M Average
D.McA.* 74 M Average
P.B. 66 M Average
A.M. 51 M Thin





























































































k = k obtained from all valid
points excluding the first 3
k' = k obtained from the 20, 40
and 60 minute points only.
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Case Initials Age Sex Build Complaint Ambulant(A) Grade k(T) k'(T) Difference k(E) k* (e) Difference
No. (yrs) or bed(B)
patient
<*) (*)
13 H.D. 46 M Obese Panic attacks A ND 1.65 1.34 16.5 4.00 2.73 37.8
14 A.B. 57 M Average Palpitations A ND 1.40 1.55 10.2 3.78 3.81 0.8
15 M.B. 57 M Average Mesenteric artery
thrombosis
A ND 0.91 CMO. 11.4 1.45 1.61 10.3
16 D.T, 23 M Average Healthy volunteer A ND 1.56 1.49 4.6 3.27 3.21 1.9
17 R.W. 77 M Average Glycosuria A ND 0.98 0.93 5.2 1.83 1.73 5.6
18 J.S. 68 M Average Intermittent
claudication
A ND 1.38 1.33 3.7 2.83 2.74 3.2
19 J »G. 62 M Average Intermittent
claudication
A ND 1.38 1.33 3.7 3.10 3.01 2.9
20 B.W. 40 F Average Healthy volunteer A ND 2.42 2.30 5.1 5.64 5.49 2.7
21 L.L. 25 F Average Healthy volunteer A ND 1.86 2.19 16.3 5.10 5.70 11.1
22 P.R. 65 M Thin Weight loss A ND 0.98 0,91 7.4 1.76 1.65 6.5
23 M.E. 59 M Thin Intermittent
claudication
A ND 0.83 0,78 6.2 1.28 1.19 7.3
24 B.M. 22 M Thin Diarrhoea A ND 1.58 1.68 6.1 3.48 3.47 0.3
Mean 5.7 6.6
Standard deviation - 4.3 i 8.5
Table VII (continued). Brief details and k values:- Cases 13 - 24* Notes : ND = Non-diabetic
k(T) = k(Total) k(&) = k(iixcess)
k = k obtained from all valid points
excluding the first 3
k' = k obtained from the 20, 40 and 60
minute points only.
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Range of k values for Diabetic and Non-diabetic subjects
Tables Till and IX record brief details respectively of diabetic
and non-diabetic subjects in the larger series studied by means of the
simple (3 point) test# In each case k has been calculated for both
"total" and "excess" blood glucose.
Figures XXXTIII and XXXIX show graphically the ranges of k
values respectively for "total" and "excess" blood glucose. In each
figure diabetic and non-diabetic ranges have both been shown and k
values (^obtained from the same three blood glucose points - see Table
Til) for Cases 1-24 have also been included.
In this series the main range of k values obtained from "total"
blood glucose figures in diabetics is from 0.20 to 1,01 (one value
lying above this range - k value 1.75) and for non-diabetics is from
0.60 to 2,74 (one value lying below this range - k value O.44).
Using "excess" blood glucose figures the main range of k values
for diabetics is from 0.40 to 2,04 (seven values lying above this,
extending up to 4*08) and for non-diabetics is from 1,52 to 7*41
(three values lying below this, extending down to 0.77)•
In both figures, therefore, there are a few points which lie
somewhat outside the main ranges but the scatter is rather more
pronounced in Figure XXXIX ("excess" blood glucose) than in Figure
XXXTIII ("total" blood glucose). The overlap between diabetic and
non-diabetic ranges is about the same in both Figure XXXTIII and
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Figure XXXIX* Excluding those values well outside the main ranges this
overlap is from 0*60 to 1.01 (39 individuals, 21 diabetics and 18 non-
diabetics) in Figure XXXVIII and from 1*52 to 2.04 (35 individuals, 1?






































































































































































































































































































































































































































































































































































































































































































































































































































































































• its. s.::.::..: •• • • ••
k 0.5 1.0 1.5 2.0 2.5
Figure XXXYIXI. Range of k(total) values for diabetic and non-diabetic subjects, using the
simple test.
U1
k 0,5 1.0 2.0 3.0 4.0 5.0 6.0
Figure XXXIX. Range of k(excess) values for diabetic and non-diabetic subjects,




Duncan (1956a) and Baird and Duncan (l957» 1959) showed that if
k was related to "total" blood sugar it should not alter for different
glucose loads in an IVGTT nor for different fasting blood sugar levels,
they claimed, however, that it did so alter, whereas if "excess" blood
sugar figures were used k remained constant within at least a twofold
variation of glucose dose.
they further showed that following treatment with carbutamide
k obtained from "total" blood sugar figures - k ("total*) - was
improved, whereas k obtained from "excess" blood sugar figures -
k ("excess") - remained the same as before treatment. OGTT blood sugar
curves had the same configuration both before and after treatment
although the curve after treatment was lower. The similarity of
OGTT curves suggested to these workers that no improvement of glucose
tolerance had occurred after treatment and therefore the unchanged k
("excess") was to be preferred to the improved k ("total"). Excess
blood sugar was also used in this way by Jokipi and Turpeinen (1954) 9
Maokler et al. (1952) end Soow and Cornfield (l954)» Bastenie et al.
(1957) found no alteration in k ("total") following carbutamide but
other workers have confirmed Baird and Duncan*s (1957) findings
(Jensen et al. 1958, Pajans and Conn i960, Lundbaek 1962).
There seems no reason, however, why this should not represent
a real improvement in glucose metabolism (Bastenie et al, 1957»
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Jensen et al, 1958, Pajans and Conn i960, Phear 1962), Admittedly
the single OGTT curve illustrated in Baird and Duncan*s (1957) paper
shows an identical rate of fall of blood sugar both before and after
treatment, but in view of the many physiological variables capable of
influencing the OGTT blood sugar curve it seems unwise to place too
much reliance on this one finding,
Amatuzio et al, (1955) used "excess" blood sugar in order to
eliminate any possible errors due to non-glucose reducing substances.
If true glucose is measured, however, there is no need for this
precaution. In any case it assumes that the quantity of non-glucose
reducing substances remains constant during the whole test and this
is probably not so (Mosenthal and Barry 1946),
Another approach was that of Wyngaarden et al, (1957) who
related the disappearance rate from the blood stream of certain
sugars to their chemical structure. The structure of glucose was
said to agree well with its disappearance rate if k ("excess") was
used but not if k ("total") was used.
Both Greville (1943) and ELad et al. (1956, 1959) also used
"excess" blood sugar but in their case the "excess" referred to was
the difference between the observed blood sugar and a mathematical
equilibrium point* This varied from 10 to 70 mg per 100 ml in
different tests - even in -the same individual - and was always less
than the initial fasting blood sugar (S^) in non-diabetics although
usually above it in diabetics. This point was called Soo •
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These workers claimed that their theories could be justified
graphically by actually measuring the slope of an IYGTT blood sugar
curve drawn on linear graph paper# Using this method, determination
of the blood sugar disappearance rate was said to be independent of
any mathematical or theoretical presuppositions. (On the other hand,
although Hlad and Elrick (1959) used a mechanical slope-reader to
obtain accurate figures from their curves, the curves themselves had
to be drawn by eye and were thus liable to error# This criticism
also applies to Greville (1943)®) Using this technique these workers
calculated k in any given IVGTT using all the points between about 5
and 90 minutes# In practice, however, one or two of the early blood
sugar readings were sometimes ignored because of "systematic departures"
(Greville 1945) from a straight line graph. Moreover, in nearly all
cases the blood sugar had fallen to or below by the end of the test#
But it has already been shown (p# 58) that the shape of the
blood sugar (or blood glucose) curve following an intravenous glucose
load is the result of at least four factors - dispersal and equili¬
bration of the injected glucose, urinary loss of glucose, cell metabolism
and final adjustment by normal homeostatic mechanisms# In some oases
a reasonably good straight line serailogarithmic graph between blood
sugar (or blood glucose) and time can be obtained as early as two
minutes after glucose injection (for example, cases 1, 2, 6t 8, 10,
11, 14 of Hamilton and Stein 1942, see also cases 5, 9# 11, 14 and
18 of the present series) and glucose disappearance may in such cases
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be regarded as exponential even at the beginning of the test. This
relationship Bust# however, be broken as soon as glucose appearance
(for example, from glyoogenolysis) recommences. Thus Greville (1943)
and Hlad et al. (1956) obtain values of k based on a composite graph
of all three phases and these values will not necessarily correspond
with the actual rate of cell metabolism.
Section of IVGTT slope used
It is clear that preference for "total" or "excess" blood sugar
will depend largely on the time during which IVGTT blood sugar readings
are considered valid for the calculation of k. It seems reasonable to
ignore the later part of the slope when the "total" blood sugar has
fallen to within 25 or 30 rag per 100 ml of S^. As to the earlier part
of the test Greville (1943) claimed (in spite of an occasional^ poorly-
fitting early point) that the whole slope from as early as five minutes
after gluoose injection could be used, provided that the appropriate
value of Sao was incorporated into the calculation. Analysis of the
mean figures of Greville,s own results (case 27» Table VI) shows,
however, that the SE is considerably smaller (that is, there is a
better straight line fit) when the first one or two points are omitted
than when all valid points are used. Table VI refers, of course, to the
special case when Soo » 0 but Table V shows that the SE is greater
if alternative values for Soo are used.
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Ikkos and Luft (1957) analysed their own and Amatuzio et al,*s
(1955) results arid came to the conolusion that the early part of an
IVGTT blood sugar slope had the features of a double exponential
function, one being concerned with glucose equilibration and the other
with true metabolism. Provided only that part of the slope after about
the 25th minute was considered, there was a good linear relationship
between log "total" blood sugar and time but not between log "excess"
blood sugar and time. They made the point that use of "excess" blood
sugar implied that the body could distinguish between endogenous and
exogenous glucose, whereas Mackler et al. (1952) had previously shown
that it could not. Furthermore, it implied that the fasting blood
sugar can be regarded as a constant base-line throughout the test
which is probably not so (Soskin et al. 1934» Searle and Chaikoff 1952,
Reichard et al. 1958)*
Pryoe (1958) suggested that one reason why k values altered with
different doses of injected glucose might be because larger glucose
loads needed longer to diffuse through the body fluids. Such differences
of k as had been found could perhaps be eliminated if blood sugar measure¬
ments were only made after the 30th minute following glucose injection.
West and Wood (1959) took up this idea and analysed Duncan*s (1956a)
figures. They demonstrated that if only the latter parts of the IVGTT
graphs were considered, (that is, between about 25 and 60 minutes after
glucose injection), k ("total") varied less than k ("excess") even for
a twofold increase in glucose dose. In other words, k ("total") remained
fairly constant within this range provided that comparison was made only
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between those parts of the graphs at comparable blood sugar levels.
Nilsson (1962) in a comparative series also found that k ("total")
was more reliable than k ("excess") if the latter part of the blood
sugar graph was considered. Lundbaek (1962), who also preferred k
("total"), reverted to the use of all available blood sugar readings
from 10 minutes onwards after glucose injection. In his case, however,
a straight line was fitted to the points by eye and this is inevitably
less accurate than mathematical methods.
(it should perhaps be pointed out here that while a number of
variants on the simple exponential equation may be clinically useful
and even highly reproducible, this does not necessarily mean that they
are a true representation of the disappearance of glucose from the
blood (ELad and Elriok 1959).)
It has been suggested that different formulae should be used
for diabetic and non-diabetic subjects (Baird and Duncan 1959).
Certainly, hepatic glycogenolysis is excessive in the diabetic (Baatenia
et al. 1957) In whom, in addition, urinary glucose loss during an
IVGTT will usually be greater than in the non-diabetic. The obser¬
vations of Ikkcs and Luft (1957) also suggest that there is some
essential difference in the nature of glucose removal from the blood
in a severe diabetic from that in a non-diabetic. These workers found
that in non-diabetics there was a good straight line fit of points
after the 25th minute on an IVGTT semilogarithmic graph if "total"
blood sugar was used but not if "excess" blood sugar was used. In
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severe diabetics, however, a reasonably good straight line fit could
be obtained for both "total" or "excess" blood sugar figures. Never¬
theless, while differences in glucose disposal undoubtedly exist, any
attempt to provide alternative formulae for diabetic and non-diabetio
subjects would defeat the primary p\irpose of the IYGTT - that of being
a diagnostic test.
In the present study the use of mathematical methods has shown,
that in most cases no particular section of the IYGTT blood glucose
slppe is consistently and obviously better than any other for the
calculation of the glucose disappearance rate. The same conclusion
is reached for Cases 27 - 33» using blood sugar. Individual graphs
indicate, however, that a calculation of k from best-fitting straight
lines based on all valid points from the 20th minute onwards will
usually represent the slope fairly closely, Hamilton and Stein
(1942) found that in many cases the use of one point more or less
made little difference to the values of k obtained, Ikkos and Luft
(1957) also found that although a simple exponential relationship
between blood sugar and time appeared to exist after the 25th minute
from the time of glucose injection, this again was only a close
approximation. Without further studies it is impossible to be sure
whether these inexactitudes exist because an IVGTT blood glucose or
blood sugar slope on semilogarithmic graph paper is actually a curve
and not a straight line at all in any part, or whether they merely
reflect the inevitable scatter of points on such a graph.
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It is worth remembering again that conclusions based on blood
"sugar" rather than blood glucose figures may be faulty and some at
least of the discrepant views here discussed can perhaps be explained
on these grounds*
"Total" or "Excess" blood glucose
On the question of whether to use "total" or "excess" blood
glucose one can be more definite* Analysis of the individual and
mean blood glucose values obtained in this series shows that even
if all valid points are used in the calculation a better fit to a
straight line is possible in the majority of cases when "total"
blood glucose figures are used* If the first three valid points
are omitted all cases show the superiority of "total" blood glucose*
This is also shown in nearly all of oases 27 - 33* using blood sugar*
Even for the two exceptions to this general finding in the present
study the value for S<=© which gives the minimum SE of points from
the best-fitting straight line is appreciably less than S^.* These
results, therefore, give no support whatever to the practice of
using "excess" (over S^) blood glucose or blood sugar for the
calculation of k*
It can be shown (see pages 170 ff) that negative values of Sao
will give an even smaller SE than Sco= 0* The larger the negative value of
S oo the smaller will be the corresponding SE until SE « 0 when S m «*oo ,
These perfectly fitting blood glucose points would, of course, be in
a horizontal line at a level of + and would be an absurdity for
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any actual IVGTT. In practice, therefore, any possible values of Sm
less than 0 need not be considered.
Simple Test,
Finally, to turn from theoretical considerations to practical
procedures, It has been shown in the present study that use of only
the 20, 40 and 60 minute blood glucose readings in an IYGTT provide
nearly as much information as readings taken every 5 minutes. Values
for k calculated by both methods differ only by an average of 5«7% (*• SO
if "total* blood glucose figures are vised. It is suggested that for a
test of this nature with so many possible variables a difference of
this degree is well within acceptable confidence limits.
If "excess* blood glucose figures are used the values for k
calculated by the two methods differ by an average of 6,6$, The
Standard Deviation from this mean ls±8,5, Both these figures are
greater than those obtained with "total" blood glucose and it would
appear, therefore, that use of "total" blood glucose provides more
reliable and consistent results.
Distribution of k values
Sometimes the normal ranges have been expressed as the means
and Standard Deviations for diabetics and non-diabetics (Baird and
Duncan 1959)* This device assumes that individual k values in these
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two groups ooour in a normal distribution and this is clearly not the
oase if a simple arithmetic scale is used* Figures XXXVIII and XXXIX
show that diabetic k values tend to be crowded together at one end of
the scale while non-diabetic values are scattered over a much wider
range* It would seem that an arithmetic scale is not the ideal* A
difference between two k values of, say, 0*4 is obviously more signif¬
icant at the lower end of the scale than at the upper end and this
proportional relationship would be much better expressed by some
form of geometric or logarithmic scale* An example of such a scale
is shown in Figure XLa and b where k ("total") values for the present
series have been arranged as histograms. It will be seen that taking
the group as a whole, k values fall very nearly into a normal unlmodal
distribution (Figure XLa). More surprisingly, perhaps, if diabetics
and non-diabetics aire considered separately they also form normal
unimodal distributions of their k values (Figure XLb)* A manipulation
of the scale like this makes no difference, of course, to the actual
ranges of k values obtained in a particular series but it does show
more clearly their unbroken distribution from very low to very high,
with a peak in the region of the "overlap" between the two groups.
Such a scale also has the effect of drawing in the few anomalous k
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It Is, perhaps, Inevitable that when testing a physiological
process such as glucose disappearance from the blood a few apparently
anomalous results (in this context, k values well outside the main ranges)
will occur. No satisfactory explanation can be offered. Differences
in the methods of blood collection and blood sugar and blood glucose
estimation in the OGTT and the IVGTT do not appear adequate by them*
selves to account for their occurrencei all the individuals with such
results in the diabetic group were true diabetics by any reasonable
definition, although it is less easy to be so sure about the non-diabetics•
One weakness of the test as reported here is the large number
of results which fall into the overlapping sections of the two
ranges. Lundbaek (1962) reported only a very small overlap in his
series while Amatuzio et al. (1955) found a clear separation. In
view of the apparently unbroken spectrum of "diabeticity" in a large
population it is difficult to see how there can be such an obvious
distinction between diabetics and non-diabetics as these authors
claim * some overlap is almost inevitable. When, however, as here,
- using k ("total") * it inoludes over a quarter of the total number
(39 oasest 21 diabetics and 18 non-diabetics) the technique or the
interpretation of the test may need further scrutiny. Why should
some "OGTT diabetics" have such high k values? Alternatively, why
should some "OGTT non-diabetics" have such low k values? It does not
appear that increasing the number of blood glucose readings from 3
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to 11 would sake any material difference, Of the 13 oases whose
k values fell into the "overlap" range and who also had the longer
(11 point) test none would move upwards or downwards clearly out
of it if k ("total") values based on the longer test were substituted
(see oases 1, 2, 5, 4» 5, 6, 7, 8, 9, 10, 17, 22 and 2J in Table VII).
A number of points may be mentioned. One reason why a diabetic
patient might have a higher than expected k value would be the
continuing effect of previously administered antidiabetic drugs* This
might be the case in 14 subjects in the present series who were receiving
chlorpropamide up to 48 hours before the test* Of these 14 patients
8 had k values within the "over-lap". However, even if these 8
individuals are excluded from the analysis the overlap range (using
k ("total") ) remains the same, namely 0*60 — 1*01, embracing 13 diabetics
and 18 non-diabetics•
Another possible reason for the high k values of the diabetics
in the "overlap" might be that they were all very mild diabetics*
There were, in faot, 6 very mild diabetics (that is, controlled on
diet alone) in the overlap section and one well above it* On the
other hand, there were 9 similarly mild diabetics well below the
overlap, with small k values* Furthermore, the "overlap" group
also included 4 patients who required insulin for adequate control
and could therefore be regarded as at least moderately severe diabetics*
It is said that diabetic-like abnormalities may be found in
non-diabetios as a result of prolonged bed rest (Loeb and Stadler 1914,
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Blotner 1945). In the overlap section 8 non-diabetics were bed-fast.
However, 6 other non-diabetics who were also bed-fast had k values
above the "overlap", (in the case of 5 individuals, only just above
it). 5 bed-fast diabetics (one requiring insulin) also had k values
in or above the overlap,
The age structure of the subjects studied may have a significant
influence on the ranges of k values obtained. In this series it must
be admitted that the two groups were not matched for age, the average
age for all diabetics being 63.7 years and for all non-diabetics
30.9 years. However, one might expect the lower average age of the
non-diabetics to have made a clearer separation between the two groups
•than would have been likely if the groups had been matched. In other
words, any overlap would be reduced and not increased. As a matter of
fact the average ages respectively of diabetics and non-diabetics in
the overlap section are much closer than for -foe two groups taken
altogether, being 65.4 years for diabetics and 59,3 years for non-diabetics.
Furthermore the non-diabetics include in their number three individuals
of 30 years old or less. If these three are excluded, the average age
of the remainder is almost the same as for the diabetics, namely
66,4 years. This, of course, makes the position of these three young
subjects even more anomalous.
It seems clear, in fact, that our main concern should be the
"non-diabetics" with low k values rather than the diabetics with high
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rallies who were, as already stated, true diabetics by any reasonable
definition* These non-diabetics, in common with all other subjects
tested were classified as such on the results of OGTT's* 14 of these
18 subjects in the "overlap" had OGTT blood sugars well below the
levels taken as the upper limits of normal at the various stages of
that test* The 2-hour blood sugar levels in the remaining 4 (oases
95, 94, HI and 114) were borderline* Hone had symptoms referable to
possible underlying diabetes and none had any family history of the
disease* However, 5 other individuals (oases 92, 112, 116, 125 and
151) also had similar borderline 2-hour OGTT blood sugar levels but k
values above the overlap range*
It is known that gluoose tolerance is less when glucose is
given intravenously than when it is taken orally (p*7l)» The 18
individuals with normal OGTT results but IVGTT k values in the "overlap"
may therefore very possibly be those who, while not as yet showing
OGTT abnormality, are on the verge of diabetes* They might thus show
diabetic responses to the slightly more severe strain of an IVGTT*
It is, of course, just this group with equivocal GTT results which
is of most interest to workers in this field* The implication of any
given result in such cases can only be known after prolonged follow
up of large numbers* Longitudinal studies of this type have only
recently been undertaken and may eventually provide satisfactory
answers to the problem, For the time being, therefore, it is
suggested that all OGTT non-diabetics in the "overlap" section of an
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IVGTT series such as this should be classed as diabetic "suspecta".
As explained, there may be any one of a number of possible
reasons (such as prolonged bed rest, chronic illness, old age or
obesity) for a low k value in a particular individual. Nevertheless,
as the same factors can also be present in other individuals without
necessarily producing equally low k values, the term "diabetic suspect"
for the former seems appropriate.
It is possible that valuable prognostic information could be
obtained in such individuals (as also in those mentioned above with
anomalous k values well outside the main ranges) by a study of insulin
levels during an IVGTT or by the use of one or other of the "provocative"
GTT's described earlier. Follow up of this group would be necessary to
discover how many of them actually develop florid diabetes but present
evidence suggests that many will. Meanwhile the existence of these
non-diabetics with k values within the diabetic range does not in¬
validate the general assertion that the IVGTT is to be preferred to the
OGTT as an accurate indicator of carbohydrate metabolism.
Mathematical Note
It has been shown in Figure IV that within the range +J00 to
-300 the further a series of points deviates (in either direotion)
from points lying in a straight line on semilogarithmio graph paper,
the greater is the scatter from best-fitting straight lines passing
through them. In this Figure line A-A represents a simple exponential
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relationship between blood glucose and time of the formt-
log (S - S oq ) « log (SQ • Sw> ) » kt, when Soo « 0.
Lines B-B, B*-B* and BW-BM represent similar relationships when Seo
is respectively -100, -200 and -300, while lines C~C, CM?* and
C-C" represent further series derived from points lying along A-A

















SE from best-fitting straight
lines of points derived from
A-A in Figure IT, for
varying values of S •
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Clearly the maximum possible positive value for S will be
somewhere between Sq and the value of S when t «■ 60, depending on
how many blood glucose points are required for the calculation of k.
On the negative side, however, there is no limit, and any value of
Soo up to - may be used. It can be shown that for a perfect
straight line series (such as A-A) an increasing negative value for
Sto will produce first an increase in the scatter of points from a
straight line, that is, an increasing SE, and then, after reaching a
maximum, a progressive diminution in SE until SE « 0 when •
Table X gives the SE from beat-fitting straight lines of points
derived from A-A in Figure 17, for different values of S<* , and Figure
XLI illustrates graphically the distribution of the same SE values with
Figure XLI. Distribution graph of SE for varying S*,
derived from a straight line series of points.
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Table XI shows the SE from best-fitting straight lines of
points derived from three actual IVGTT results in the present series
(cases, 3» 22 and 26) for different values Soo • Only negative
values of S «*, are shown. Alterations of SE for different positive
values of So, may be seen in Tables IV and Vi in all, increasing Sc
produces an increase in SE, In Table XI all valid points have been
used for the ealoulation in the case of No, 22, while the first three
valid points in each case have been omitted from the calculation in
Nos, 3 and 26, Figure XLII illustrates the approximate distribution
graph of SE for varying S for any one of these three oases. In
this figure both positive and negative values of SM have been
incorporated.
Prom Tables IV, V, XI and Figure XLII it will be seen that the
minimum value for SE is when Sea • «•<*>, On the other hand, Table
X and Figure XLI (for a perfect straight line and figures derived
from it) show two minima, one when S « » 0 and the other when
S co *»-<*> . Thus the graphs of SE against S« derived respectively
from hypothetical and actual IVGTT's are essentially different*
There are two possible interpretations of these findings. The
first is that they may simply reflect the scatter of points on an
actual IVGTT graph compared with the perfect straight line series
in the imaginary test represented by A-A in Figure IV, Increasing
negative values of SM (that is, the addition of increasingly large
numbers to the observed blood glucose readings) would progressively
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No. 22, points 1-11 Nos.3, points No. 26, points 4-10
S «o | SB 3 CO 1 SE So, | SE
0 2.11 0 1.03 0 1.04
-10 2.08 -10 0.97 -10 0.95
-20 2.04 -20 0.96 —20 0.83
ot 2.00 -50 0.95 -30 0.75
-40 1.97 -40 0.90 -40 0.68
-50 1.94 -50 0.87 -50 0.62
-60 1.90 —60 0.85 —60 0.57
-70 1.87 -70 0.82 -70 0.52
-80 1.84 -80 0.80 -80 0.48
-90 1.81 -90 0.78 -90 0.45
-100 1.78 -100 0.76 -100 0.42
-200 1.52 -200 0.60 -200 0.25
-300 1.52 -300 0.50 -300 0.18
-400 1.16 -400 0.42 —400 0.14
... « * • -500 0.37 -500 0.12
... * • • -600 0.35 -600 0.11
... • • • -700 0.29 -700 0.10
... • • • -800 0.27 -800 0.09
• • • #« • -900 0.24 -900 0.08
-1000 0.68 -1000 0.22 -1000 0.07
-5000 0.18 Ml ... ...
Table XX. SB from beat-fitting straight lines of points
derived from actual IVGTT graphs (cases 3, 22
and 26) for varying values of So* .
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smooth out any Irregularities until a perfect straight line is
obtained when S <*> « - °o ,
Figure XLII. Approximate distribution graph of SE for varying Soo
derived from actual IVGTT graphs (Cases 3* 22 and 26).
An alternative explanation, however, is that there is no
straight line section on a semilogarithmic IVGTT graph. That is, that
there is no simple exponential relationship between blood glucose and
the time after glucose injection in an IVGTT. Perhaps a more complex
relationship should be sought.
While, therefore, use of the IVGTT on the assumption that it
represents a simple exponential relationship is convenient in
practice, it is suggested that the ideal interpretation has yet to
be devised. More study, perhaps along the mathematical lines discussed
above, is required before a fully satisfactory answer can be found.
CONCLUSIONS
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1. In the interpretation of the IVGTT, "total" blood glucose
figures should be used rather than "excess" blood glucose.
2. No definite conclusions may be drawn from this study as to
the most appropriate section of the blood glucose curve to be used in
the interpretation of an IVGTT. A straight line fitted to all points
between the 20th minute after glucose injection and the last point
before the blood glucose falls to within 25 mg per 100 ml of the
original fasting figure will represent the results of most IVGTT's
reasonably accurately. The inclusion of one or two points on either
side of this section will, however, usually make little difference.
5. There are physiological and mathematical grounds for
suggesting that no simple exponential relationship between blood
glucose and time after glucose injection exists at any time during
an IVGTT. The assumption of such a relationship is, however,
oonvenient in practice and serves very well for ordinary purposes.
4. Use of blood glucose readings taken at 20, 40 and 60
minutes after glucose injection will provide a result nearly as
accurate as a test involving readings at five-minute intervals. This
simpler test is recommended as a satisfactory substitute for everyday
use.
5. With this technique the main ranges of k ("total")
values in this series yreres» Diabetics, 0.20 to 1*01
Non-diabetics, 0.60 to 2,74
It is suggested that those individuals with k values below 1.01
who are not already diabetic be termed diabetic "suspects".
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Individual case auataarlea and detaila ol glucose tolerance teats
Notes (a) Flood sugar and blood glucose values are expressed In ag
per 100 ml. to the nearest milligramme, (For detailed
technique see pages 88-91 }.
<b) TTrine sugar was estimated by Clinitest tablets and is
recorded simply as 0, Trace, +, 4-f, +++ or 4-H-+,
(o) Times are recorded in hours (after oral glucose) for
0CTT*s and minutes (after the said-point of glucose
infection) for XVGT?'s» F « Fasting,
(a) Blood glucose, k and SE for IFGTT's are recorded for both
"total" — T - and "excess" (over S^) - E - values,
(e) As the blood glucose falls during an TVGTT, k values
arc negative. For convenience, however, they are all
here recorded as positive.
(f) All k and SE values are multiplied by 100,
(g) Blood glucose levels less than 25 ag per 100 ml in
excess of are included in brackets,
(h) Subjects are graded either obese, average or thin and
as either ambulant or non-ambulant.
M.W. Male. 67 yrs. Obese. Ambulant,
Known diabetic for two years. Treated with oral antidiabetic
drugs and diet only.
Time Blood glucose
OGTT not done IVGTT
Using all valid points
Using points 4-11




















E.McD. Female, 67 yrs. Obese, Ambulant,
Osteo-arthritis of both knees. Known diabetic for 6 years*
Treated with diet and oral antidiabetic drugs.
Time Blood gluoose
f E












Using all valid points k 0,86 1.74
SE 2.26 5.48
Using points 4 * 11 k 0.73 1.72
SE 1.44 3.52
Using 20,40, 60 minute points k 0.78 1.85
SE 0.18 2.82
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A.D. Female.58 yrs. Obese.Ambulant,
Known diabetic for 9 years. Father and one sister also have
diabetes. Admitted for investigation of epigastric pain. No




Using all valid points
Using points 4-11






















H.H, Female, 58 yrs. Obese, Ambulant.
Known diabetic for 4 years. Ho family history of diabetes.
Requires insulin for adequate control but not liable to ketosis.
Time Blood gluoose
* E












Using all valid points k 0.86 5.90
SE 5.07 12.10
Using points 4 - 10 k 0.77 4.47
SE 0.31 10.59
Using 20, 40 minute points k 0,74 5.47
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5. M.B. Female, 66 yrs. Obese, Ambulant,
Known dlabetlo for 3 years. Admitted for re-stabilisation.
Requires insulin for adequate control but not liable to ketosis.
Time Blood glucose
OGTT not done IVGTT
Using all valid points
Using points 4-11





















6, G.McR. Male. 61 yrs. Obese. Non-ambulant.
Admitted with popliteal artery embolism following an attack of
paroxysmal supraventricular tachycardia, OGTT showed mild diabetes*
Treated with diet alone.
Time Sugar Time Blood gluoose
Blood Urine T E
OGTT 7 86 0 IVGTT P 94 -
1 210 0 5 329 255











Using all valid points k 1.17 1.98
SE 3.3*. 4.50
Using points 4 - 11 k 0.99 1.82
SE 2.12 4.59
Using 20,40,60 minute points k 0.92 1.73
SE 2.55 6.84
W.W. Hale 77 yrs. Average. Ambulant.
Known diabetic for 14 years. Treated with diet and oral anti¬
diabetic drugs. Admitted for investigation of hepato-
splenomegaly. No definite cause found.
Time Blood gluoose
OGTT not done T E












Using all valid points k 0.83 1.45
SE 1.92 2.79
Using points 4-11 k 0.73 1.54
SB 1.23 2.62
Using 20, 40, 60 minute points k 0.74 1.58
SE l.U 3.46
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C,F, Male* 59 yrs. Average, Ambulant,
Admitted for investigation of intermittent claudication. Found
to have left femoral artery thrombosis. Diabetes found on
routine testing. Treated with diet alone.
Time Sugar Time Blood glucose
Blood Brine T E
OGTT F 152 0 I7GTT F 119 -
1 296 Trace 5 562 243










Using all valid points k 0.91 1.66
SE 4.58 6.57
Using points 4-11 k 0.74 1-47
SE 1.01 2.42
Using 20,40,60 minute points k 0.72 1.45
SE 0.24 1.25
MoA. Male. 74 yrs. Average, Ambulant.
















Using all valid points k 0,65 1.00
SE 1.70 3.15
Using points 4-11 k 0.70 1.14
SE 1.58 2.85
Using 20, 40, 60 minute points k 0.68 1,10
SE 2.93 5.45
P.Bt Male, 66 yrs. Average, Non-ambulant,
Admitted for investigation of weight loss. Diabetes found on
routine testing. Requires insulin for adequate control but
not liable to ketosis.
Time Sugar Time Blood glucose
Blood Urine T E
OGTT P 143 0 IVGTT P 171 4R»
1 252 0 5 428 257










Using all valid points k 0,86 1,88
SE 4.45 6.82
Using points 4-11 k 0,65 1.58
SE 2.53 4.25
Using 20, 40, 60 minute points k 0,72 1.73
SE 3.14 4.81
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A«H. Male. 51 y*s. Thin, Ambulant,
Admitted for manipulation of right shoulder for osteoarthritis.
Known diabetic for 16 years. Requires insulin for adequate
control but not liable to ketosis.
Time Blood glucose
OGTT not done IVSTT
Using all valid points
Using points 4-11




















B«Bjl Female, 58 jrs. Thin. Ambulant,
Admitted with a history of polyuria and thirst for three weeks.
Heavy glycosuria but no ketosis. Requires insulin for control.
Time Sugar Time Blood gluoose
Blood Urine T E
OGTT F 299 -M-++ IVGTT F 192 -
1 440 +++♦ 5 346 154










Using all valid points k 0,64 1.97
SE 1,66 2.J2
Using points 4-11 k 0,55 1.90
SE 1.14 2.16
Using 20, 40, 60 minute points k 0.56 1.91
SE 1.79 1.99
232
IJ. H»D, Male* 46 yra. Obese. Ambulant.
Admitted for investigation of "panic" attacks. No organic
cause found. No previous evidence for or family history of any
diabetic tendency.
Sugar Blood glucose
Blood Brine T E
OGTT P 102 0 IVGTT P 88 me
1 176 0 5 311 223









( 60 94 6 )
Using all valid points k 1.81 5.68
SB 6.15 14.59
Using points 4-10 k 1.65 4.00
SB 4.05 16,10
Using 20, 40 minute points k 1.34 2.73
SB
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A.B. Male, 57 P**3# Average, Ambulant,
Admitted for investigation of "palpitations". No abnormality
found.
Time Sugar Time Blood glucose
Blood Brine T E
OGTT F 106 0 IVGTT F 94 -
1 170 0 5 219 125









( 60 112 18 )
Using all valid points k 1.54 3.24
SE 1.79 7.58
Using points 4-10 k 1.40 3.78
SE 1.51 5.02
Using 20, 40 minute points k 1.55 3.81
SE ** •*
M.3« Hale. 57 yra. Average. Aiabulant.
Admitted following the thrombosis of the superior mesenteric
artery. No previous evidence for or family history of any
diabetic tendency.
Time Sugar Time Blood glucose
Blood Brine T s
OGTT F 84 0 IVGTT P 105 mm
1 122 0 5 428 525










Using all valid points k 1.05 1.60
SE 5.84 5.00
Using points 4-11 k 0.91 1.45
SE 5.58 4.95
Using 20, 40, 60 minute points k 1.02 1.61
SE 2.51 2.10
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D,T« Mala. 25 yrs* Average* Ambulant*
Healthy medical student. No previous evidence for or family-
history of any diabetic tendency.
Time Sugar Time Blood glucose
Blood Urine T E
F 94 0 IVGTT F 05 •
1 155 0 5 270 185










Using all valid points k 1.46 2.80
SE 2.89 9.28
Using points 4 • 11 k 1.56 5.27
SS 2.52 6.49
Using 22, 40i 60 minute points k 1.49 5.21
SS 0.81 9.27
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R»W« Male. 77 yrs. Average. Ambulant.
Glycosuria found on routine testing by General Practitioner, No




Blood Urine T E
F 95 0 IVGTT F 82
1 174 0 5 263 181










Using all valid points k 1.08 1.90
SE 3.66 5.48
Using points 4-11 k 0.98 1.83
SE 3.80 6.38
Using 20, 40# 60 minute points k 0.95 1.73
SE 3.18 13.41
J*S* Male* 68 yra, Average* Ambulant.
Admitted for investigation of intermittent claudication*
Found to have bilateral common iliac artery thrombosis. Ho
previous evidence for or family history of any diabetic tendency*
Time Sugar Time Blood glucose
Blood Brine T B
OGTT F 100 0 IVGTT F 81 •
1 122 0 5 250 169










Bsing all valid points k 1.51 2.48
SB 1.69 6*29
Using points 4 - 11* k 1.58 2*83
SB 1.41 5.74
Bsing 20* 40* 60 minute points k 1.55 2.74
SE 0*24 5.65
J.6, Male, 62 yrs. Average. Ambulant.
Admitted for investigation of intermittent claudication. No
previous evidence for or family history of any diabetic tendency.
Time Sugar Time Blood glucose
Blood Brine T E
OGTT F 100 0 IVGTT F 88 est
1 152 0 5 313 225










Using all valid points k 1.62 5.15
SE 4.30 4.50
Using points 4 * 11 k 1.38 3.10
SE 1.41 4.54
Using 20, 40, 60 minute points k 1.33 3.01
SE 0.24 7.44
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20. B.W. Female. 40 yrs. Average. Ambulant.
Healthy doctor. No previous evidence for or family history of
any diabetic tendency.
Time Sugar Time Blood glucose
Blood Urine T E
OGTT F 76 0 IVGrTT F 85
I 134 0 5 270 185







( 45 80 -5 )
( 50 60 -25 )
( 60 50 -35 )
Using all valid points k 2.13 4.23
SE 6.55 17.23
Using points 4-8 k 2.42 5.64
SE 7.44 19.20
Using 20, 40 minute points k 2.30 5.49
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L*L* Female» 25 yrs. Average* Ambulant.
Healthy laboratory technician. Ho previous evidence for or






y 97 0 IVGTf F 85 m
I 142 0 &€VI 169















Using all valid points
Using points 4-9













PTR. Halo* 65 yrs. Shin* Ambulant.
Admitted for investigation of weight loss* No definite cause
found.
Time Sugar Time Blood glucose
Hood Brine T E
OGTT F 94 0 IVGTT F 113 -
1 170 ++ 5 375 262










Using all valid points k 1.03 1*75
SE 2.11 2.64
Using points 4-11 k 0.98 1.78
SE 1.81 2.58
Using 20, 40, 60 minute points k 0.91 1.65
SE I.64 0.99
M*E« Hale. 59 y10. Thin. Ambulant*
Admitted for investigation of intermittent claudication* No
previous evidence for or family history of any diabetic
tendency*
Time Sugar Time Blood glucos<
Blood Urine s
F 86 0 IVGTT F 60 •
1 140 0 5 250 190










Using all valid points k 0.91 1.28
SB 2.75 3.53
Using points 4 * 11 k 0.85 1.28
SE 2.00 2.99
Using 20* 40* 60 minute points k 0*78 1.19
SB 2.53 3.09
24* B.Mft Hale. 22 yra. Thin, Ambulant.
Admitted for investigation of persistent diarrhoea. No organic
cause found* No previous evidence for or family history of any
diabetic tendency.
Tine Sugar Time Blood glucose
Blood Brine T E
F 106 0 IVGTT F 75 m
1 170 o 5 287 212









( 60 85 10
Being all valid points k 2.08 3.88
SE 6.J1 5*73
Being points 4 - 10 k 1.58 3*48
SE 2.38 4.15
Being 20, 40 minute points k 1.68 3.47
SE «>
















Using all valid points k 0.76 1.77
SE 1.49 1.62
Using points 4 - 11. k O.69 1.75
SE 0.53 1.34
Using 20, 40, 60 minute points k 0.74 1.93
SE 0.47 4.87















60 115 11 )
Using all valid points k 1.65 3.89
SE 1.53 9.04
Using points 4-10 k 1.57 4.37
SE 1.04 8.99
Using 20, 40 minute points k 1.50 3.57
SE m mm '
Mean blood sugar values, k and SE for/non-diabetic patients













( 60 111 22 )
Using all valid points k 1.72 3.46
85 5.36 5.55
Using points 3-9 k 1.52 3.85
SB 0.85 5.77
Using 20, 40 minute points k 1.51 3.18
SE
Mean blood sugar values, k and SE













• 60 171 56
Using all valid points k 0,78 1.75
SE 1.97 2.29
Using points 3-8 k 0,69 1.88
SE 0.53 2.25
Using 20, 44* 60 minute points k 0,71 1.72
SE 0,20 3.34
Mean blood sugar values, k and SE for^/non-diabetic patients











( 60 113 19
Using all valid points k 1.51 5.37
SE 3.70 2.19
Using points 3 » 7 k 1.29 3.38
SE 1.03 1.65
Using 20, 44 minute points k 1.35 3.24
SE «• *•
Mean blood sugar values, k and SE for/cliabetic patients from















Using all valid points k 0.80 1.93
SE 2.78 5.19
Using points 5-9 k 0.70 1.90
SE 1.59 2.92








Mean blood sugar values, k and SE for/non-diabetic patients

















Using points 5-8 * k 1.38 5.83
SE 1.52 2.57
Using 20.5» 55*5# 55*5 minute k 1.59 3.75
points SE 2.66 3.20
S«tU<2A/v
Mean blood sugar values, k and SE for/diabetic patients from
data reported by Bckoa and Luft (1957)*
Using all valid points
Using points J> - 11





















Mean blood sugar values, k and SE for/non-diabetic patients















Using all valid points k 1.55 3.02
SE 1.30 4.04
Using points 3-11 k 1.48 2.95
SE 1.00 3.66
Using 20, 40, 60 minute points k 1.51 5.19
SE 1.38 5.63
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54* M.O'C. Male, 54 yrs. Obese, Ambulant,
Admitted for cholecystectomy (chronic cholecystitis). Glycosuria
noticed on two or three occasions in the previous few years but
no treatment given. Controlled with diet alone.
Time Sugar Time Blood glucose
Blood Urine T E
P 128 0 I7GTT P 65 •
1 220 * 20 133 68
2 205 +-H- 40 122 57
60 100 35
k 0,72 1.67
35» Male, 55 yrs. Obese, Ambulant,
Admitted following severe epistaxis. Known hypertensive, GTT
done routinely. Treated subsequently with diet alone.
Time Sugar Time Hood glucose
Blood Urine T E
P 144 0 IVGTT P 112 -
1 256 0 20 212 100




M.W. Male, 63 yrs. Obese, Ambulant,
Admitted with herpes zoster ophthalmicus. Glycosuria noted on
routine urine testing. Treated with oral antidiabetic drugs
and diet.
Time Blood glucose
OGTT not done T E
IVGTT
Fasting blood sugar on
F 257 -




RJD. Male, 68 yrs. Obese. Ambulant,
New diabetic admitted for stabilisation. Treated with oral
antidiabetic drugs and diet.
Time Blood glucose
T E
OGTT not done IVGTT F 111 -
Fasting blood sugar on 20 166 55




J8. J.W. Hale. 49 yrs. Obese. Ambulant*









39* B.8. Male* 62 yrs. Obese* Ambulant*
Known diabetio* Controlled with oral antidiabetic drugs and diet.
Time Blood glucose








4&* B.F. Hale. 80 yre. Obese. Ambulant.
Admitted for investigation of intermittent claudication.
Known diabetic. Controlled with oral antidiabetic drugs and diet.
Time Blood glucose







41. W.MoD. Male. 81 yrs. Obese, Non-ambulant.
Admitted for treatment of gross "hypostatic" leg oedema. Mild
diabetes found on routine testing. Controlled with oral anti¬




Blood Urine f E
F 110 0 IVGTT F 100 -
1 210 0 20 200 100




42* B.W. Male* 74 y*s. Obese* Non-ambulant.
Admitted for treatment of gangrene of the toes of one foot*
Mild diabetes found on routine testing. Controlled with oral
antidiabetic drugs and diet*
Time Sugar Time Hood glucose
Blood Urine T B
p 84 0 IVGTT P 83 -
1 200 0 20 233 150
2 164 0 40 216 133
60 200. 117
k 0*38 0.63
45* A.W* Male* J6 yrs, Obese* Ambulant*
Admitted for routine herniorrhaphy, Glycosuria noted on ward
testing. No other diabetic symptoms. Requires insulin for
adequate oontrol but not liable to ketosis*
Time Sugar Time Blood glucose
Blood Urine T B
P 128 +++ IVGTT P 300 -
1 190 +++ 20 400 100




44. MtW, Male. 59 y^s. Obese. Ambulant.
Admitted with concussion following a road accident* Had noticed
thirst and polyuria for several months previously. Requires
insulin for adequate control but not liable to ketosis*
Time Sugar Time Blood gluoose
Hood Urine T E
OGTT F 248 +++ rVGTT F 225 mm
1 584 +++ 20 325 100
2 596 +++ 40 500 75
61 275 50
k 0.41 1.71
E.J. Female. 84 yrs. Obese. Ambulant.
Known diabetio. Controlled with oral antidiabetic drugs and diet.
Time Blood glucose
OGTT not done T E






46. P.A. Female. 55 yrs. Obese. Ambulant*
New diabetio. Glycosuria found by General Practitioner at home*
Controlled with oral antidiabetic drugs and diet*
Time Sugar Time Mood glucose
Blood Urine T E
P 220 0 IVGTT T 162 -
1 350 20 275 112
2 310 +++ 40 250 87
60 225 62
k 0.48 1.49
47. J«R* Female* 64 yrs* Obese. Ambulant#
Known diabetic. Controlled with oral antidiabetic drugs and diet*
Time Blood glucose
T E






46. J.0T Female. 52 yrs. Obese. Ambulant.
Admitted for investigation and treatment of incipient gangrene
of the left great toe. Mild diabetes found on routine testing,
Treated with diet alone.
Time
OGTT
Sugar Time Blood glucose
Blood Urine T E
F 160 Trace IVGTT F 83 •
1 540 0 20 373 290
2 500 TTTT 40 350 267
60 333 250
k 0.32 0.42
49* J.0*T. Female. 60 yrs. Obese. Ambulant.
Admitted for tonsillectomy. Glycosuria noted on ward testing.
Treated with diet alone.
Time Sugar Time Hood glucose
Blood Urine T E
F 126 0 IVGTT F 100 -
1 312 0 20 450 350




50. S»C. Female. 71 yrs. Obese. Ambulant,
Admitted following thrombosis of the posterior inferior
cerebellar artery. Glycosuria noted on ward testing.
Controlled with oral antidiabetic drugs and diet.
Time Blood glucose
T E
OGTT not done IVGTT F 166 -
Fasting blood sugar on 20 535 167
admission, 156 mg/lOOml. 40 500 134
60 235 67
k 1.01 2.50
51. M.O. Female. 49 y*s. Obese* Ambulant*
Known diabetic. Controlled with oral antidiabetic drugs and diet.
Time Sugar Time Blood gluoose
Blood Brine T E
F 123 0 IVGTT F 120
1 216 0 20 227 107




52. Mis. Female. J6 yxs. Cbeae, Ambulant,
Admitted for treatment of duodenal ulcer. Glycosuria noted on
ward testing. Controlled with oral antidiabetic drugs and diet,
Time Blood glucose
T E
OGTT not done IVGTT F 228 -
Fasting blood sugar on 20 370 142
admission, 264 mg/100 ml. 41 357 129
60 342 114
k 0.23 0.56
53* M,B, Female, 69 yrs. Obese, Ambulant,
Admitted with severe Trichomonas vaginitis and endogenous
depression. Mild diabetes found on routine testing. Treated
with diet alone.
Time Sugar Time Blood gluoose
Blood Urine T S
F 150 0 IVGTT F 125 -
1 - 0 20 185 60




54• M*Q* Female. 64 yrs, Obese* Non-ambulant*
Admitted with vomiting and abdominal pain* Barium meal
suggestive of pyloric stenosis* Condition settled with
conservative measures* Glycosuria noted on ward testing*
Treated with diet alone*
Time Sugar Time Hood glucose
Blood Urine T £
F 130 0 IVGTT F 100 -
1 236 + 20 300 200
2 140 Trace 40 250 150
60 150 30
k 1.75 3*47
55* A«I>. Female* 75 yrs. Obese* Non-ambulant*
Admitted for excision of multiple small epitheliomata on both
legs* Glycosuria noted on ward testing* Treated with diet alone*
Time Sugar Time Blood glucose
Blood Urine T £
F 156 Trace IVGTT F 100
1 504 0 20 200 100




56. M.S. Female 72 yrs. Obese. Non^-ambulant.
Admitted for treatment of igchaemic ulcer of right second toe.
Known diabetic controlled with oral antidiabetic drugs and diet.
Time Sugar Time Blood glucose
Blood Urine T E
F 150 0 I7GTT F 100 -
1 224 0 21 200 100
2 178 0 40 190 90
60 180 80
k 0.28 0.56
57« M«R. Female, 71 yrs. Obese. Ambulant,
Known diabetic. Requires insulin for adequate control but not
liable to ketosisi.
Time Sugar Time Blood glucose
Blood Urine T E
0GTT F 190 0 IV0TT F 100 -
1 m «■» 20 360 260




58, F,M, Female, 75 y*s. Obese, Ambulant,
Admitted for investigation of recurrent "transient cerebral
isohaemic attacks", Known diabetic. Requires insulin for
adequate control but not liable to ketosls.
Time Sugar Time Blood glucose
Blood Urine T E
p 124 0 IVCTT F 80 -
1 220 0 20 140 60
2 210 0 40 150 50
60 120 40
k 0.45 1.11
59, S,C, Female. 65 yrs. Obese. Ambulant,
Known diabetic. Requires insulin for adequate control but










60# H«H. Female, 58 yre. Obese. Ambulsni,










61. W,G, Male. 63 yrs. Average, Ambulant,
Known diabetic with diabetic pseudo-tabes. Controlled with
oral antidiabetic drugs and diet.
Time Sugar Time Hood glucose
Blood Urine T E
OGTT F 158 Trace IVGTT ? 87
1 230 Trace 20 225 138




M.W, Male# 39 yrs. Average, Ambulant*
New diabetic, complaining of thirst and polyuria. Admitted for
stabilisation. Controlled with oral antidiabetic drugs and diet,
Time Blood glucose
T E
OGTT not done IVGTT P 125 -
Pasting blood sugar on 20 200 75
admission, 144 mg/lOQ ml. 40.5 195 70
60 180 55
k 0.26 0.77
S,S, Male, 57 yrs. Average, Ambulant,
Glycosuria found on routine testing while under investigation for
hypertension. Diabetes controlled with oral antidiabetic
drugs and diet.
Time Sugar Time Blood glucose
Hood Urine T E
P 90 0 IVGTT ? 64 «*
1 200 i i» »TTTT 20 143 78




64* ?Mai©, 79 yrs, Average, Koja-ambuiant#
Admitted for treatment of ischaemie log pain and aneurism of
the popliteal artery, GTT done as roritine, Mild diabetes
treated with diet alone,
Time Sugar Time Blood glucose
Blood Urine T E
p 144 0 IVGTT P 150 <m
1 280 0 22 300 150
2 200 0 45.5 270 120
65 240 90
k 0,46 1.24
65. J.B. Male, 61 yrs. Average, tfon-ambulant.
Admitted following a cerebrovascular accident and embolism of
the popliteal artery in the paralysed leg, GTT done as routine.
Mild diabetes treated with diet alone.
Time Sugar Time Blood glucose
Blood Urine T E
P 126 0 IVGTT P 166 -
1 250 0 20 566 200




66. T.O'C. Male, 67 yrs. Average. Non-ambulant.
Admitted for investigation and treatment of intermittent
claudication. GTT done as routine. Mild diabetes treated
with diet alone.
Time Sugar Time Blood glueose
Blood Urine T E
OGTT P 96 0 I7GM P 57
1 220 0 20 186 129
2 163 0 40 157 100
60 132 75
k 0,86 1.36
P'HcC. Male. 62 yrs. Average, Ambulant.
Known diabetic. Requires insulin for adequate control but
not liable to ketosis.
Time Sugar Time Blood glucose
Hood Urine T E
P 270 0 IVGTT P 187 m
1 590 20 500 112




S.Vf. Male. 32 yrs. Average. Ambulant.











59 yrs. Average. Ambulant.
Complained of pruritus vulvae. Glycosuria found on routine
urine testing* Diabetes controlled with oral antidiabetic
drugs and diet*
Time Sugar Time Blood glucose
Hood Urine T E
y 186 0 IVGTT y 162 -
1 300 « «- *-ITT 20 400 258




70* S»R. Female# 45 y*s. Average. Ambulant.
Known diabetic. Requires Insulin for adequate control but not
liable to ketosis.
Time Sugar Time Blood glucose
Blood Urine T E
OGTT F 160 0 IVGTT F 160 -
1 550 0 20 272 Ill
2 280 0 40 244 84
60 222 61
k 0.51 1.49
71. G.W. Male. 65 yrs. Thin. Ambulant.
Admitted for investigation and treatment of intermittent
claudication* GTT done as routine. Mild diabetes treated
with diet alone.
Time Sugar Time Blood glucose
Blood Urine T E
F 102 0 IVGTT F 110
1 230 Trace 20 520 210




72, J*S* Male. 46 yrs. Thin. Ambulant,
New diabetic. Complained of thirst and polyuria. Controlled
with oral antidiabetic drugs and diet.
Time Sugar Time Blood glucose
Blood Brine T E
OGTT ? 266 -HHH- I7GTT F 200 -
1 440 -HHH- 21 542 142
2 410 +-Hh+ 42.5 315 115
61 271 71
0.58 1.71
75* H.W, Hale, 78 yrs. Thin, Ambulant.
Known diabetic. Controlled with oral antidiabetic drugs and
diet.
Time Blood glucose
OGTT not done T E
IVGTT ? 200 m
25 280 80
42 240 40
( 60 220 20 )
k 0.Q1 4.08
273
74* V*H. Male. 61 yrs. Thin. Non-ambulant.
Admitted following aoute myocardial infarction. Glycosuria
noted on routine ward testing. Controlled with oral anti¬
diabetic drugs and diet.
Time Blood gluoose
T E
OGTT not done IVGTT P 160 -




75* J*J. Male, 65 yrs, Shin, Non-ambulant,
Admitted with chronic nephritis. Glycosuria noted on routine
ward testing* Mild diabetes treated with diet alone.
Time Sugar Time Blood gluoose
Blood Urine T E
P 126 0 IVGTT P 100 m
1 148 0 20 500 200




J.N. Male. 65 yrs, Thin, Non-ambulant.
Admitted for investigation and treatment of intermittent
claudication, GTT done as routine. Mild diabetes treated with
diet alone.
Time Sugar Time Blood glucose
Blood Brine T E
F 120 0 IVGTT F 200 -
1 204 Trace 18.5 350 150
2 220 ++ 40 130
60 320 120
k 0.22 0.54
F.T. Male. JO yrs. Thin. Ambulant.
Admitted for investigation of "weak legs", No abnormality found.










704 R.M. Male. 79 y^s» Thin, Ambulant,
Known diabetic. Requires insulin for adequate control, Liable
to ketosis.
Time Blood glucose







79* jjtiu Male, 72 yrs. Thin, Ambulant,
Admitted with a history of several "little strokes". Glycosuria
found on routine ward testing. Requires insulin for adequate
control. Liable to ketosis.
Time Sugar Time Blood glucose
Blood Urine T £
P 300 411" 1 > rVGTT P 237
1 540 ++++ 21 387 150




80. F.H. Female. 81 yrs, Thin. Hon-anbulant.
Admitted for treatment of gangrene of both feet. Mild diabetes
found on routine GTT. Treated with diet alone.
Time Sugar Time Blood glucose
Blood Brine T E
F 92 0 IVGTT F 92 m
1 260 0 26 216 124
2 200 0 40.5 191 99
66 183 91
k 0.59 0.74
81* R.B. Female. 26 yrs. Thin. Ambulant,










82, M.S. Female, JO yrs, Thin, Ambulant,
Hew diabetic, presenting with thirst and polyuria, Requires
insulin for adeqxi&te control. Liable to ketosis.
Time Blood glucose
T E
OGTT not done. 3TGTT F 337 -
Fasting blood sugar on 25.5 500 165
admission, 540 mg/100 ml. 40 462 125
61 437 100
k 0.55 1,29
8J, C,V, Female. 66 yrs. Thin, Ambulant.
Known diabetic. Requires insulin for adequate control. Liable
to ketosis.
Time Blood glucose








84. J»W. Male, 65 yrs. Obese. Ambulant.
Admitted for investigation of peripheral neuritis. No
previous evidence for or family history of diabetes.
time Sugar Time Blood glucose
Blood Brine T 3
F 90 0 I7GTT F 70 -
1 144 0 20.5 140 70
2 102 0 40 110 40
60 100 30
k 0.87 2.20
85. A.S. Male. 30 yrs. Obese. Ambulant.
Admitted for investigation of obesity and aene. Cushing's
syndrome excluded. No previous evidence for or family history
of diabetes.
Time Sugar Time Blood glucose
Blood Brine T B
F 94 0 htgtt f 95 -
1 132 0 20 165 70




86, T.D. Male, 65 yrs. Obese. Non-ambulant,
Admitted for investigation and treatment of lschaeraic leg pain.
No previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
F 90 0 ITOTT F 75 -
1 180 0 20 450 575
2 94 0 40 300 225
62 150 75
k 2.65 5.89
®7* J«C» Male, 83 yrs. Obese, Non-ambulant,
Admitted for investigation and treatment of ischaemic leg




Blood Brine T E
F 74 0 IVGTT F 89 mm
1 126 0 20 166 77




88. E,W. Female, 57 yrs* Obese, Ambulant,
Admitted for treatment of extensive psoriasis. Ho previous
evidence for diabetes. Mother had diabetes.
Time Sugar Time Blood glucose
Blood Brine T £
OGTT F 100 0 IVGTT F 80 -
1 140 0 24 253 153
2 88 0 44 130 100
60 160 80
k 1.06 1.82
89. M.K, Female, 33 yrs. Obese. Ambulant.
Admitted for treatment of "varicose" ulcers of both legs. Ho
previous evidence for diabetes. Mother had diabetes.
Time Sugar Time Blood glucose
Blood Brine T £
OGTT F 100 0 IVGTT F 86 -
1 100 0 20 200 114




90. A,H. Female. 50 yrs. Obese. Ambulant.
Admitted for investigation and. treatment of intermittent
claudication. No previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Blood Urine T £
F 98 0 I7GTT F 110 -
1 144 0 20 306 196
2 116 0 40 237 127
61 175 65
k 1.36 2.70
91. D.X* Female. 38 yrs. Obese. Ambulant.
Admitted for investigation of "blackouts". No organic cause
found. No previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
OGTT
Blood Urine T £
F 94 0 ITOTT F 75 -
1 122 0 21 210 135




E.C, Female, 53 yrs, Obese, JTcn-ambulant•
Admitted for investigation and treatment of ischaeuiic leg ulcers.
No previous evidence for or family history of diabetes.
Time Sugar Time Hood glucose
Blood Brin© T E
F 112 0 IVGTT F 100 -
1 130 0 20 275 175
2 120 0 40 200 100
60 150 50
k 1,52 3.13
E,B. Female. 72 yrs. Obese. Non-ambulant.
Admitted for investigation and treatment of ischaemlc foot
ulcers. No previous evidence for or family history of diabetes.
Time Sugar Time Hood glucose
Hood Brine T E
OGTT F 86 0 IVGTT F 78 «*
1 116 0 20 187 109




94# AtO'fl. Female. 75 Obese. Non-ambulant.
Admitted for investigation end treatment of ischaeraic pain in
the foot. No previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
F 80 0 IBGTT F 61 -
1 110 0 21 153 72
2 125 0 40 111 50
60 100 59
k 0.74 1.58
95. M.D. Female. 62 yrs. Obese* Non-ambulant.
Admitted for investigation and treatment of intermittent
claudication. No previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
F 92 0 IFGTT F 100 -
1 176 0 20 200 100




?.G. Male. 55 Average. Ambulant.
Glycosuria noted after routine herniorrhaphy operation. No
previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
F 94 0 I7GTT F 89 4*
1 128 0 20 233 144
2 80 0 40 155 66
( 61 111 22 )
k 2.05 3.87
J«*w"» Male. 44 yrs. Average. Ambulant,
Admitted with massive angioneurotic oedema. Known to have had
glycosuria for at least ten years. No other evidence for or
family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
F 62 Trace IVGTT F 100 -
1 84 + 20 200 100
2 60 ++ 40 140 40
60 130 30
k 1.08 3.01
98* J«<?« Male* 61 yrs, Average* Ambulant*
Admitted for investigation and treatment of intermittent
claudication* No previous evidenoe for or family history of
diabetes*
Time Sugar Time Blood glucose
Blood Urine T E
OGTT P 102 0 IVGTT F 88 m*
1 180 0 20 222 134
2 100 0 40 177 89
60 133 45
k 1.28 2.73
99* H*N» Male. 16 yrs. Average. Ambulant,
Admitted for investigation of KLeine-Levin syndrome. No




Hood Urine T E
F 86 0 IYGTT P 66 mm
1 120 0 20 128 62




100, J.R, Male, 61 yrs. Average. Ambulant,
Admitted for investigation and treatment of intermittent
claudication, No previous evidence for or family history of
diabetes.
SugarTim© Time Blood glucose
O&TT
Blood Urine T E
F 90 0 IVGTT F 62 «*»
1 130 0 20 150 88
2 70 0 40 137 75
( 61 75 15 )
k 0.44 0.77
101, F«M. Male, 21 yrs. Average, Ambulant,
Healthy medical student. Ho previous evidence for or family
history of diabetes*
Time Sugar Time Blood glucose
Blood Urine T E
0GTT F 119 0 IVGTT F 87 «■»
1 119 0 20 214 127




102, 0,T), Mats, 21 yrs. Average. Ambulant,
Healthy medical student. Ho previous evidence for or family
history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T 2
p 88 0 IVGCT P 87 •
1 132 0 20 175 88
2 90 0 40,5 1X7 50
( 60 81 • 6 )
k 2.15 6.01
105, W,A« Male. 21 yrs. Average, Ambulant,
Healthy medical student. Ho previous evidence for or family
history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
P 94 0 IVGTT P 71 M
1 104 0 20 157 86
2 &B 0 41 117 46
( 61 85 14
k 1.40 5.00
288
104# J.MoD. Male# 24 yra# Average* Ambulant#
Admitted for investigation of hypertension. Mo previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
p 112 0 ITOCT P 77 -
1 103 0 20 215 138
2 105 0 40 182 105
60 155 78
k 0.B9 1*58
105. H.J# Male. 52 yrs. Average# Ambulant#
Admitted following a mild, cerebrovascular accident# Ho
previous evidence for or family history of diabetes#
Time Sugar Time Blood glucose
mood Urine T E
p 112 0 IVGTT P 90 •
1 154 0 20 200 110




206. U,R« Male. 46 yra. Average. Ambulant.
Admitted following a syncopal attack. Ho previous evidence for
or family history of diabetes.
Time Sugar Time Blood glucose
OGTT
Blood brine T s
F 110 0 IYGTT F 70 -
1 114 0 20 150 30
2 63 0 40 1X0 40
( 60 80 10 )
k 1.55 5*47
107. J.T»« Mai®. 48 yrsm Average, Ambulant.
Admitted for medical treatment of duodenal ulcer. Ho previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
P 98 0 IVGTT F 70 -
1 140 0 20 200 150




108* J.Cfc Male, 54 y^'s. Average, Ambulant.
Admitted for investigation of recurrent transient cereoral
iach&e&ic attacks. Found to have carotid stenosis. Mo previous
evidence for or family history of diabetes.
Time Sugar lime Hood glucose
Blood Urine T S
OGTT F 94 0 XVGfT F SO
1 166 0 20 160 30
2 108 0 40 120 40
60 110 30
k 0.94 2.45
109, W.H. Male. 64 yrs. Average, Mon-ambulant.
Admitted for treatment of femoral artery aneurism. Ho previous
evidence for or family history of diabetes,
Vim© Sugar Time Hood glucose
Blood Urine T 5
0GTT F 106 0 ITOTT P 64 «f»
1 128 0 20 210 146




110. T.M, Male. 61 yrs. Average, Non-ambulant.
Admitted for investigation and treatment of ischaeraic pain In
the foot. Ho previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
p 102 0 I70TT P 86
1 175 0 20 235 149
2 100 0 40 192 106
60 I64 73
k 1.02 1,79
111. H.0*R. Hale. 65 yrs. Average. Ron-ambulant.
Admitted for surgical treatment of aortic aneurism. Ho previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
P 116 0 I7GTT P 75 -
1 160 0 20 183 108




112« D.,s> Mala, 46 yts, Average, Hon~aabalant«
Admitted during an exacerbation of chronic bronchitis, No
previous evidence for or family history of diabetes.
Time Sugar Time Mood glucose
Blood Urine T E
F 74 0 IFC-TT F 80 •
1 180 0 20 260 180
2 124 0 41 213 133
60 173 93
k 1.02 1.63
113# W.B, Male, 62 yra. Average, Koa-ambulaat,
Admitted for investigation and treatment of intermittent
claudication. Ho previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Hood Urine T E
F 66 0 IF8TT F 115 -
1 116 0 23 225 110




114. A»C« Halo. 75 yrs. Average. Non-ambulant.
Admitted lor investigation, and treatment of iaehaeiaic pain in
both. feet. No previous evidence for or family history of diabetes,
lime Sugar rime flood glucose
flood Urine T E
F 106 0 IVO'i'T F 83 *
1 180 0 20 185 100
2 122 0 40 166 83
60 133 50
k 0.80 1.73
115. S.g. Female. 54 yrs. Average. Ambulant.
Admitted for investigation of low back pain. No previous
evidence for or family history of diabetes.
Time Sugar Time Blood gluGOse
Blood Urine T E
0GTT F 64 0 IVGTT F 100 m
1 66 0 23 211 ill
2 56 0 40 166 66
( 60 111 11 )
k 1.39 3.01
294
116. E.B. Female. 37 yrs. Average. Ambulant#
Admitted for treatment of disc sciatica. No previous evidence
for diabetes. Had had two children with birth weights of 15 and
10+ lbs, respectively.
Time Sugar Time Blood glucose
Blood Urine T E
F 86 0 rVGTT F 78 mm
1 128 0 20 206 128
2 124 0 40 178 100
60 134 56
k 1.09 2.09
117. E.P. Female. 55 y^s. Average. Ambulant.
Admitted for investigation of recurrent leg cramps. No previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
0GTT F 100 0 IVGTT F 80 mm
1 120 0 20 200 120
2 66 0 40 125 45
( 60 100 20
k 2.35 4.90
295
118. M<C» Female. 52 yrs, Average. Ambulant.
Under treatment for pruritus vulvae. No previous evidence for




Blood Urine T E
F 100 0 IVGTT F 75
1 140 Trace 20 200 125
2 116 0 40 150 75
61 112 57
k 1.41 2.95
119. M.G. Female. 56 yrs. Average. Ambulant.
Admitted for investigation of recurrent abdominal pain. No
previous evidenoe for or family history of diabetes.
Time Sugar Time Blood glucose
OGTT
Blood Urine T E
F 70 0 IVGTT F 88 -
1 133 0 20 178 90
2 114 0 40 122 34
( 60 111 23 )
k 1.87 4.82
296
120. J.F. Female. 16 yrs. Average. Ambulant.
Admitted for investigation of recurrent abdominal pain. No
previous evidence for or family history of diabetes*
Time Sugar Time Blood gluoose
Blood Brine t E
f 86 0 IVGTT f 83 mm ■
I 86 0 20 235 150
2 96 0 40.5 185 100
61 150 67
k 1.08 1.98
121. J.M. Female. 21 yrs. Average. Ambulant.
Healthy medical student. No previous evidence for or family
history of diabetes*
Time Sugar Time Blood glucose
Blood Brine t E
f 94 0 I7GTT f 62 -
1 98 0 21 175 115
2 68 0 40 106 44
(60 75 15 )
k 2.64 5.00
297
122. M*T« Female. 56 yxa. Average. Ambulant.
Admitted for investigation of paraesthesiae in both feet. No
organic cause found* No previous evidence for or family
history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T £
F VO<X\ 0 3VGTT F 100 -
1 180 0 21 270 170
2 114 0 40 225 125
66.5 185 85
k 0.85 1.52
125. A.V. Female, 49 yrs. Average. Ambulant.
Admitted for investigation of thirst and polyuria* No
abnormality found. No previous evidence for or family history
of diabetes.
Time Sugar Time Blood glucose
Blood Urine T £
OGTT F 112 0 I7GTT F 50 -
1 140 0 20 225 175




124. F.C. Male. 45 y*s. Thin. Ambulant.
Admitted for investigation of fainting attacks. No previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
F 92 0 ITOTT F 66 eta
1 140 0 20 233 167
2 94 0 40 189 122
60 153 67
k 1.40 2.29
125. P.O. Male. 69 yrs. Thin. Ambulant.
Admitted for amputation of the leg for severe ischaemic pain.
No previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
F 92 0 IV0TT F 100 •
1 170 0 20 550 250




126. J,M» Male. 64 yrs, Thin. Ambulant.
Admitted for treatment of ischaemic leg ulcer. Ho previous
evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
F 93 0 IFGrTT F 87
1 150 0 20 257 150
2 78 0 40 187 100
60 162 75
k 0.88 1.78
127. C.D. Hale. 54 yrs. Thin. Ambulant.
Admitted for investigation of reourrent cerebral transient
ischaemic attacks. Found to have oarotid stenosis. Ho
previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Urine T E
OGTT F 110 0 I70TT F 78 -
1 168 0 20 178 100
2 90 0 40 134 56
(60 95 17 )
1.44 2.95
500
128. R«S» Male. 44 yrs. Shin. Ambulant.
Under treatment for pruritus ani. No previous evidence for
or family history of diabetes.
Time Sugar Time
Blood Urine















129. P.R. Male. 64 yrs. Thin. Ambulant.
Under treatment for disc sciatica. Found to have glycosuria on
one occasion on routine testing. No previous evidence for or
family history of diabetes*
Time Sugar Time Blood glucose
Blood Urine T E
p 93 0 IVGTT P 100 .
1 120 0 20 535 233




130. G.W. Male, 73 F8, Thin. Ambulant.
Admitted for investigation and treatment of intermittent
claudication. Ho previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Blood Brine T B
p 80 0 IVGTT P 115 -
1 148 0 20 425 310
2 110 0 40 525 210
60 275 160
k 1.22 1.80
131. H.M. Male. 45 yrs. Thin. Ambulant,
Admitted for investigation of chronic diarrhoea. Ho organic
cause found. Ho previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
P 110 0 I7BTT P 100 -
1 180 0 20 200 100




132, J.D. Male. 75 y^s. Thin, Non-ambulant,
Admitted for investigation and treatment of ischaemic pain in
both legs. No previous evidence for or family history of diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
p 83 0 IVGTT P 62 •
1 155 0 20,5 169 107
2 80 0 40,5 137 75
60.5 112 50
k 1*03 1.90
133* W«T, Male, 67 yrs. Thin. Non-ambulant,
Admitted for Investigation and treatment of ischaemic pain in
the left foot. No previous evidence for or family history of
diabetes.
Time Sugar Time Blood glucose
Blood Brine T E
P 105 0 IVGTT P 63
1 180 0 20 175 112
2 90 0 40 150 87
60 157 74
k 0,60 1,02
